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IV. Summary 
Pseudomonas aeruginosa is a threatening opportunistic pathogen that causes severe acute and 
chronic nosocomial infections in immunocompromised and catheterised patients. It is prevalent in 
burn wound infections and is generally multi-drug resistant. Understanding the genetic programs 
underlying infection is essential to develop highly needed new strategies for prevention and therapy.  
Global transcriptomic analysis of P. aeruginosa infecting various hosts was carried out. In vivo gene 
expression was successfully performed by developing accurate, specific technical procedures for 
sample collection, transportation and microarray preparation. The protocol was developed on burn 
wound infection samples and subsequently used for the analysis of CF patient sputum samples, as 
well as for lettuce and mouse tumour infection models. Gene expression of three multi-drug 
resistant P. aeruginosa burn wound isolates was profiled across all infection conditions and non-
infection controls (planktonic and biofilm growth on rich LB medium). The transcriptomic analysis 
suggested that the main factors expressed by P. aeruginosa upon infection of burn wounds are iron 
and zinc acquisition as well as alginate production. The bacterial state during burn wound infection 
was not fully acute, with bacterial cells undergoing serious iron limitation and having a slower 
metabolism. Iron acquisition and alginate production were shown to be important mechanisms 
common among the infection conditions studied, namely burn wound, CF patient and mouse tumour 
model.  
Two models for P. aeruginosa infection were tested. The tumour mouse model is a promising 
mammalian infection model whereby P. aeruginosa exhibits anaerobic growth, biofilm formation and 
expresses the type III secretion system. This model is being further tested in order to assess if it can 
be used as a chronic infection model. The plant infection model using lettuce leaves may be useful 
for the study of certain factors such as QS systems, but yielded different results as compared to the 
real mammalian infections and cannot therefore be used as a reliable infection model. 
The multivariate statistical analysis of the combined expression data shows that the burn wound 
infection is most closely related in its global expression profile to the tumour infection model among 
all of the conditions. All tested infection and control conditions were statistically different from each 
other. 
Finally, the Quorum Sensing (QS) inhibitory potential of a promising novel anti-pseudomonas 
compound, protoanemonin, was thoroughly tested. Its presence caused not only inhibition of QS but 
also induction of iron starvation regulated genes in P. aeruginosa.  
The features observed and data generated here on P. aeruginosa upon infection of a host, provided a 
number of leads that can be considerably extended in future work. The effect of zinc and the 
regulation of zinc response may be a promising new path to understand and combat virulence of P. 
aeruginosa. In addition to the zinc effect and proposed targets such as glycine betaine production 
enzymes, there are a number of hypothetical unknown factors which may play a crucial role in 
infection. Examples are the proteins coded by the cluster PA4063-65 and PA4834-37, putatively 
coding for a novel siderophore system.  
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The analysis of the gene expression data from the work presented here thus provided a wealth of 
new insights and established a foundation for future work directed at the understanding of P. 
aeruginosa infection and at finding new prevention and treatment strategies. 
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1. Introduction 
1.1. Pseudomonas aeruginosa: a dangerous opportunistic pathogen 
Pseudomonas aeruginosa is a Gram-negative polar flagellated rod which is a member of the  
γ-proteobacteria group (Olsen et al., 1994). It is widespread in nature and can be found 
inhabiting many environmental niches such as water, soil, plants and animals. P. aeruginosa 
is also an important opportunistic pathogen that can cause both acute infections in severe 
burns and urinary tract immunocompromised patients and also chronic infections in the 
lungs of patients with the genetic disease cystic fibrosis (Chugani & Greenberg, 2007). P. 
aeruginosa deriving from the patient’s own endogenous gastrointestinal microbiota or from 
an environmental source are the most common causes of burn wound infections in many 
burn wound centres (Altoparlak et al., 2004). Hospitals often harbour multi-resistant strains 
of P. aeruginosa which have been detected from hospital floors, bed rails, sinks and from the 
hands of medical personnel (Chitkara & Feierabend, 1981). Multi-drug resistant clones can 
remain in the hospital for many years because of transfer from patient to patient (Hsueh et 
al., 1998) and the high percentage of patient mortality and morbidity render P. aeruginosa 
as one of the major nosocomial pathogens (Altoparlak et al., 2004). Data collected over 
three years from the Centre for Burn Treatment in Siemianowice Sląskie (Poland) shows that 
both P. aeruginosa and Staphylococcus aureus are the major strains isolated from burn 
wounds (Table 1-1). Moreover, the antibiotic resistance of the clinical strains of P. 
aeruginosa is increasing with time (Table 1-2), which clearly complicates their eradication. 
Diseases caused by P. aeruginosa are multifunctional and are connected with the production 
of several virulence factors (Lee et al., 2006). Virulence factors and their role in infections 
have been studied for many years using a number of animal models. However, the 
correlation of the results obtained from the animal model generally diverged considerably 
from those of clinical infections (Rumbaugh et al., 1999). In 1975, Stieritz and Holder 
developed a burn mouse model that was clinically relevant to burn wound sepsis. That 
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model was used to examine and identify a number of virulence factors and regulators that 
are now known to play an important role in burn wound infections (Saelinger et al., 1977, 
Pavlovskis & Wretlind, 1979, Nicas & Iglewski, 1985, Arora et al., 2005). These virulence 
factors can be differentiated into either cell associated factors such as adhesins, alginate, 
pili, flagella and lipopolysaccharides or extracellular factors such as elastase, exoenzyme S, 
exotoxin A, hemolysins, iron-binding proteins, leukocidins and proteases (Tredget et al., 
2004, Church et al., 2006). It has only been more recently, with the development of medium 
and high-throughput gene expression techniques, that the dynamics and regulation of those 
virulence factors could be studied in the context of different infection models. 
Table 1-1: Number of patients with nosocomial infections and percentage of pathogens isolated from burn 
wounds at the Centre for Burn Treatment, Siemianowice Śląskie, Poland (Bielecki et al. 2008). 
Number of patient with 2003  2004 2005 
Burn wounds 468 437 490 
Nosocomial infections 207 135 191 
Microorganism    
Pseudomonas aeruginosa 27 37 26 
Staphylococcus aureus  27 (19 MRSAa) 26 (13 MRSAa) 30 (11 MRSAa) 
Acinetobacter baumannii  20 12 14 
Proteus mirabilis  10 11 11 
Escherichia coli 4 5 6 
Klebsiella pneumoniae 5 5 4 
Streptococcus pyogenes 3 2 5 
Enterococcus faecalis 4 3 3 
Candida spp. 0 1 0 
a - Staphylococcus aureus MRSA- Methicillin-resistant Staphylococcus aureus 
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Table 1-2: Percentage of P. aeruginosa clinical 
strains resistant to given antibiotics. Strains were 
isolated between 2003 and 2005 in the Centre for 
Burn Treatment, Siemianowice Śląskie, Poland 
(Bielecki et al. 2008).  
 
 
 
Antibiotic 2003 2004 2005 
Colistin 0 2 0 
Aztreonam 20 20 18 
Tazocin 28 26 46 
Meropenem 25 13 42 
Imipenem 25 17 39 
Ciprofloxacin 25 45 40 
Ceftazidime 64 54 48 
Amikacin 75 68 67 
1.2. Burn wound infections 
Thermal destruction of the skin barrier and concomitant depression of local and systemic 
host cellular and humoral immune responses are pivotal factors contributing to infectious 
complications in patients with severe burns. The burn wound surface (in deep partial-
thickness and in all full-thickness burns) is a protein-rich environment consisting of avascular 
necrotic tissue (eschar) that provides a favourable niche for microbial colonization and 
proliferation. The avascularity of the eschar results in impaired migration of host immune 
cells and restricts delivery of systemically administered antimicrobial agents to the area, 
while toxic substances released by eschar tissue impair local host immune responses (Church 
et al., 2006).  
Burn eschar normally becomes colonized with the patient’s own flora (predominantly Gram-
positive bacteria) within 3-5 days of injury. This initial colonization is subsequently replaced 
by Gram-negative flora present in the hospital (Erol et al., 2004), among which the P. 
aeruginosa is most common (Table 1-1). If the patient's host defences and therapeutic 
measures (including excision of necrotic tissue and wound closure) are inadequate or 
delayed, microbial invasion of viable tissue occurs, which is the hallmark of an invasive burn 
wound infection (Church et al., 2006). 
 
Introduction 
 
20 
 
1.3. Cystic fibrosis pulmonary infections 
P. aeruginosa pulmonary infection in cystic fibrosis (CF) patients is largely responsible for the 
high mortality rate (Lyczak et al., 2000). CF is caused by mutations of the gene encoding the 
CF transmembrane regulator (CFTR), which functions as a chloride channel in epithelial 
membranes (Collins, 1992). The failure to secrete chloride by CFTR together with abnormal 
sodium absorption from the airway lumen results in isotonic salt concentrations, which 
increases mucus viscosity and impairs mucociliarity and clearance of the lungs (Ratjen & 
Doring, 2003). P. aeruginosa invades the mucus layer, which in deeper fractions is deprived 
of oxygen (Worlitzsch et al., 2002). This makes the microenvironment of CF pulmonary 
infection different from that of the burn wound infection. Chronic infection with P. 
aeruginosa infection leads to epithelial surface damage and airway plugging, progressively 
impairing airway conductance which results in the decline of pulmonary function (Lyczak et 
al., 2002).  
1.4. Insights into pathogenecity through global gene expression profiling 
The advent of sensitive molecular techniques has furthered our understanding of genomics 
through sequencing of the whole genome of relevant P. aeruginosa strains. The genome 
sequence and annotation of the strain P. aeruginosa PAO1, originally isolated from a burn 
wound in 1975 (Stieritz & Holder, 1975), was published  in 2000 (Stover et al., 2000). Then in 
2006, Lee and colleagues reported the genome sequence of the highly virulent strain PA14. 
The sequencing of a further 5 strains is still in progress and can be monitored on the 
Pseudomonas Genome Database (www.pseudomonas.com). The availability of the whole 
genome sequences and annotations of these important strains open up new avenues to 
study infections. High-density DNA microarrays are a powerful tool to explore the complexity 
of P. aeruginosa genetic programs. Transcriptional profiling of P. aeruginosa allows us to 
gain insights into regulation networks and environmental responses underlying 
pathogenesis. Figure 1-1 presents the principles of microarray experiment. 
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Figure 1-1: Experimental process of microarray preparation and analysis. Adapted from Butte (2002). RNA is 
isolated from bacteria, labelled and hybridised to the microarray. Then the array is scanned with laser light 
and the raw data analysed statistically. 
With such techniques at hand, it has been possible to design and execute in vitro 
experiments under conditions known to be prevalent during host infection. Such conditions 
include: free-iron limitation in host tissues, oxidative stress generated by superoxide 
produced by polymorphonuclear leukocytes (PMNs) and biofilm formation, which both 
allows the pathogen to increase its resistance against antibiotics and to overcome nutrition 
shortage. 
1.4.1. Iron acquisition 
Bacteria require iron as a cofactor for redox-dependent enzymes. The ability to acquire iron 
ions from infected host cells is one of the important factors that enable the pathogen to 
thrive in the host and thus to trigger its virulence programs. During infection, iron is limited 
by the host as it is usually bound to proteins such as transferrin, lactoferrin, ferritin or bound 
as heme to hemoglobin. P. aeruginosa possesses a number of mechanisms based on iron-
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chelating compounds called siderophores, such as pyoverdine or pyochelin as well as the 
heme uptake system (Takase et al., 2000, Letoffe et al., 1998). Pyoverdine acts also as a 
signal molecule that controls the production of secreted virulence factors like exotoxin A, 
endoprotease and pyoverdine itself (Lamont et al., 2002) and as a signal for biofilm 
development (Banin et al., 2005). Ochsner et al (2002) used the microarray technique to 
study bacterial responses to iron starvation while Palma et al (2003) examined the short-
term response of iron addition to iron-starved P. aeruginosa cells. Furthermore, in addition 
to the genes previously known to be responsible for iron uptake and metabolism (namely 
pyoverdine, pyochelin and heme uptake) these studies found over 40 genes encoding for 
hypothetical and conserved hypothetical proteins. They also demonstrated that many 
regulators are iron-dependent. These studies underscore the role of iron in virulence and 
suggest obvious candidates for detailed functional analysis. 
1.4.2. Oxidative stress response 
Another type of stress that P. aeruginosa has to overcome upon infection, is the oxidative 
stress generated by the superoxide produced by PMNs, which is a host response to infection 
(Salunkhe et al., 2005). Studies on the response to hydrogen peroxide were carried out in 
different experimental settings, such as the early adaptation response after exposing the 
cells for 10 and 20 minutes to hydrogen peroxide (Palma et al., 2004, Chang et al., 2005), or 
the steady-state response to hydrogen peroxide upon continuous exposure (Salunkhe et al., 
2005). These 3 studies on the effect of hydrogen peroxide revealed the activation of several 
protective mechanisms, including antioxidant defence systems such as catalase and DNA 
repair. Downregulation of the primary metabolism was also observed in these studies. Chang 
et al (2005) reported suppression of iron–uptake related genes as well as the induction of 
pyocins, which may be a defence mechanism against the oxidative attack by host cells. Both 
studies of Palma and Salunhke reported that iron regulated genes were activated upon 
exposure to hydrogen peroxide. However, only about 40% of the differentially regulated 
genes in the Chang experiment matched those in Palma’s study. This was likely due to 
differences in the experimental design and procedures. Salunkhe and colleagues expanded 
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the experiment by using a reference strain of P. aeruginosa PAO1 and two strains isolated 
from the sputum of CF patients – TB and 892, which were two variants of the same clone. 
The transcriptional profiles indicated that strains named as TB and 892 were more proficient 
in their response to hydrogen peroxide (Salunkhe et al., 2005). These findings illustrate the 
need for accurate experimental design of expression profiling and demonstrate that more 
than 1 clone should be examined in gene expression experiments to render conclusions 
more accurate.   
1.4.3. Quorum sensing 
Quorum sensing (QS) is the mechanism that allows bacteria to “sense” the density of the 
bacterial population and to respond to it in an organized manner, regulating thereby a large 
battery of genes, including those coding for virulence factors. The P. aeruginosa QS consists 
of three systems. Two of them are the directly interrelated N-acylhomoserine lactone (AHL)-
dependent systems las and rhl. The third employs 2-heptyl-3-hydroxy-4-quinolone, the 
Pseudomonas Quinolone Signal (PQS) (Pesci et al., 1999, Gallagher et al., 2002, McKnight et 
al., 2000, Diggle et al., 2003). The complex interplay of these systems and the regulators 
involved is shown on Figure 1-2. The las system consists of the transcriptional regulatory 
protein LasR and its cognate signalling molecule, N-(3-oxododecanoyl) homoserine lactone 
(3O-C12-HSL), whose production is directed by the autoinducer synthase encoded by lasI. The 
rhl system consists of the RhlR protein and an autoinducer synthase encoded by rhlI, which is 
involved in production of the cognate autoinducer N-butyryl homoserine lactone (C4-HSL) 
(Smith & Iglewski, 2003, Wagner et al., 2003).  Although its production is enhanced by the 
las system, it can be formed in the absence of lasR (Diggle et al., 2003). The PQS biosynthesis 
is regulated by the PqsR regulator, which was formerly known as MvfR. PqsR is a membrane-
associated LysR-type transcriptional activator which also regulates elastase, phospholipase, 
3-oxo-C12-HSL and pyocyanin (Diggle et al., 2007a). Exogenous PQS induces expression of 
the elastase B genes and rhlI (McKnight et al., 2000). 
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Figure 1-2: Quorum sensing systems in P. aeruginosa.  
Rumbaugh and colleagues (1999) were the first to show the involvement of the QS systems 
in burn wound infections. They produced single P. aeruginosa mutants in lasR, lasI and rhlI 
as well as double lasI and rhlI mutants. In comparison to the P. aeruginosa parent strain 
PAO1, lasI and rhlI mutants were significantly less virulent. In addition, both mutants were 
much less efficient than PAO1 in spreading across the bodies of burnt and infected mice. The 
most significant decrease in virulence was observed in the mutant with both lasI and rhlI 
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disrupted, which pinpoints the combinatorial influence of genes and interacting traits in 
virulence and, as referred to above, is the hallmark of P. aeruginosa pathogenesis (Lee et al., 
2006). It was also discovered that the strain with a disrupted regulatory gene lasR, which 
was incapable of producing elastases (LasA and LasB), exotoxin A and alkaline protease, was 
also unable to disseminate to distal host sites in a colonized burn wound. The virulence of 
strains with the non-disrupted lasR gene but with specific mutations in lasA, lasB, toxA 
(encoding exotoxin A) and rpoS gene was not as strongly reduced as in the strain with the 
lasI and rhlI mutation. Moreover, all these mutants were able to spread effectively across 
the burned skin and the body of the infected mice (Rumbaugh et al., 2000). This fact 
suggests that QS regulates other virulence factors that are important in burn wound 
infections which were not known at that time, and that overall virulence is mediated by a 
larger set of these factors. Its full complexity has only been revealed once genome-scale 
expression profiling became available. 
Hentzer et al., (2003), Schuster et al., (2003) and Wagner et al., (2003) examined the global 
QS response to the effect of different purified acyl-homoserine lactones on autoinducer 
synthase mutants. The joint analysis of the data from these experiments provides a 
comprehensive overview of the QS regulon, that is, the joint set of genes that are regulated 
by QS systems. In addition, there are sets of data from experiments made on other 
regulators, which together, co-regulate the las and rhl QS circuits. These include: i) Vfr – a 
global regulator of P. aeruginosa virulence, which responds to the alarmone cAMP and 
induces lasR transcription (Albus et al., 1997, Wolfgang et al., 2003); ii) QscR – LuxR type 
regulator without cognate synthase. It delays the activation of several QS controlled genes 
and activates its own set of target genes (Lequette et al., 2006) iii) VqsR – a virulence and 
quorum sensing regulator (Juhas et al., 2005); iv) the alternative sigma factor RpoS (Schuster 
et al., 2004); v) PrpB – a two component response regulator (Dong et al., 2005); and vi) MvfR 
(PqsR) – a multiple virulence factor regulator that activates the direct precursor of PQS, as 
referred to above (Deziel et al., 2005). Recently, Bredenbruch et al (2006) reported that, in 
addition to its known function as a signal molecule, PQS has iron-chelating activity in the cell, 
leading to activation of iron acquisition and oxidative-stress response genes. It has also been 
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suggested that the PQS’s location in the cell envelope may facilitate siderophore-mediated 
delivery, although PQS itself does not function as a siderophore (Diggle et al., 2007b). 
Furthermore, it was shown that the PQS precursor 2-heptyl-4(1H)-quinolone (HHQ), which 
does not form an iron complex, can act as a signal molecule per se (Diggle et al., 2007b). 
1.4.4. Biofilm formation 
The ability to form biofilms is one of the essential factors for the prevalence of infection. 
Biofilm formation provides protection to bacteria from a wide range of environmental 
challenges, such as UV exposure, metal toxicity, acid exposure, dehydration and salinity as 
well as infection challenges such as phagocytosis and several antibiotics and antimicrobial 
agents (Hall-Stoodley et al., 2004). The crucial role of biofilms in P. aeruginosa chronic 
infections such as cystic fibrosis and otitis media have been well established (Singh et al., 
2000, Ehrlich et al., 2002). Recently Schaber and colleagues examined the role of biofilm in a 
thermally injured mouse model of acute infection (Schaber et al., 2007). Using light, electron 
and confocal scanning laser microscopy they demonstrated that P. aeruginosa forms biofilms 
in burn wounds after 8h of infection and bacterial cells congregate around the blood vessels. 
Importantly, the same study showed that a QS mutant strain PAO1-JP2, which is known to be 
less virulent in burn wound infection, was still able to form biofilms in burn wounds. The 
authors suggested that QS is needed for efficient blood vessel invasion subsequent to biofilm 
formation and following the increase in local cell density (Schaber et al., 2007). Several 
studies on biofilm development by P. aeruginosa were designed as a comparison of 
planktonic cultures with those at different stages of biofilm formation (Hentzer et al., 2005, 
Waite et al., 2006, Waite et al., 2005). These studies revealed that the profiles of the genes 
expressed at the different stages of biofilm development were similar to those of the 
planktonic stationary phase, which underscores the hypothesis that the majority of the 
bacteria present in a biofilm are in stationary phase physical state. Biofilm formation 
involves several adaptive responses such as anaerobic oxidation and iron-limitation stress 
(Hentzer et al., 2005).  
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Another study measured the genome-wide transcriptional response of a biofilm exposed to 
the beta-lactam antibiotic imipenem (Bagge et al., 2004).  The P. aeruginosa biofilm induced 
by addition of imipenem revealed more than five-fold differential regulation of 34 genes as 
compared to the non-induced biofilm control. The most upregulated gene was the ampC, 
which encodes for a beta-lactamase precursor. Also, the alginate biosynthesis pathway was 
upregulated, whereas the flagellum-encoding and pilus-encoding genes were downregulated 
in the imipenem-exposed biofilm (Bagge et al., 2004). The expression of the alginate 
pathway is dependent upon the sigma factor AlgU. AlgU also induces the transcription of 
rpoH, which regulates different stress responses. Moreover, AlgU has been associated with 
the negative control of flagellum synthesis (Bagge et al., 2004). Although alginate itself is not 
a barrier for beta-lactam antibiotics, the high numbers of beta-lactamases produced by P. 
aeruginosa may accumulate in the extracellular biofilm matrix and hydrolyse beta-lactam 
antibiotics as they penetrate the biofilm (Bagge et al., 2004). QS systems have been 
suggested to be essential for biofilm formation and have been reported to be involved in 
biofilm-specific gene expression (Davies et al., 1998, De Kievit et al., 2001). However, this 
statement was later challenged by experiments in which QS mutant strains were able to 
form similar biofilms to the parent strains (Heydorn et al., 2002, Schaber et al., 2007). 
Hentzer and colleagues tested the QS regulon in biofilms and found that about 80% of the 
previously reported QS regulated genes were differentially expressed. Interestingly, 144 
genes were QS regulated specifically in biofilm growing cells. Forty-four percent of the genes 
from this biofilm-specific, quorum-sensing regulon were related to the response to iron 
limitation, as reported previously by Ochsner (2002). These findings pinpoint an important 
link between QS and the iron regulatory system (Hentzer et al., 2005). 
Altogether, the various experiments described above provided us with a relatively extensive 
list of genes differentially regulated under the various conditions. This “library” can be used 
as a reference for all subsequent experiments and may complement them, although it 
should be emphasized that the impact of differences in experimental settings, such as 
growth phase, physical and chemical conditions may be the reason for the relatively poor 
correlation among the lists of genes generated in those various studies.  
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Despite its intrinsic value, a list of differentially regulated genes per se remains simply a list, a 
catalogue of relatively dispersed information. The real challenge lies on understanding how 
these gene sets are embedded in the various hierarchical metabolic and regulatory networks 
operating in P. aeruginosa, and on how these networks behave as a function of changing 
environmental conditions and interactions with the host. Clearly, it is this wiring and 
complex interplay of the many regulatory and metabolic networks that renders P. 
aeruginosa highly effective in its infection and persistence. 
1.4.5. Host-pathogen interactions 
Although the in vitro experiments described above yielded important insights into some of 
the factors involved in virulence, they remain laboratory experiments with only indirect 
relation to the real infection and host-pathogen interactions. More recently, experiments 
have involved placing P. aeruginosa in contact with eukaryotic cells and monitoring its global 
transcriptional response. Such approaches attempt to mimic more realistic infections by 
P. aeruginosa. Several models were developed to mimic lung infection in cystic fibrosis 
patients. Frisk et al. (2004) measured the transcriptional profiles of P. aeruginosa following 
interaction with primary normal human airway epithelial cells (PNHAE) after 4 and 12 hours. 
After 4 hours, 41 genes were differentially expressed with regard to a control consisting of P. 
aeruginosa cells growing in the same medium but without the presence of eukaryotic cells. 
Among the activated genes, there were 24 encoding putative proteins involved in membrane 
transport as well as 3 encoding transcriptional regulators. Interestingly, the pyoverdine 
pathway involved in iron acquisition was downregulated as well as the gene pchD encoding 
for a pyochelin biosynthesis protein. After 12 hours, 121 genes were differentially regulated. 
Several genes involved in phosphate acquisition were significantly upregulated, as well as 
the virulence factor plcN encoding a nonhemolytic phospholipase C precursor, which 
hydrolyzes phosphatidylcholine and phosphatidylserine present in both the outer and inner 
leaflets of eukaryotic erythrocytes, respectively. A possible role for PlcN in P. aeruginosa in 
vivo lung infection may be relevant since phosphatidylcholine is also an abundant 
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constituent of the lung surfactant and thus may serve as a substrate for the extracellular 
enzyme PlcN (Konig et al., 1997, Frisk et al., 2004).  
The genes responsible for siderophore-mediated iron acquisition were downregulated at 
both 4 and 12h following contact with eukaryotic cells. Since the pyoverdine, pyochelin and 
iron-regulated genes have been earlier shown to be important for P. aeruginosa infections 
(Vasil & Ochsner, 1999, Lamont et al., 2002) these results were surprising. The authors 
suggested that iron might be released upon damage of PNHAE cells caused by interaction 
with P. aeruginosa cells (Frisk et al., 2004). They also suggested that a non-siderophore-
mediated iron acquisition system, such as heme uptake may play an important role in P. 
aerugionosa infections (Takase et al., 2000). 
Another interesting experiment performed with the epithelial cells involved using the wild- 
type strain of P. aeruginosa PAO1 and a mutant unable to synthesise the type III secretion 
system and rhamnolipids. The infection with the mutant resembled a chronic infection, 
where there was no significant damage to the epithelial cells, whereas the wild-type strain 
mimicked the acute infection with injury to the epithelium (Chugani & Greenberg, 2007). 
Both strains were grown on primary different human airway epithelia and in TSB medium as 
the control. All data sets were compared and the differentially expressed genes were 
grouped into overlapping or specific genes to chronic and acute infection. In the overlapping 
set, 82% and 74% of the genes for the wild-type and mutant, respectively, had been 
previously shown to be activated by iron starvation (Ochsner et al., 2002). This finding is on 
the contrary to Frisk et al., but since there is considerable evidence that bacteria infecting 
the host have to overcome the low-iron availability (Schaible & Kaufmann, 2004) and taking 
into account that Chugani and Greenberg were able to prevent injury to the epithelial cells in 
their experiments, they assumed that this miscorrelation was simply due to the different 
experimental settings which again highlights the need for standardization in experimental 
design. 
Another approach to understand pathogenesis of lung infections in cystic fibrosis patients 
was taken by Wolfgang et al. 2004, who profiled global gene expression in response to 
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muco-purulent respiratory liquid derived from chronically infected adult CF patients. This 
work reported the activation of the Rhl-dependent quorum sensing network and repression 
of a number of genes encoding proteins involved in flagellar-mediated chemotactic motility 
including fliC, which encodes for flagellin (Wolfgang et al., 2004). Flagella are highly 
immunogenic, so that downregulation of fliC is likely to be an adaptive response to avoid 
host defences. Interestingly, the authors also compared their microarray data with the data 
sets of QS regulated proteins by Schuster et al. (2003) and found that a number of genes, not 
previously reported to be part of the QS regulon, were significantly activated or repressed in 
the context of CF respiratory liquid response (Wolfgang et al., 2004). While in their 
experiment the putative operon encoding a complete ABC transport system (PA2327-
PA2331) was repressed by the QS system, this system had been reported to be activated by 
QS in the study by Schuster et al (2003). Wolfgang et al (2004) suggested that QS signalling in 
the lung environment extends beyond the response network observed in laboratory settings 
(Wolfgang et al., 2004). This important and unsurprising observation is crucial for the design 
and execution of future in vivo experiments and for the expectations that may be derived 
from them.  
1.5. In vivo infection models 
P. aeruginosa is a classical opportunistic pathogen and is able to cause infections in a range 
of higher organisms. The range of host species has an advantage for research in permitting 
the development of numerous infection models (Williams et al., 2007). Adding to the well 
established murine models (Stieritz & Holder, 1975) we can also add a range of non-
vertebrate eukaryotic infection models. These models include Caenorhabditis elegans, 
Drosophila melanogaster, Dictyostelium discoideum (a soil-leaving amoeba), Arabidopsis 
thaliana, Galleria mellonella (greater wax moth), silkworm larvae, alfalfa and lettuce (Rahme 
et al., 1997, Tan & Ausubel, 2000, D'Argenio et al., 2001, Cosson et al., 2002, Kaito et al., 
2002, Silo-Suh et al., 2002, Miyata et al., 2003). 
The considerable differences reported among similar in vitro experiments that stemmed, 
unto a large extent, from the variability in experimental settings (Vasil, 2003), clearly show 
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that the true picture of bacterial infection and host-pathogen interactions can be achieved 
only by means of thorough in vivo experiments. So far, only a few laboratories have 
succeeded in performing global gene expression profiling of pathogens at the site of an 
infection. This is largely due to some technical obstacles such as RNA isolation, insufficient 
amount of mRNA and difficulties with finding a realistic in vivo model. For the burn wound to 
date there is no published work on the in vivo gene expression program of P. aeruginosa. A 
very interesting in vivo experiment was performed by Mashburn et al. (2005) by growing P 
aeruginosa in rat peritoneum. A P. aeruginosa strain was inoculated in a dialysis membrane 
chamber (DMC) and implanted into the peritoneal cavity of rats. Two independent 
experiments were carried out in this setting. In the first, P. aeruginosa was cultured alone, 
whereas in the second, P. aeruginosa grew in a co-culture with Staphylococcus aureus. The 
latter experiment mimicked well a real infection as during infection of either CF or burn 
wound patients, P. aeruginosa is rarely present alone and it tends to appear in combined 
infections (Hoffman et al., 2006). Mashburn and colleagues were able to perform microarray 
analysis of P. aeruginosa in co-culture with S. aureus because of differences in RNA 
extraction methods of the Gram negative and the Gram positive bacteria, which enabled 
them to separate the P. aeruginosa RNA. It is currently very difficult to separate the RNA 
from different Gram negative bacteria.  
As in previous studies, iron acquisition systems were shown to play a crucial role in the 
homogeneous P. aeruginosa experiments. Genes involved in synthesis and binding of 
pyoverdine and pyochelin were induced as well as genes involved in heme uptake, such as 
the gene hasAp, which was induced over 2000-fold. The induction of genes encoding 
proteins involved in transport and metabolism of amino acids indicates that P. aeruginosa 
uses amino acids as a carbon source in the peritoneum (Mashburn et al., 2005). Also two of 
the previously isolated genes by IVET, fptA and np20, were significantly upregulated in the 
pure-culture setting. In the in vivo co-culture experiment with S. aureus, the most striking 
feature as compared to that with P. aeruginosa alone was that 95% of repressed genes 
during growth in the presence of S. aureus were regulated by iron availability (Mashburn et 
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al., 2005). To explain this, the authors proposed a model where P. aeruginosa lyses the S. 
aeureus and uses the released iron to grow under a low-iron environment. 
In vivo transcriptional profiling of the samples collected from infected patients will certainly 
provide invaluable insights into host-pathogen interactions and into the mechanisms of 
pathogenesis. This is one of the main aims of this PhD work. So far, there are still only few 
such experiments reported for microbial infections in humans. In 2005, LaRocque et al. 
reported on the in vivo expression profiling of Vibrio cholerae during early and late infection, 
and Roos and Klemm (2006) described a experiment with Escherichia coli in the context of 
human urinary tract infection. In both studies the authors compared and analysed the 
differences between the differentially regulated genes obtained from their studies and those 
from in vitro growth from previous experiments. Unsurprisingly, these analyses showed that 
in vivo programs are much more complex than those obtained in in vitro experiments due to 
the influence of many and possibly still unknown factors. However, for P. aeruginosa, it was 
not until more recently that a study reported transcriptomic profiling of P. aeruginosa’s 
mRNA extracted directly from lungs of a Cystic Fibrosis patient (Son et al., 2007). A highlight 
from this experiment was the up-regulation of the genes responsible for antibiotic resistance 
and for the use of nutrient sources used by P. aeruginosa in the lung, which comprise: lung 
surfactant and amino acids. The same study compared the expression patterns from a 
clinical strain and a PAO1 type strain. They found that, in contrast to the PAO1 control, many 
virulence factors including alginate, lipase, phospholipase, rhamnolipid hemolysin, hydrogen 
cyanide production and pyochelin, are constantly expressed in the clinical strain. Although 
the study involved only one patient, the results provide evidence for the adaptation of P. 
aeruginosa strain to the CF lung environment over years of chronic infection, which is 
consistent with biomedical and epidemiological observations in various clinical studies 
(Smith et al., 2006) 
1.6. New anti-pseudomonal targets  
One of the pivotal targets for treatment of P. aeruginosa is the QS sensing system, for which 
there are a number of inhibitors (QSI) that act upon the cells. Briefly, there are three 
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possibilities to target and inhibit QS: i) by blocking AHL production, ii) by inactivating signal 
molecules and, iii) by jamming the signal receptor. The latter is the most extensively studied 
in the context of drug development. Rasmussen and colleagues (2005a) screened a vast 
library of synthetic and natural compounds to test if they can act as QSI. The most active 
synthetic compound was 4-nitro-pyridine-N-oxide (4-NPO) while among the natural 
compounds a garlic extract was the most inhibitory. Transcriptomic analysis confirmed that 
QS regulated genes were inhibited by both blockers. Furthermore, the study found that both 
compounds reduce the tolerance of the P. aeruginosa biofilm to tobramycin and virulence in 
a Caenorhabditis elegans infection model (Rasmussen et al., 2005a). Garlic was also shown 
to promote rapid clearing of P. aeruginosa from the lungs in QSI-treated mice in a pulmonary 
infection model (Bjarnsholt et al., 2005). In addition, penicilic acid and patulin, produced by 
Penicillium species, were shown to target 45% and 60% of the P. aeruginosa’s QS regulated 
genes, respectively (2005b). However, the most widely studied group of compounds is that 
of halogenated furanones, which have been reported to interfere with the QS systems 
(Givskov et al., 1996, Manefield et al., 2002). Furanone C-30, a synthetic furanone derivative, 
was found to inhibit almost 80% of the QS regulated genes and also to attenuate P. 
aeruginosa in a pulmonary mouse model (Hentzer et al., 2003). The biofilm formed in the 
presence of furanone C-30 is susceptible to grazing by PMN (Rasmussen et al., 2005a, 
Bjarnsholt et al., 2005). Another potential compound of interest is the macrolid 
azithromycin, which is conventionally used against gram-positive bacteria. Recently, the 
impact of this drug was assessed at the transcription and protein expression level of P. 
aeruginosa under infection-related conditions. Azithromycin inhibited the QS regulon as well 
as formation of biofilm (Nalca et al., 2006), and it was shown to affect the polymerisation of 
alginate (Hoffmann et al., 2007). Its QS inhibitory properties were also confirmed in vivo in a 
CF mouse model (Hoffmann et al., 2007).  
Most QS inhibitory compounds proposed so far have been targeted at Cystic Fibrosis 
patients. The first steps in bacterial burn wound infections are the colonisation of the wound 
and subsequent formation of biofilms on the epithelial surface. However, although QS 
systems are undoubtfully important in the invasion of blood vessels by P. aeruginosa 
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(Rumbaugh et al., 1999, Schaber et al., 2007), colonisation and biofilm development may be 
achieved independently of QS systems, as demonstrated by Schaber et al. (2007). Even when 
bacteremia from burn wound infection is not developed, the colonisation itself also 
complicates the treatment of burn patients. Infected wounds cannot be treated with skin 
grafts and persistent burn wound infection greatly extends the time of hospitalisation. One 
possibility is to introduce siderophore-like antibiotics, which may be transported by the 
bacterial cell, which recognizes the antibiotic as its own siderophore (Budzikiewicz, 2001, 
Braun & Braun, 2002). Recently, the synthesis of such compounds, namely pyochelin–
norfloxacin conjugates was reported (Rivault et al., 2007). Further research is needed in 
order to assess the bactericidal properties on different P. aeruginosa isolates. Another 
approach to target iron acquisition was developed by Furci et al. (2007), who proposed the 
inhibition of bacterial heme oxygenase, which is responsible for the last step in heme 
utilisation. By screening in-silico inhibitory compounds against certain 3D enzyme structures 
and through subsequent experimental assays, the group was able to identify novel inhibitors 
of the heme oxygenase of Neisseria meningitidis, which were also active against P. 
aeruginosa’s heme oxygenase but not against the human kind which is an encouraging 
result. Another line of investigation is the blockage of siderophore synthesis. In this regard, 
Ferreras et al. (2005) reported the synthesis and evaluation of a small molecule, salicyl-AMS, 
which inhibits the synthesis of salicylic acid-derived siderophores like mycobactins from 
Mycobacterium tuberculosis, yersiniabactin from Yersinia pestis and importantly pyochelin 
from P. aeruginosa. Thus, iron acquisition systems are becoming one of the most promising 
drug targets (Ferreras et al., 2005, Quadri & Luis, 2007). Clearly, much more research is 
necessary for the development of functional antimicrobial agents effective against multi-
resistant infections. Genome-wide and targeted expression profiling will be central in this 
endeavour. 
1.7. Analysis of transcriptomic data 
Microarray technologies allow researchers to determine expression of several thousands of 
genes simultaneously. The Affymetrix P. aeruginosa GeneChip® contains probe sets 
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representing 5900 P. aeruginosa gene transcripts and various controls. Once the raw data 
from hybridisation are obtained, they are subjected to thorough analysis. It starts with data 
normalisation and the quantification of gene expression levels. The approaches used to 
analyse the gene expression data set can be divided into two categories: supervised and 
unsupervised. Supervised routines are used for finding the expression levels that are 
significantly different between groups and finding those genes that accurately predict a 
characteristic of the sample (Butte, 2002). Unsupervised routines seek to find internal 
structure or relationships in the global data set. Figure 1-3 presents the scheme that could 
be used to analyse microarray data sets. A detailed review about each routine is beyond the 
scope of this introduction and can be found elsewhere (Brazma et al., 2001, Knudsen, 2002, 
Amaratunga & Cabrera, 2004). There is a number of methods used for filtering differential 
expression such as fold change or rank products (Breitling et al., 2004). Under the umbrella 
of unsupervised approaches, the most often used routines are: cluster determination for 
determining groups of genes or samples with a similar pattern of gene expression using 
hierarchical clustering or self-organizing maps (Golub et al., 1999, Tamayo et al., 1999); 
feature determination and data visualisation of genes or conditions using ordination 
approaches such as principal component analysis (PCA) (Alter et al., 2000) or 
multidimensional scaling (MDS) (Tzeng et al., 2008).  
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Figure 1-3: Scheme of the typical microarray data analysis approach using supervised and unsupervised 
routines. 
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2. Project rationale 
With the increasing prevalence of bacterial infections across the world, a deeper 
understanding of the pathogen behaviour upon the infection is fundamental for the 
development of effective treatment strategies. Global in vivo gene expression profiling is a 
powerful tool to gain insights into the pathogen behaviour upon infections. It may also 
provide the basis for the discovery of novel virulence systems or rediscovery of factors that 
had not been previously considered important for infection. The scope of this work was thus 
to evaluate the genetic expression programs used by P. aeruginosa upon real in vivo 
infection conditions. The main focus was on burn wound infections and their comparison 
with other infections and infection models. 
The approach followed was to compare the gene expression of P. aeruginosa infecting burn 
wounds and CF patients with different models that attempted to capture the effects of 
infection. To that end, a number of technical aspects had to be addressed, namely, the 
development of an accurate method to collect the material (RNA) and to technically obtain 
gene expression profiles from P. aeruginosa clones from an in vivo infection. The availability 
of realistic infection models is crucial for the testing of the hypotheses generated. Two 
models were proposed: a lettuce infection model and a novel mouse tumour infection 
model. These two models were assessed thoroughly by the analysis of global expression 
patterns.  
Finally, the effects of a potentially novel anti-pseudomonal compound, protoanemonin, 
were tested using a combined transcriptomic and proteomic approach, coupled with QS 
inhibition assay. 
Thus, by drawing on the current knowledge on P. aeruginosa infections, this PhD thesis was 
designed to answer a number of questions related to the following aims:  
i) To elucidate the genetic programs used by P. aeruginosa during different infections: 
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• What are the main factors expressed by P. aeruginosa during a burn wound 
infection? 
• What are the genetic programs used by P. aeruginosa in pulmonary infection 
of cystic fibrosis? 
• Which factors are common to both infections and which are condition-
specific? 
 
ii. To appraise various models mimicking in vivo infections:  
• Are there any good infection models that can mimic real in vivo infections? 
• Is the lettuce model adequate and can plant infections be used to compare 
the transcription profile under different mammalian infectious conditions? 
• Is our novel mouse tumour model colonised by P. aeruginosa a good chronic 
infection model? 
• How does the transcription profiling compare among all the different 
conditions? 
o Can we find any trends? 
o Are there commonalities between different infection sites and 
models? 
• Does a global transcriptomic study provide us leads and the means to find 
possible targets for infection prevention? 
iii. To test the potential of an anti-pseudomonal compound – protoanemonin as a case 
study: 
• What is the impact of protoanemonin on the level of global expression? 
• What is the response of P. aeruginosa measured by secreted proteins? 
• Can protoanemonin be proposed as novel anti-pseudomonal compound? 
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3. Materials and Methods 
The general overview of the transcription experiments is presented on Figure 3-1 with 
indication of sections, in which given techniques or protocols are described. Other Materials 
and Methods are described within the chapter. 
 
Figure 3-1: An overview of the experimental approach used to address the aims of this thesis, highlighting 
the key techniques used to perform global transcript analysis of P. aeruginosa. The numbers shown in 
parentheses indicate the section where the protocols are described in full. 
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3.1. Strains and Media 
3.1.1. Bacterial Strains 
All bacterial strains used in this work are listed in Table 3-1. 
 Table 3-1: Bacterial strains used in this work 
Bacterial strain Description Origin 
Escherichia coli TOP10 Electrocompetent cells Invitrogen 
Escherichia coli HB101(RK600) Conjugation helper strain Boyer and Roulland-
Dussoix, 1969 
Pseudomonas putida KT2440 Environmental strain Bagdasarian et al., 1981 
Pseudomonas aeruginosa PAO1 Wildtype burn wound isolate Stieritz and Holder, 1975 
Pseudomonas aeruginosa PA14 Wildtype burn wound isolate Rahme et al., 1995 
Pseudomonas aeruginosa PA14 ∆anr Transposon mutant Liberati et al., 2006 
Pseudomonas aeruginosa PA14 ∆cupA1 Transposon mutant Liberati et al., 2006 
Pseudomonas aeruginosa PA14 ∆pqsA Transposon mutant Liberati et al., 2006 
Pseudomonas aeruginosa PBCLOp1 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp2 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp4 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp5 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp6 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp7 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp8 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp9 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp10 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp11 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp14 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp17 Burn wound isolate This work 
Pseudomonas aeruginosa PBCLOp18 Burn wound isolate This work 
Pseudomonas aeruginosa PBMHHp1 CF patient isolate This work 
Pseudomonas putida KT2440-pBBRMCS5-LITE Bioluminescence This work 
Pseudomonas aeruginosa PAO1-pBBRMCS5-LITE Bioluminescence This work 
Pseudomonas aeruginosa PBCLOp10-pHL320 Bioluminescence This work 
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3.1.2. Media 
3.1.2.1. Luria Bertani Medium (LB) 
The LB medium (Sambrook et al., 1989) was used as standard medium for all bacterial 
strains. 
In 1000 ml H2O: 
10 g Bacto Tryptone  
5 g Yeast extract 
10 g NaCl 
The pH was adjusted to 7.0 with 5M NaOH. Medium was autoclaved at 1210C for 20 min. LB 
agar was obtained by adding 15 g per 1 l of liquid LB medium. 
3.1.2.2. MacConkey Agar medium 
MacConkey Agar was used as a medium for isolation and differentiation of P. aeruginosa 
strains from other possible bacteria present in clinical isolates. MacConkey agar selects 
Gram-negative bacteria and distinguishes between lactose fermenters and non-fermenters. 
In 1000 ml H2O: 
8 g MacConkey agar (BD, Sparks, MD, USA) 
Dissolved by heating, autoclaved at 1210C for 20 min. 
3.1.2.3. Columbia Blood Agar (BD) 
Columbia Blood Agar (BD) plates were used for growth of P. aeruginosa to determine the 
haemolytic activity. Strains cultivated on these plates were further analysed by Vitek2 
(Biomerieux, Marcy l'Etoile, France) system for resistance patterns with the standard Vitek 
procedures. The resistance report was made with the Vitek2 Systems Version 02.01n 
(Biomerieux). 
3.1.2.4. ABT medium 
The ABT medium with casamino acids was used for the experiment of P. aeruginosa 
response to protoanemonin, both for transcriptomic and proteomic analysis. 
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Stock solutions: 
A10: 
In 1000 ml H2O: 
20 g (NH4)2SO4 
60 g Na2HPO4 
30 g KH2PO4 
30 g NaCl 
After dissolving, the pH should be adjusted to 6.4 and the solution autoclaved 
BT: 
In 900 ml H2O: 
1 ml of 1 M MgCl2 
1 ml of 0.1 M CaCl2 
1 ml of 0.01 M FeCl3 
1 ml of 2.5 mg/ml γ thiamin 
After dissolving the solution should be autoclaved 
Glucose: 
20% glucose in H2O 
Casamino acids (CAS AA): 
20% casamino acids 
Glucose and CAS AA should be filter sterilized 
 
Final ABT medium: 
10 ml A10 
90 ml BT 
2.5 ml glucose (20 %) 
2.5 ml CAS AA (20 %) 
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3.2. In vitro Bacterial growth 
In vitro growth of P. aeruginosa clinical strains was performed in order to obtain non-virulent 
controls. The host site of the infection is rich in aminoacids, therefore in order to mimic the 
nutrient composition and physiological state of the cells during the infection the LB medium 
was chosen. 
3.2.1. Planktonic growth in LB medium 
All bacterial cultures were grown separately in 100 ml LB broth at 370C and 160 rpm in 1000 
ml baffled Erlenmeyer flask until an optical density measured by 1:10 dilution of 0.6 (early 
stationary phase) at 600 nm. Afterwards, bacteria were harvested for RNA isolation as 
described below (see section 3.5.1). 
3.2.2. Biofilm growth 
Overnight pre-inoculum of P. aeruginosa was diluted to an optical density of 0.05 at 600 nm 
with 10% LB. The plastic Permanox® (Nunc, Rochester, NY, USA) slides were put into 100 ml 
of the diluted culture in 500 ml Erlenmeyer flask. Flasks were kept at 370C for 24h without 
shaking. Biofilm formation was observed on the plastic slides. Slides were washed two times 
in the fresh LB medium than dipped in RNAprotect reagent (Qiagen, Hilden, Germany) and 
biofilms were scraped by a cell scraper. The procedure followed was the same as for other 
RNA samples and is described in section 3.5.1. 
3.2.3. ABT minimal medium growth with protoanemonin treatment 
Overnight pre-inoculum of P. aeruginosa PAO1 growing in ABT minimal medium 
supplemented with 0.5% casamino acids was used to inoculate 200 ml of the same media to 
an optical density of 0.05 at 600nm. The P. aeruginosa PAO1 culture was incubated at 370C 
with shaking (160 rpm). When the culture reached middle exponential phase at the OD600 of 
0.5 it was split into halves. One half was treated with 125 µM of protoanemonin and the 
second served as a control. Cultures were harvested for proteomic (see section 3.7) and 
transcriptomic analysis (RNAprotect reagent, Qiagen) (section 3.5.1) at the late 
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exponential/early stationary phase at the OD600 of 2.0. The experiment was performed in 
triplicate. 
3.3. In vivo conditions 
3.3.1. Burn wound sample collection 
3.3.1.1. Criteria for choosing patients 
The samples of P. aeruginosa infecting burn wounds were collected at the Centre for Burn 
Treatment (CLO) in Siemianowice Śląskie, Poland. The sampling protocol was approved by 
the Bioethical Commission of Silesian Medical Academy. Only patients with clinically 
confirmed P. aeruginosa burn wound infection were chosen for sample collection. To 
minimize invasion during sample collection, the samples were taken only from patients with 
liquid burn wound exudates. Liquid exudates were taken from burn wound surface using 
sterile forceps and immediately transferred to vials containing RNAprotect bacteria reagent 
(Qiagen) in order to prevent the degradation of RNA. The buffer with the sample was 
vortexed, incubated for 10 - 15 minutes at room temperature and centrifuged for 15 min at 
4000 x g. The supernatant was discarded and the pellet frozen at -200C. 
During sampling a standard swabs were also taken from the same area of the wound in 
order to collect the original clone of P. aeruginosa. 
3.3.1.2. Sample transport 
Frozen samples were transported on dry ice and stored at -700C until RNA extraction. Swab 
samples were transported at room temperature.  
3.3.1.3. Clinical strain isolation 
Swab samples were plated onto both LB and MacConkey agar plates immediately after 
arrival back to the laboratory. P. aeruginosa was differentiated from other bacteria by 
morphology difference (colony shape, colour, plate selection) taken into account previous 
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microbiological data obtained from the CLO. Table 3-2 summarizes all the bacterial species 
isolated from different patients. 
Table 3-2: Strains isolated from patients with burn wound infection. 
Patient Microorganism isolated 
P1 Pseudomonas aeruginosa PBCLOp1 
Proteus mirabilis 
Escherichia  coli 
P2 Pseudomonas aeruginosa PBCLOp2 
Acinetobacter baumannii 
P3 Proteus mirabilis 
P4 Pseudomonas aeruginosa PBCLOp4 
P5 Pseudomonas aeruginosa PBCLOp5 
Staphylococcus aureus 
P6 Pseudomonas aeruginosa PBCLOp6 
Acinetobacter baumannii 
P7 Pseudomonas aeruginosa PBCLOp7 
Acinetobacter baumannii 
Proteus mirabilis 
P8 Pseudomonas aeruginosa PBCLOp8 
Acinetobacter baumannii 
P9 Pseudomonas aeruginosa PBCLOp9 
P10 Pseudomonas aeruginosa PBCLOp10 
P11 Pseudomonas aeruginosa PBCLOp11 
P14 Pseudomonas aeruginosa PBCLOp14 
Acinetobacter baumannii 
Enterococcus feacalis 
P15 Pseudomonas aeruginosa PBCLOp15 
Acinetobacter baumannii 
P16 Pseudomonas aeruginosa PBCLOp16 
Proteus mirabilis 
P17 Pseudomonas aeruginosa PBCLOp17 
3.3.2. Cystic Fibrosis patient sputum sample collection 
A sputum sample was kindly donated by 1 CF patient with their complete permission and 
knowledge. The patient had confirmed to have a chronic P. aeruginosa infection. The 3 ml of 
sputum was resuspended in RNAprotect bacteria reagent (Qiagen), incubated for 30 min. at 
room temperature and then centrifuged for 15 min at 4000 x g. The supernatant was 
discarded and the pellet frozen at -700C until further use.  
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Part of the sputum sample was not treated with RNAprotect in order to isolate the clinical 
strain of P. aeruginosa. The strain was isolated on Columbia agar following the selection on 
the MacConkey agar. 
3.3.3. Tumour mouse model 
3.3.3.1. Infection of tumour-bearing mice 
Six-week-old female BALB/c mice were purchased from Harlan (Germany). All animal 
experiments were performed in accordance to the institute’s and government regulations. 
Cells of the colon adenocarcinoma cell line CT26 (ATCC CRL-2638) were grown in IMDM 
medium (Gibco, Karslruhe, Germany) supplemented with 10% (v/v) fetal calf serum, 2 mM L-
glutamine and 10 mM HEPES. For injection into mice CT26 cells were trypsinised, washed 
and finally resuspended in phosphate-buffered saline (PBS). 106 cells were injected 
subcutaneously in the abdomen. Mice bearing tumours of approximately 4–6 mm diameter 
were intravenously injected with 5 × 106 CFU of bacteria suspended in PBS. 
3.3.3.2. Recovery of bacteria from tissues 
At selected time points, tissue samples were obtained (spleen, liver and tumour). Samples 
were transferred into 3 ml of sterile ice-cold PBS containing 0.1% (v/v) Triton X-100 and 
subsequently disrupted with a Polytron PT3000 homogenizer (Kinematica, Littau, 
Switzerland). For enumeration of bacteria, homogenates were serially diluted in PBS and 
streaked onto LB agar. 
3.3.3.3. Bioluminescence in vivo imaging 
Plasmids used for bioluminescence analysis:  
• pHL320 (Loessner et al. unpublished), containing an optimised version of the green-
emitting luciferase from click beetle present in pCBG99-Basic plasmid (Promega) and 
subcloned downstream of the constitutive promoter Pbla, transferred into the shuttle 
vector pUCP20 (West et al., 1994b). 
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• pBBRMCS5-LITE (Marques et al., 2005) containing the luxCDABE gene cassette of 
Photorhabdus luminescens from plasmid pLite27 (Marincs & White, 1994) under the 
constitutive Plac promoter,  introduced into broad-host-range vector pBBR1MCS-5 
(Kovach et al., 1995). 
In vivo visualisation of tumour infection was performed using transformed strains P. 
aeruginosa PBCLOp10-pHL320, P. aeruginosa PAO1-pBBRMCS5-LITE and P. putida KT2440- 
pBBRMCS5-LITE. Mice were infected using the method mentioned above. Mice infected with 
the strain PBCLOp10-pHL320 received an intraperitoneal dose of 3 mg D-luciferin substrate 
(Caliper Life Sciences, Hopkinton, MA, USA) diluted in 100 µl PBS before analysis. 
Subsequently, mice were anaesthetised with 2 % isoflurane using the XGI-8 gas anesthesia 
system (Caliper Life Sciences). Pseudocolored images of photon counts and photographic 
images were obtained according to the instructions of the manufacturer. The software Living 
Image 2.5 (Caliper Life Sciences) was used for image analysis and quantification of emission 
intensities which are expressed as radiance (p s-1 cm-2 sr-1). 
3.3.3.4. Tumour collection for P. aeruginosa RNA extraction 
Three days post-infection (p. i.) mice were necrotised and infected tumours prepared for 
stabilization of bacterial RNA in the following way: the tumours were cut into 2-4 pieces, put 
on the nylon filter for cell cultures (70 µm pore size) and suspended in with 2 ml of 
RNAproctect Bacteria Reagent (Qiagen) on 2 cm petri dish. The tumour was squeezed 
through the membrane with sterile spatula. The resulting mixture in RNAprotect reagent 
was collected to the 2 ml reaction tube and centrifuged for 5 min at maximum speed. The 
pellet was frozen at -70°C for further RNA extraction performed as described in section 
3.5.1. 
3.3.4. Lettuce infection model 
3.3.4.1. Infection of lettuce leaves 
The protocol for using romaine lettuce leaves as a model of P. aeruginosa infection and 
P. putida KT2440 injection as control, was performed as described previously (Filiatrault et 
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al., 2006). P. aeruginosa strains were grown aerobically overnight at 37°C and P. putida 
KT2440 at 30°C in LB broth, washed twice with 10 mM MgSO4, and diluted in sterile MgSO4 
to a bacterial density of 1 x 108 CFU/ml. Lettuce leaves (Mini-Roma lettuce purchased 
commercially) were prepared by washing with distilled H2O and 0.1% bleach. Lettuce mid-
ribs were inoculated with 10 µl of bacterial suspension at a density of 1 x 108 CFU/ml 
(corresponding to 1 x 106 bacteria) by injecting the end of the plastic tip into the rib and 
placed in plastic containers containing Whatman paper moistened with 10 mM MgSO4. 
Lettuce was incubated at 37°C or 30°C, and symptoms were monitored daily over the course 
of 5 days. As a negative control, lettuce leaves were inoculated only with 10 mM MgSO4.
 A 
separate lettuce leaf was used for each strain. The experiments were repeated three times. 
3.3.4.2. Sample collection for RNA extraction 
Five days post infection the 2 cm2 piece from original place of injection site was cut out from 
the leaf and putted to 15 ml reaction tube with 3 ml RNAprotect Bacteria Reagent (Qiagen). 
The sample was vortexed for 30 seconds and the solid parts of the plant tissue discarded. 
Resulting mixture was incubated for 5 min at room temperature and centrifuged for 15 min 
at 4000 x g. The supernatant was discarded and the pellet frozen at -70°C for further RNA 
extraction performed as described in section 3.5.1. 
3.4. DNA methods 
3.4.1. Genotyping of clinical P. aeruginosa strains 
The genotyping of P. aeruginosa isolates was performed according to protocols and 
techniques developed at the Klinische Forschergruppe led by Prof Burkhard Tümmler at 
Medizinische Hochschule Hannover (MHH). The method is based on binary microarray 
(Wiehlmann et al., 2007), which consists of 58 targets representing the core and the 
accessory genome. The core genome is analysed by 13 single-nucleotide polymorphisms 
(SNPs) at seven conserved loci and two multiallelic loci (flagelin fliC and pyoverdine receptor 
fpvA). The accessory genome is tested with set of genetic markers that identify 10 genomic 
islets and six types of genomic islands (Wiehlmann et al., 2007). All targets are amplified 
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from the P. aeruginosa colonies by the multiplex primer extension reaction with random 
labelling performed by incorporation of biotin-16-dUTP. The multiplex amplificate is 
hybridised under the high stringency with the oligonucleotide microarray of the target 
sequences that is inserted into the tip of a standard Eppendorf-like microtube. The 
hybridisation signals are automatically converted to the multilocus genotype. The 16 binary 
SNP genotypes are represented by a four-digit hexadecimal code. The 16 SNPs are divided 
into four groups of four SNPs each, and the 16 possible combinations in each group are 
differentiated by 16 characters: 0–9, A–F. 
The illustration of clonal diversification was generated using an eBurst algorithm (Feil et al., 
2004). The clinical strains were analysed together with the database of MHH which contains 
more than 1700 isolates from 658 independent sources (both clinical and environmental).  
3.4.2. Plasmid DNA isolation 
Plasmid DNA was extracted using QIAprep Spin Miniprep Kit (Qiagen) following supplier 
instructions. The size and purity of plasmid DNA was tested on 1% agarose gels prefaced 
with restriction enzyme digestion. The size was checked in comparison to 1kb DNA ladder 
(Invitrogen) 
3.4.3. Agarose gel electrophoresis 
Agarose gel electrophoresis was performed according to Sambrook et al., (1989). Each DNA 
sample was mixed with the 1/5 volume of loading buffer and loaded on a 1% (w/v) gel. The 
TAE buffer was used as a running buffer. 
3.4.4. P. aeruginosa electrocompetent cells 
P. aeruginosa was grown on the LB agar plate at 37°C. Freshly grown colonies were 
transferred from plate to 1.5 ml reaction tube and resuspended in 1 ml sterile H2O. Bacteria 
were washed 3 times with 500 µl of H2O. Finally, cell pellet was dissolved in 20 µl of H2O.   
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3.4.5. Electroporation 
Plasmid DNA was mixed with electrocompetent cells of P. aeruginosa or E. coli TOP10, put to 
fresh electroporation cuvette. Electroporation was done in following settings: potential 2.5 
kV (Pseudomonas) or 1.8 kV (E. coli), capacity of 25 µFD and resistance of 200Ω.  
Directly after the electroporation, 800 µl of LB medium was added to the mixture and 
transferred to sterile reaction tube. The mixture was incubated at 37°C for 1 h with 180rpm 
shaking. After incubation 50 or 100 µl of bacterial suspension was plated on LB agar plates 
(50 µg/ml Gentamycin or Carbenicillin 50 µg/ml) and incubated overnight at 37°C. 
3.4.6. P. putida KT2440 conjugation  
Plasmid pBBRMCS5-LITE was transformed to P. putida KT2440  by triparental mating using 
the E. coli TOP10 harbouring plasmid pBBRMCS5-LITE as a donor strain and E. coli 
HB101(RK600) as a helper strain. 10 ml of LB medium, containing adequate antibiotic 
(Gentamycin 10 µg/ml for the donor, chloramphenicol 20 µg/ml for the helper and ampicilin 
100 µg/ml for the host), was inoculated with each of strains and incubated at 37°C or 30°C 
until the cultures reached the optical density of OD600nm = 0.8-1.0. In 2 ml sterile reaction 
tube, the 2 ml of host strain P. putida KT2440 were centrifuged for 1 min at 7000 rpm and 
the supernatant was discarded. To the pellet, 1 ml of helper strain E. coli HB101(RK600) and 
500 µl of donor strain solution were added (equilibrated so there is ratio of 2 : 1 : 0.5 of host, 
helper and donor) and centrifuged again for 1 min at 7000 rpm. The mixture was washed 
twice with LB, to remove the traces of antibiotics, and resuspended in 100 µl of LB medium 
without antibiotics. The conjugation suspension was disposed in the sterile nitrocellulose 
filter (0.45 µm diameter) and placed on LB agar plate. After overnight incubation at 30°C the 
bacterial cells from the filter were resuspended in 2 ml of LB medium and serial dilutions 
were plated on the LB agar with gentamycin and ampicillin in order to select the P. putida 
KT2440 transconjugants harbouring the pBBRMCS5-LITE vector. 
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3.5. Transcriptomic analysis  
3.5.1. Total RNA isolation 
Analysis of gene expression of the pathogen directly in infection site is limited by various 
factors connected with RNA extraction. The RNA extracted from clinical samples will most 
likely be a mixture of the bacterial RNA with the host RNA. Due to the low quantity of RNA, 
the procedure for isolation and preparation was optimized for the quality of microarrays on 
the samples collected from burn wound patients. 
3.5.1.1. RNA isolation 
All samples for the RNA measurement were stabilised with RNAprotect bacteria reagent 
(Qiagen). Samples were mixed with this reagent, incubated for 5 - 15 min at room 
temperature and centrifuged for 15 min at 4000 x g in the 4°C. Supernatant was discarded 
and pellet frozen in -70°C. In deep freezer the RNA should remain intact for up to one 
month. Prior to the RNA extraction samples were thawed on ice.  
RNA isolation was performed using RNAeasy Mini Kit (Qiagen) according to manufacturer’s 
instructions with some minor modifications: samples were treated with 600 µl of TE buffer 
containing 1 mg/ml Lysozyme, incubated for 10 min with periodic vortexing every 2 min for 
15 sec. Then, 1050 µl of RLT buffer containing 1% β-mercaptoethanol was added. The sample 
was vortexed and centrifuged for 2 min at maximum speed (ca. 13000 rpm). The 
supernatant was transferred to a fresh 15 ml tube and 750 µl of absolute ethanol was added. 
The sample was loaded onto a spin column where the DNA was digested using RNase-free 
DNase I. The RNA was then eluted twice from each column with 50 µl and then 30 µl of 
RNase-free water. Eluted RNA was treated a second time with DNase I to ensure that all 
traces of genomic DNA were removed. The isolated RNA was stored at -70°C. 
Materials and Methods 
 
52 
 
3.5.1.2. RNA quality measurement 
The yield of the isolated RNA was measured by light absorption at 260nm in Eppendorf 
photometer. The quality and possible degradation was checked by formaldehyde gel 
electrophoresis or by 2100 BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA). Using 
photometrical measurements it is possible to estimate the quality of RNA by calculating the 
ratio of absorption between 260nm and 280nm. The RNA is considered pure and the least 
degraded when the A260:A280 ratio is within 1.7 and 2.1. (Sambrook et al., 1989) 
3.5.1.3. Formaldehyde gel electrophoresis 
In order to obtain a better resolution of the RNA on an agarose gel, electrophoresis was 
performed on a formaldehyde-agarose (FA) gel. The composition of loading buffer and 
agarose gel (see recipes below) prevent RNA from forming secondary structures.  
1.2% FA gel consists of: 
 1.2 g agarose, 10 ml 10x Running buffer, 100 ml RNase-free water, 1.8 ml of 37% 
formaldehyde and 1 µl of 10 mg/ml ethidium bromide solution. 
10x FA gel buffer:  
200 mM 3-[N-morholino]propanesulfonic acid (MOPS), 50 mM sodium acetate, 10 mM 
EDTA, pH adjusted to 7 with 5M NaOH. 
1x FA gel running buffer:  
100 ml 10x FA gel buffer, 20 ml 37% formaldehyde, 880 ml RNase free water. 
5x RNA loading buffer: 
 16 μl saturated aqueous bromophenol blue solution, 80 μl 500 mM EDTA (pH 8.0), 720 μl 
37% formaldehyde, 2 ml 100% glycerol, 3084 μl formamide, 4 ml 10x FA gel buffer, RNase-
free water up to 10 ml. 
The casted gel is first equilibrated by running without RNA at 7 V/cm for 30 min. The samples 
are mixed with 5x loading buffer and incubated for 5 min at 65°C, then cooled on ice and 
Materials and Methods 
 
53 
 
transferred to the gel wells. The samples run at 7 V/cm with the 0.5-10 kb RNA ladder 
(Invitrogen) as the standard. 
3.5.2. Bacterial RNA enrichment 
Since the extracted RNA from the in vivo samples contained both bacterial and eukaryotic 
RNA (i.e. human or mouse), the samples had to be enriched for bacterial RNA. This was 
achieved with the MicrobEnrich Kit® (Ambion, Austin, TX, USA). The basis of the kit is the 
hybridisation of the eukaryotic ribosomal RNA and the messenger RNA to the magnetic 
beads. Hybridisation occurs between specific 18S and 28S RNA regions and polyA tails of 
eukaryotic mRNA. Since there are reports that bacterial mRNA posses poly adenylated 
(polyA) tails to some extent (Saravanamuthu et al., 2004) all of the samples including the 
controls were treated for enrichment.  
That prevents obtaining false positives in microarray analysis. Figure 3-2 presents Agilent 
BioAnalyzer results of total RNA before enrichment and after. 
 
Figure 3-2: Agilent bioanalyzer results of bacterial RNA enrichment from sample p10; a) samples before 
enrichment, peaks from bacterial ribosomal RNA (16S and 23S) are seen together with eukaryotic ribosomal 
RNA (18S and 28S); b) sample p10 after enrichment, only bacterial ribosomal signals are detected 
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3.5.3. RNA amplification  
One of the main bottlenecks in the transcriptomic analysis of host-pathogen interactions is 
the amount of bacterial RNA that can be isolated from the sample taken from the site of 
infection. The well established P. aeruginosa GeneChip® from Affymetrix (Santa Clara, CA, 
USA) requires 10 µg of RNA per microarray. Even with burn wound infections, where the 
amount of bacterial cells is relatively large this amount was never obtained. A promising way 
to overcome this obstacle was with the use of bacterial RNA amplification. This was 
performed using the MessageAmp Bacteria Kit (Ambion). The procedure consists of the 
following steps: i) total enriched bacterial RNA is treated with an enzyme polyadenylation 
polymerase to produce polyA tails, ii) single stranded cDNA is produced using reverse 
transcriptase and oligo dT primers, iii) second strain cDNA is produced, and iv) double 
stranded cDNA serves as a template for in vitro transcription using T7 RNA polymerase and 
T7 oligonucleotides. During the in vitro transcription reaction modified nucleotides where 
used: biotin-11-CTP (PerkinElmer Life Sciences, Waltham, MA, USA) and biotin-16-UTP 
(Roche Applied Science, Basel, Switzerland). As a result we obtained antisense biotinilated 
RNA, ready to use for GeneChip® hybridisation. 
3.5.4. Affymetrix microarrays analysis 
The use of amplified RNA is common with eukaryotic microarrays, but the original procedure 
for P. aeruginosa GeneChip® (Affymetrix) was prepared only for single stranded terminally 
labeled cDNA procedure. Comparing to the standard procedure (without amplification), 
amplifying RNA for microarray analysis does not change the final outcome as reported by 
Francois et al., (2007). The hybridisation and washing steps were performed in the 
Affymetrix Array facility in HZI Braunschweig (Dr. Robert Geffers). Because the RNA was 
amplified, some changes were introduced to the original Affymetrix protocol, such as that 
the RNA was fragmented using 5x fragmentation buffer instead of DNaseI treatment. The 
total amount of amplified and fragmented RNA used per chip was 6.5 µg. 
The process of sample preparation for each chip was as follows: 
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• The RNA from each single condition was pooled together after the enrichment.  
• Amplification step was performed on each condition 
• Amplified RNA was hybridised onto duplicate microarray chips in order to have 
technical replicates 
Initial steps of data analysis were done in Array facility using Affymetrix Microarray Suite 
Software 5.0 with default parameters. Once raw data files of scanned pictures were 
obtained further bioinformatic analysis was made as described in section 3.7. 
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3.6. Statistical analysis 
The statistical approach used to analyse the microarray data in this work is indicated in red 
in Figure 3-3. 
 
Figure 3-3: Scheme of the typical microarray data analysis approach using supervised and unsupervised 
routines. Those routines used for this work are indicated in red. 
Classification or class 
prediction: 
• Linear discriminant 
analysis (LDA) 
• Promotor analysis 
• Recursive partitioning i.e. 
Decision or classification 
trees  
• Support vector machines 
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3.6.1. Microarray data normalisation 
All of the analyses mentioned in sections 3.6.2 and 3.6.3 were performed with applications 
belonging to appropriate software packages from Bioconductor microarray analysis suite 
(Gentleman et al., 2004). The quality of all chips was assessed by fitting a linear model to the 
probe level data using the function “fitPLM” from the “affyPLM” package. Subsequently, the 
distribution (boxplots) of RLE (Relative Log Expression) and NUSE (Normalised Unscaled 
Standard Errors) were manually analysed. Expression values were computed using the 
“Robust Multichip Average” algorithm (Irizarry et al., 2003). The computations were done 
using function “rma” from the package “affy”. 
3.6.2. Differential Expression 
As the number of replicates was low, the “Rank Products” algorithm was used to identify 
differentially expressed genes (Breitling et al., 2004). It has been shown that this algorithm 
performs well when the number of replicates is low (Jeffery et al., 2006).  The algorithm 
addresses the multiple testing problems by calculating for every gene an estimate of 
percentage of false-positives (pfp), if this gene and all genes with lower pfp would be 
considered as significantly differentially expressed. Thus, it is an estimate of False Discovery 
Rate (FDR). The value of 0.05 was accepted as a cut-off for pfp. The computations were 
performed using function Rpadvance from the “RankProd” package. A list of significantly 
differentially expressed genes was created for every pair of growth conditions (burn wound, 
lettuce, mouse tumour, planktonic, biofilm, CF patient infection). 
3.6.3. Hierarchical clustering 
On all genes that showed significant expression change in at least one pairwise comparison 
between the experiments (1677 genes) hierarchical clustering was performed (correlation 
was used as the distance measure, the clustering was performed with the “hclust” function 
from the R software suite, http://www.r-project.org/). Subsequently, the outcome of the 
clustering was used to identify groups of genes following similar pattern of expression 
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changes (222 groups were created). The expression values were averaged within each of the 
groups to form for each of them a group-wide expression pattern. Finally, the hierarchical 
clustering was performed on the groups, following the same procedure as previously. The 
dendrogram, together with the heatmap composed of the group-wide expression values 
were plotted. 
3.6.4. Multivariate statistics 
For the unsupervised approach of gene expression visualisation the non-metric 
multidimensional scaling (nMDS) routine was used. The nMDS was shown to be useful to 
represent high dimensional data in a low dimensional space with preservation of the 
similarities between data points. When the data configuration is Euclidean, MDS is similar to 
principle component analysis (PCA), which can remove inherent noise with its compact 
representation of data (Tzeng et al., 2008). However, PCA is a linear algebraic routine which 
is restricted to the domain of Euclidean input spaces where variance is a properly defined 
concept (Strickert et al., 2007). It was shown that nMDS is more powerful to present data in 
low-dimensional spaces (Taguchi & Oono, 2005, Strickert et al., 2007). 
Non-parametric multivariate statistical analysis was performed using PRIMER v6 (Plymouth 
Marine Laboratory, UK) (Clarke, 1993). The multivariate routines applied here were non-
metric multidimensional scaling (nMDS), analysis of similarity (ANOSIM) and similarity 
percentage analysis (SIMPER) described previously (Wilber et al., 2007). Sample-similarity 
matrices were calculated from gene expression level data using the Euclidean distance (the 
commonly used dissimilarity measure) (Butte, 2002). In this case, each gene is a point in 
multidimensional space where each axis (dimension) is a separate infection condition and 
the coordinate on each axis is the level of gene expression (Wen et al., 1998). MDS was used 
to ordinate each sample with each other sample based on the comparative expression level 
of 1677 genes, which were those that were differentially regulated in at least one 
comparison between in vivo and in vitro conditions. The program used 50 random restarts to 
find the optimal ordination and stress value. The stress value of each MDS value plot 
represents an estimation of the quality of fit of the data. A stress value below 0.1 
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corresponds to an ideal ordination indicating that there is no real prospect of 
misinterpretation, a stress value below 0.2 corresponds to a useful indicating a valuable 2D 
representation and stress value higher than 0.2 indicates that the plot is close to random 
(Clarke & Warwick, 2001).  
Analysis of similarity (ANOSIM) was used to test for significant differences between 
predefined groups of samples (burn wound infection, mouse tumor infection, lettuce 
infection, biofilm and planktonic growth). It produces a test statistic (R) which can range 
from -1 to 1 and is a useful comparative measure of the degree of separation between 
groups. An R-value higher than 0 indicates the null hypothesis is true, and that there are no 
significant differences between groups. R usually falls between 0 and 1 which indicates some 
degree of distinction between groups. An R-value lower than 0.25 indicates barely separable 
groups, a R-value higher than 0.5 indicates clear differences between groups with some 
degree of overlap, and a R-value higher than 0.75 indicates well separable groups  (Wilber et 
al., 2007). When testing more than two groups a global R test indicates if differences 
between groups are present that may be worth examining further. If the Global R is not 
significant, generally no further interpretation is permissible. If it is significant, R-values for 
each pairwise comparison should be examined. Similarity percentages analysis (SIMPER) was 
used to determine which of the genes mostly contribute to the similarity and dissimilarity 
between different infection conditions. 
3.7. Proteomic analysis 
3.7.1. Extracellular proteins extraction 
Supernatants obtained after centrifugation of the bacterial cultures at 6000 x g for 15 min at 
4°C were passed through a 0.2-µm-pore-size filter. Deoxycholic acid (sodium salt) was added 
to a final concentration of 0.2 mg/ml. After 30 min of incubation on ice, the proteins were 
precipitated by addition of trichloroacetic acid to a final concentration of 10% (w/v) and 
incubated at 4°C overnight. After centrifugation at 10000 x g for 30 min the precipitated 
proteins were resuspended in an appropriate amount of rehydration solution (7 M Urea, 
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Serdolit, 2 M Thio-urea, 4% w/v CHAPS, 20 mM Trizma base). Protein extracts were re-
precipitated with 2D Clean-Up Kit (Amersham Bioscience, Pittsburgh, PA, USA), resuspended 
in 200 µl of rehydratation solution and stored at -70°C until further use. 
3.7.2. Two-dimensional gel electrophoresis 
3.7.2.1. Isoelectric focusing 
Analytical determinations were carried out with 100 μg of protein mixture determined by 
Bradford test (Bio-Rad protein assay, Bio-Rad, Hercules, CA, USA), diluted up to 300 μl with 
rehydration solution in the presence of ampholytes and under reducing conditions on 
ReadyStrip IPG strips, 17 cm, pH 4-7 (Bio-Rad). Passive rehydration was carried out for 2h at 
20°C on the focusing tray. Samples were covered with silicon oil to avoid dehydration. Active 
rehydration was performed at 50 V for 12 h. Isoelectric focusing was done at a final voltage 
of 10000 V on Protean®IEF cell (Bio-Rad) until reaching 75 kWh. Focused samples were 
stored at -70°C until the second dimension step. 
3.7.2.2. Second dimension: equilibration and SDS-PAGE 
Focused ReadyStrip IPG strips were equilibrated first in equilibration buffer containing Urea 
6 M, Trizma Base 0.375 M (pH 8.6), Glycerin 30% v/v, SDS 2% w/v and DTT 2% w/v and later 
in the same buffer replacing DTT with iodoacetamide 2.5% w/v. After equilibration, second-
dimension separation was performed on 12-15% gradient SDS polyacrylamide 20x20 cm gels 
with the focused sample embedded in 0.5% IEF agarose in a Protean Plus Dodeca Cell (Bio-
Rad) at 100 V overnight. The gels were fixed in 10% trichloroacetic acid solution for a 
minimum of 3 h, stained with 0.1% w/v Coomassie™ Brilliant Blue G-250 solution overnight 
and finally destained with distilled water. Images of the 2-DE gels were captured with a 
molecular imager GS-800 calibrated densitometer (Bio-Rad) and processed using Z3 image 
analysis software (Compugen, San Jose, CA, USA) for protein differential expression analysis. 
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3.7.3. Protein differential expression 
Differential expression (DE) analysis was done using Z3 image analysis software version 3.0.7 
(Compugen). Briefly, scanned gel images were saved in grayscale, 300 dpi with no 
adjustments. Images were first subject to automatic spot detection, with automatic 
minimum spot contrast and manually adjusted minimum spot area (100, arbitrary units). 
Detected spots were edited manually in order to obtain an optimal pattern. A three 
independent replicates for each reference condition were analysed and combined using the 
Raw Master Gel (RMG) algorithm. Comparison of the RMG reference gel was performed in 
triplicate, that were independently wrapped and matched to the reference RMG to obtained 
at least three independent DE sets. DE was defined as the ratio of spot expression in a 
comparative image to the expression of a corresponding spot in a reference image. 
Upregulation corresponds to a two-fold or higher DE values and downregulation to 0.5-fold 
or lower DE values. 
3.7.4. Protein identification 
Protein spots were excised manually from the gels. Spots were destained, and digested 
overnight using sequence grade modified trypsin (Promega, Madison, WI, USA). The 
peptides were eluted and desalted with ZipTip® (Millipore, Bedford, MA, USA). For MALDI-
ToF analysis, the samples were loaded along with α-cyano-4-hydroxycinnamic acid matrix. 
The target was then analysed using an Ultraflex II ToF (Bruker Daltonics Inc. Billerica, MA, 
USA) and resulting spectra were used for Peptide Mass Fingerprint (PMF), analysed using 
FlexAnalysis 2.0 and Biotools 2.2 software (Bruker Daltonics Inc.). Database search was 
carried out on NCBInr database using Profound version 4.10.5 (Proteometrics, New York, NY, 
USA). 
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4. Results 
4.1. Analysis of P. aeruginosa burn wound isolates  
4.1.1. Resistance patterns 
All fourteen P. aeruginosa strains isolated from burn patients were characterised for their 
susceptibility to 20 common antibiotics (Table 4-1) using the VITEK2 system (Biomerieux). 
The difference in resistance to these antibiotics was compared to P. aeruginosa strains PAO1 
and PA14. Among the commonly used anti-pseudomonal agents are: the beta-lactams 
(piperacilin, cefoperazone, ceftazidime, cefepime, imipenem and meropenem); 
fluoroquinolons (ciprofloxacin and levofloxacin); and the aminoglicosides (gentamycin, 
tobramycin and amikacin) (Rossolini & Mantengoli, 2005). However, clinical strains acquire 
resistance to such agents, becoming multitresistant and complicating the eradication from 
nosocomialy infected patients.  
The isolated P. aeruginosa strains from the Centre for Burn Treatment in Sieminowice Śląskie 
(CLO) presented a broad spectrum of antibiotic resistance, with some exhibiting a similar 
pattern to PAO1 and PA14 and others to the more multiresistant strains. For example, 
isolates PBCLOp5, PBCLOp11 and PBCLOp14 exhibited a resistance pattern similar to PAO1 
and PA14 whereas isolates PBCLOp4, PBCLOp6, PBCLOp7 and PBCLOp15 showed resistance 
to piperacilin as well as to aminoglicosides and fluoroquinilons. The strains that have 
resistance to more antibiotics were isolates PBCLOp10 and PBCLOp17, which were resistant 
to both piperacilin and the combination of piperacilin with beta-lactamase inhibitor 
tazobactam. PBCLOp10 is susceptible to fluoroquinolones, while PBCLOp17 is only 
susceptible to carbapenem antibiotic meropenem, making it the most multiresistant of these 
14 clinical strains.  
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Table 4-1: Antibiotic resistance patterns of clinical P. aeruginosa strains. R = Resistant, S = Susceptible and I = 
Intermediate. R in bold represents the result different than in the wildtype strains.  
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PAO1 R R S S R R R R R I I S S S S R I I R R 
PA14 R R S S R R R R R I I S S S S R S S R I 
PBCLOp1 R R S S R R R R R R S S S R R R R R R R 
PBCLOp2 R R S S R R R R R R S I S R R R R R R R 
PBCLOp4 R R R S R R R R R R S I S R R R R R R R 
PBCLOp5 R R S S R R R R R R S S S S S R S S R R 
PBCLOp6 R R R S R R R R R R S I S R R R R R R R 
PBCLOp7 R R R S R R R R R R S I S R R R R R R R 
PBCLOp8 R R S S R R R R R R S S S R S R S S R R 
PBCLOp9 R R S S R R R R R R R S S R R R I I R R 
PBCLOp10 R R R R R R R R R R I I R R R R S S R R 
PBCLOp11 R R S S R R R R R R I I S I S R R I R R 
PBCLOp14 R R S S R R R R R R S S S S S R S S R R 
PBCLOp15 R R R S R R R R R R S I S R R R R R R R 
PBCLOp16 R R R S R R R R R R S I S R S R S S R R 
PBCLOp17 R R R R R R R R R R R R S R R R R R R R 
*Full name: Trimethoprin/Sulfamethoxazole 
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4.1.2. Genotyping of P. aeruginosa strains  
Genotyping analysis was used to determine the population structure of P. aeruginosa at the 
CLO. Figure 4-1 presents the genetic tree aligning approximately 1700 P. aeruginosa isolates 
from Medizinische Hohschule Hannover with the 14 burn wound strains collected in this 
work. Well studied strains of P. aeruginosa are indicated as blue and the isolated strains as 
green. This phylogenetic tree shows that the six isolates PBCLOp1, 2, 4, 6, 7, 15 are 
representatives of the same clone. Interestingly, since sampling of strains PBCLOp1 and 
PBCLOp15 was performed two years apart it can be assumed that this clone is permanently 
residing at the CLO. Also, the clones PBCLOp4, 6, 7 and 15 exhibited resistance to the same 
antibiotics (Table 4-1), while strains PBCLOp1 and PBCLOp2 differed only in piperacilin 
resistance. Strains PBCLOp5, 10, 14 and 17 are the other group of highly similar but not 
identical clones. They are closely related to the P. aeruginosa strain CHA which is a highly 
virulent isolate from a CF patient in France (Morales et al., 2004). Strains PBCLOp8 and 11 
are also closely related to each other. PBCLOp9 and 16 are different from other strains in the 
database.  
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Figure 4-1: Genetic tree constructed with the eBurst algorithm. The branches joined together have a 
difference of one SNP. The clones which have a difference greater than one SNP are not connected. Blue dots 
indicate strains that are previously reported, while green dots indicate strains that were isolated in this 
work. Red circles indicate clones used for transcriptional profiling in this work.  
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4.2. Elucidating the genetic programs of P. aeruginosa in different 
infection conditions 
The principal aim of this work was to assess the difference of the genetic programs between 
the non-virulent and virulent conditions by comparing their transcription profiles. While the 
burn wound infection is the key in vivo condition addressed in this work, it is followed by the 
preliminary analysis of a clinical strain from a CF patient, and 2 models of infection: the plant 
infection model performed on lettuce leaves and the novel tumour mouse infection model. 
The non-virulent conditions serving as controls were planktonic and biofilm growth on rich 
LB broth. The differential gene expression is calculated by comparing each in vivo sample to 
both of these non-virulent conditions.  
4.2.1. Burn wound infection 
A number of preliminary tests assessing microarray hybridisation revealed that successful 
analysis can only be obtained when using pure cultures of P. aeruginosa. That is, even when 
bacterial RNA was extracted in sufficient amounts from clinical samples, only those samples 
which comprise homogenous P. aeruginosa could be used. Thus, these isolates were 
PBCLOp10, PBCLOp11 and PBCLOp17 and are all different clone variants of P. aeruginosa 
(Figure 4-1). Therefore, the data obtained was not clone specific but incorporates distinctive 
P. aeruginosa characteristics. 
4.2.1.1. Transcription profiling 
Table 8-1 on page 146 in appendix shows the differentially expressed genes that have a 
percent-of-false positive (pfp) value lower than 0.05. When comparing the burn wound 
infection with the 2 control conditions of planktonic and biofilm growth, there were 244 and 
232 genes upregulated, and 334 and 270 genes downregulated, respectively. This whole list 
of significantly regulated genes provides a comprehensive overview on the state of P. 
aeruginosa cells during a burn wound infection. It is not possible to describe all of these 
genes here, so only those genes with higher changes and also those that appear interesting 
from the point of view of infection will be further presented and discussed (Table 4-2).  
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Table 4-2: Summary of those genes that were differentially expressed (pfp < 0.05) and that also have a higher 
change or appear interesting in the context of burn wound infection. 
PA Number Gene 
Fold change compared to: 
Product Name Planktonic Biofilm 
PA0102  7.46 12.11 probable carbonic anhydrase 
PA0105 coxB -12.23  cytochrome c oxidase, subunit II 
PA0106 coxA -35.41  cytochrome c oxidase, subunit I 
PA0107  -34.07  conserved hypothetical protein 
PA0108 coIII -69.43 -3.09 cytochrome c oxidase, subunit III 
PA0472 fiuI   3.93 probable sigma-70 factor, ECF subfamily 
PA0652 vfr 2.36  transcriptional regulator Vfr 
PA0707 toxR 4.34 4.16 transcriptional regulator ToxR 
PA0762 algU  2.75 sigma factor AlgU 
PA0763 mucA  4.78 anti-sigma factor MucA 
PA1300   5.49 probable sigma-70 factor, ECF subfamily 
PA1581 sdhC 3.13  succinate dehydrogenase (C subunit) 
PA1582 sdhD 3.10  succinate dehydrogenase (D subunit) 
PA1787 acnB 2.07  aconitate hydratase 2 
PA1912  2.53 3.23 probable sigma-70 factor, ECF subfamily 
PA2426 pvdS 5.42 10.43 sigma factor PvdS 
PA2624 idh 5.28  isocitrate dehydrogenase 
PA2640 nuoE -4.48 -4.59 NADH dehydrogenase I chain E 
PA2643 nuoH -5.17 -4.35 NADH dehydrogenase I chain H 
PA2646 nuoK -3.44 -3.24 NADH dehydrogenase I chain K 
PA2647 nuoL -2.63 -2.53 NADH dehydrogenase I chain L 
PA3407 hasAp 31.45 33.33 heme acquisition protein HasAp 
PA3540 algD 3.96 3.90 GDP-mannose 6-dehydrogenase AlgD 
PA3600 rpl36  434.78 1000.00 conserved hypothetical protein 
PA3601 ykgM  232.56 175.44 conserved hypothetical protein 
PA4063  29.07 24.75 probable ATP-binding component of ABC 
PA4064  5.04 4.56 transporter 
PA4065  3.92 3.97 hypothetical protein 
PA4175 piv  5.62 protease IV 
PA4370 icmP  2.92 
Insulin-cleaving metalloproteinase outer 
membrane protein precursor 
PA4834  6.45 6.07 hypothetical protein 
PA4835  14.31 13.40 hypothetical protein 
PA4836  22.42 20.24 hypothetical protein 
PA4837  24.15 22.17 probable outer membrane protein precursor 
PA4896  3.43 3.54 probable sigma-70 factor, ECF subfamily 
PA5170 arcD  3.84 arginine/ornithine antiporter 
PA5171 arcA  3.65 arginine deiminase 
PA5172 arcB  3.60 ornithine carbamoyltransferase, catabolic 
PA5173 arcC  4.14 carbamate kinase 
PA5373 betB 4.85 3.87 betaine aldehyde dehydrogenase 
PA5374 betI 28.01 7.17 Transcriptional regulator BetI 
PA5499 np20 4.18 5.68 Transcriptional regulator np20 
PA5500 znuC 2.39  zinc transport protein ZnuC 
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Ribosomal proteins and zinc 
The genes PA3600 and PA3601 exhibited the highest upregulation (Table 4-2). These two 
genes are annotated as encoding “conserved hypothetical proteins” (Pseudomonas Genome 
Database at www.pseudomonas.com). Based on similarity searches, their products are 
predicted to be paralogues of the 50S ribosomal protein L36 encoded by rpmJ (PA4242) and 
the 50S ribosomal protein L31 encoded by rpmE (PA5049), respectively. Paralogues of 
proteins L36 are also present in Vibrio cholerae and Neisseria meningitidis, while paralogues 
of L31 are found in Escherichia coli, Bacillus subtilis, Vibrio cholerae and Neisseria 
meningitidis (Makarova et al., 2001). The difference between them is that the first contains 
the metal-binding Zn-ribbon, which consists of four conserved cysteins, whereas the second 
is void of metal chelating residues. The Zn binding form is designated C+ and the paralogue 
C- (Makarova et al., 2001). The genes PA3600 and PA3601 are C- forms. Detailed studies 
regarding the swap of these two proteins in ribosome structure have been performed on 
Bacillus subtilis and Streptomyces coelicolor (Nanamiya et al., 2006, Owen et al., 2007, Shin 
et al., 2007). It was revealed that expression of C- form of ribosomal proteins L31 and L36 is 
connected with zinc limitation and regulated by the zinc uptake regulator zur (Owen et al., 
2007). Indeed, among the genes upregulated in the burn wound infection there was a np20 
gene (see PA5499, Table 4-2) which is homologous to E. coli gene zur encoding zinc uptake 
regulator and it has been reported to be involved in virulence (Gallagher et al., 2002). In 
comparison with planktonic growth, gene znuC encoding a zinc transport protein was 
upregulated. It is interesting that the overexpression of genes PA3600 and PA3601 as well as 
np20 has been observed when P. aeruginosa cells were in contact with eukaryotic tissue, e.g. 
in rat peritoneum (Mashburn et al., 2005) or in the epithelial cell lines (Chugani & 
Greenberg, 2007). 
Iron starvation regulated genes 
One of the major bottlenecks that bacterial pathogens have to overcome is the availability of 
iron (Takase et al., 2000, Letoffe et al., 1998). In the transcription profile of burn wound 
infection, iron starvation genes are clearly upregulated. In this work, 50 of the 118 genes 
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that Ochsner et al (2002) reported to be involved in iron starvation, were differentially 
regulated (Table 4-3). 
P. aeruginosa possesses two distinct endogenous siderophores, pyoverdine and pyochelin. 
The pyoverdin synthesis pathway (involving pvd genes) was upregulated in comparison to 
both controls. However, the pyochelin synthesis pathway was more expressed (involving pch 
genes) during planktonic growth. This was expected, as pyochelin is less efficient than 
pyoverdine, thus under iron limited conditions during host infection the siderophores are 
expressed in a hierarchy promoting a more efficient system. In addition to ferric iron 
provided by siderophores, P. aeruginosa acquires iron from heme and heme-containing 
proteins such as haemoglobin. In this work, the gene hasAp encoding the heme acquisition 
protein was overexpressed together with the gene hemO (pigA) encoding for heme 
oxygenase which degrades heme to biliverdine and releases iron.  
Table 4-3: Expression values of those genes (previously reported to response to iron starvation by Ochsner et 
al,. 2002) that were differentially expressed in respect to the planktonic and biofilm growth in this work. 
PA 
number 
Gene Fold change compared to: Product name 
Planktonic Biofilm 
PA0472 fiuI  3.93 probable sigma-70 factor, ECF subfamily 
PA0672 hemO  6.84 heme oxygenase 
PA0707 toxR 4.34 4.16 transcriptional regulator ToxR 
PA1134  3.67 3.69 hypothetical protein 
PA1300   5.49 probable sigma-70 factor, ECF subfamily 
PA1301   4.22 probable transmembrane sensor 
PA2033   3.03 hypothetical protein 
PA2034  -1.29 4.14 hypothetical protein 
PA2383  2.69 4.24 probable transcriptional regulator 
PA2384  3.09 12.29 hypothetical protein 
PA2385 pvdQ 5.70 5.47 PvdQ 
PA2386 pvdA 4.16 4.36 L-ornithine N5-oxygenase 
PA2393  2.84 3.47 probable dipeptidase precursor 
PA2395 pvdO 3.79 3.90 PvdO 
PA2404  2.94 4.19 hypothetical protein 
PA2405  4.01 4.63 hypothetical protein 
PA2406  3.51  hypothetical protein 
PA2407  2.57 2.50 probable adhesion protein 
PA2411  6.05 15.46 probable thioesterase 
Results 
 
70 
 
PA2412  5.76 13.16 conserved hypothetical protein 
PA2413 pvdH 3.69 4.69 L-2,4-diaminobutyrate:2-ketoglutarate 4-
aminotransferase, PvdH 
PA2424 pvdL 3.23 4.57 PvdL 
PA2425 pvdG 2.34 3.78 PvdG 
PA2426 pvdS 5.42 10.43 sigma factor PvdS 
PA2531  2.33  probable aminotransferase 
PA3397 fpr 2.93  ferredoxin—NADP+ reductase 
PA3407 hasAp 31.45 33.33 heme acquisition protein HasAp 
PA3530 bfd  2.67 conserved hypothetical protein 
PA3811 hscB 2.32  heat shock protein HscB 
PA3812 iscA 2.46  probable iron-binding protein IscA 
PA4175 piv  5.62 protease IV 
PA4220 fptB -2.67 7.49 hypothetical protein 
PA4221 fptA -1.40 3.72 Fe(III)-pyochelin outer membrane receptor precursor 
PA4223 pchH -3.51 2.93 probable ATP-binding component of ABC transporter 
PA4224 pchG -3.41 3.83 pyochelin biosynthetic protein PchG 
PA4227 pchR  5.21 transcriptional regulator PchR 
PA4230 pchB -1.31 4.32 salicylate biosynthesis protein PchB 
PA4370 icmP  2.92 Insulin-cleaving metalloproteinase outer membrane 
protein precursor 
PA4467   10.06 hypothetical protein 
PA4468 sodM 3.57 16.95 superoxide dismutase 
PA4469   9.95 hypothetical protein 
PA4470 fumC1  15.70 fumarate hydratase 
PA4471 fagA 3.22 7.59 hypothetical protein 
PA4570   14.01 hypothetical protein 
PA4833   5.77 conserved hypothetical protein 
PA4896  3.43 3.54 probable sigma-70 factor, ECF subfamily 
PA5150   3.58 probable short-chain dehydrogenase 
PA5217   2.71 probable binding protein component of ABC iron 
transporter 
PA5531 tonB  3.06 TonB protein 
 
The iron starvation response also induces many factors directly involved in virulence. For 
example, the transcriptional regulator toxR (regA) controls the expression of Exotoxin A. 
There were also two proteolitic enzymes overexpressed: (i) the gene icmP encoding an 
insulin-cleaving metalloproteinase outer membrane protein precursor, which is capable of 
cleaving beta and alpha fibrinogen chains (Fricke et al., 1999); and, (ii) the protease IV 
encoded by piv (also known as prpL) which is an endoprotease that cleaves iron containing 
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proteins and which has been reported to be necessary for corneal infection and contributes 
to persist in rat chronic pulmonary infection model (O'Callaghan et al., 1996, Wilderman et 
al., 2001). Interestingly, in the burn wound infection, there was no significant increase in 
expression of 2 other proteases well known to be involved in P. aeruginosa virulence in 
other infection conditions, namely, elastase and alkaline protease. 
Uncharacterised gene clusters 
There are many genes encoding hypothetical and conserved hypothetical proteins  
differentially expressed in all analyses done. The two predicted operons (using Prodoric 
database, prodoric.tu-bs.de), PA4063-PA4066 and PA4834-PA4837 are worth closer analysis. 
According to the Pseudomonas Genome Database, the gene PA4063 encodes a protein that 
is exported across the inner membrane (Lewanza et al., 2005). According to database the 
genes PA4064 and PA4065 are predicted to be an ABC-type antimicrobial peptide transport 
system, ATPase and permease component, respectively. The last gene in this operon, 
PA4066, encodes a putative lipoprotein which has also been proven to be transported across 
the inner membrane (Lewenza et al., 2005). It can be hypothesised that the operon PA4063-
PA4066 encodes the antimicrobial transport system. 
The gene PA4837 has a 45% aminoacid similarity to the ferrichrome iron receptor in 
Enterobacter agglomerans. Also, this gene is predicted to encode FhuE, an outer membrane 
receptor for ferric coprogen and ferric-rhodotorulic acid, while also being a TonB-dependent 
receptor. The following gene in the operon is PA4836, which encodes a hypothetical 
conserved protein with a conserved domain of nicotianamine synthase protein. This protein 
is involved in iron acquisition in plants. However, it is not clear what is exactly the product of 
this gene in P. aeruginosa. The gene PA4835 encodes for a hypothetical protein with at least 
one transmembrane helice. The last gene in the cluster, PA4834, is predicted to encode a 
putative permease. It is possible that the last 2 genes encode for the transporter of a novel 
siderophore encoded by PA4836 while the product of the first gene in this operon is 
responsible for the receptor sensing this siderophore. 
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Energy production and metabolism 
When comparing the burn wound infection to the planktonic growth control, there was 
upregulation of the citrate cycle genes encoding for the proteins responsible for 
transformation of citrate to 2-oxoglutarate acnB (PA1787) and idh (PA2624). The genes sdhC 
and sdhD, encoding for succinate dehydrogenase C and D subunits were also overexpressed. 
Succinate dehydrogenase transforms succinate to fumarate and is one of the complexes 
included in oxidative phosphorylation. The other oxidative phosphorylation complexes, 
NADH dehydrogenase (PA2640, PA2643, PA2646 and PA2647) and Cytochrome C oxidase 
(PA0105-8) were all downregulated. When the burn wound infection is compared to the 
biofilm growth there was downregulation of all complexes of oxidative phosphorylation. All 
proteins from these systems contain both heme and iron, thus the conditions of iron 
starvation could explain the lower expression of genes encoding these proteins. Another 
interesting finding was the overexpression (in comparison with the biofilm growth) of the 
arginine deaminase pathway (involving the genes arcABCD), which may use arginine as a 
source of energy by fermentation during anaerobic conditions (Vander Wauven et al., 1984). 
This finding raises the question of whether P. aeruginosa infecting burn wound has the 
anaerobic fermentation active parallel to the inhibited aerobic oxidation. That could be 
connected with the limited iron, which is needed for active oxidative phosphorylation 
complexes.  This hypothesis will be further discussed in section 5.2. However, these different 
results may be also due to the heterogeneity of the cellular states in the samples, as they 
generally a mixture of bacteria at different depths in a biofilm, where steep oxygen gradients 
prevail. In general, it can be seen that P. aeruginosa residing at the burn wound surface have 
lower viability and are less metabolically active compared to the planktonic and biofilm 
growth on rich LB medium.  
In comparison to both controls, the induction of the PA0102 gene encoding a probable 
carbonic anhydrase can be observed. This is a zinc containing enzyme that catalyzes the 
interconvertion of carbon dioxide and bicarbonate. Carbonic anhydrase has been reported 
to be involved in maintaining the pH in the cytoplasm of Helicobacter pylori colonising gastric 
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mucosa (Bury-Mone et al., 2008). Also, the same gene is upregulated when Salmonella 
enterica serovar Typhimurium is taken up by macrophages (Valdivia & Falkow, 1997).  
The gene betB encodes a betaine aldehyde dehydrogenase, which is regulated by the 
product of gene betI. Both of these genes were upregulated when comparing burn wound 
infection with the control conditions. Betaine aldehyde dehydrogenase is responsible for 
production of glycine betaine which is the major osmoprotectant for bacterial cells (Csonka 
& Hanson, 1991). There are also reports showing that P. aeruginosa is able to utilise 
phosphatydylocholine from lung surfactant as carbon and nitrogen sources. The first step in 
the transformation of this compound is the cleavage of phophatidylocholine by 
phospholipase C, which results in phophorylcholine transformed later with use of enzymes 
encoded by bet operon (Son et al., 2007). However, only betB was shown to be 
overexpressed in this work. 
4.2.1.2. Regulatory networks 
The genome of P. aeruginosa encodes 5570 open reading frames. These genes are regulated 
via an extensive network of transcriptional regulators and two-component regulatory 
systems (Stover et al., 2000). Various regulators are responsible for standard housekeeping 
reactions within the cell but also for virulence factors and survival during infection. Figure 4-
2 presents a simplified interrelation between various regulators which were upregulated in 
the burn wound infection and the genes which were controlled by these regulators. 
When comparing the burn wound infection to the in vitro planktonic growth there was an 
overexpression of the vfr gene encoding for the virulence factor regulator Vfr, which is a 
cAMP receptor protein and has been termed due to its effect on the production of several 
virulence factors (West et al., 1994a). Regulation of these factors is principally due to the 
induction of the las QS system (Albus et al., 1997), followed by subsequent induction of the 
rhl system by las. The Vfr regulator also directly controls ToxR, the regulator of Exotoxin A 
production and the synthesis of Protease IV (gene piv) (West et al., 1994a). 
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One of the regulators overexpressed during the burn wound infection (compared to the 
biofilm control) is AlgU. This is an alternative sigma (σ) factor also known as RpoE or σ22 
belonging to the family of extracytoplasmic function (ECF) sigma factors. It has been shown 
to be important in converting from the nonmucoid to mucoid phenotype in CF patients 
(Schurr et al., 1996), as well as in oxidative and heat-shock stress (Schurr & Deretic, 1997). 
AlgU induces the expression of algD (PA3540) which is the first gene in the alginate 
biosynthesis operon algD-A (PA3540-PA3551). The anti-sigma factor of AlgU is MucA 
encoded by the mucA gene, which was also upregulated in the burn wound infection. This 
underscores the precise regulation of alginate production in bacteria infecting the host 
(Schurr et al., 1996). AlgR is another transcriptional regulator involved in alginate 
production, which was also upregulated during the burn wound infection. This member of 
the LytTR family of a two-component transcriptional regulator (Nikolskaya & Galperin, 2002) 
is also reported to be required for twitching motility utilizing type IV pili (Whitchurch et al., 
1996) and represses the production of hydrogen cyanide and the putative cbb3-type 
cytochrome PA1557 (Lizewski et al., 2004).   
PvdS is another ECF sigma factor upregulated in the burn wound infection. Figure 4-2 
presents the genes upregulated by PvdS. PvdS, together with anti-sigma factor FpvR 
(PA2388) regulates the production of pyoverdine and also controls the production of the 
different extracellular virulence factors, i.e. Protease IV and exotoxin A. While PvdS is 
controlled by a Fur repressor (ferric uptake regulator), the other genes controlled by Fur are 
shown in Figure 4-2. 
In addition to PvdS and AlgU there are 19 ECF sigma factors present in the P. aeruginosa 
genome. Of these, 14 display sequence similarity with iron starvation sigma factors (Llamas 
et al., 2008), while of these, 4 are induced during the burn wound infection: (i) PA0472 
encoding ECF protein Fiu, which regulates iron uptake via ferrichrome (Llamas et al., 2008); 
(ii) PA1300 with a similarity of 54% to E. coli FecI and probably regulates heme uptake 
(Llamas et al., 2008); (iii) PA1912 encoding FemI ECF protein which regulates the uptake via 
heterologous siderphore mycobactin/carboxymycobactin, and (iv) PA4896 with a similarity 
of 64% to E. coli FecI and functions for siderophore uptake (Llamas et al., 2008). 
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Figure 4-2: Graphic presentation of the regulatory relations in the burn wound infection. The network was 
created using the web based interface ProdoNet (Klein et al., 2008). The legend was adapted from 
http://prodoric.tu-bs.de/prodonet/ 
Results 
 
76 
 
4.2.2. Cystic Fibrosis pulmonary infection - a preliminary investigation 
To assess the possible differences and similarities of in vivo gene expression of a CF isolate as 
compared to planktonic controls, transcription analysis was performed on a sputum sample 
obtained from a CF patient. The CF patient’s sputum was treated in a similar manner to the 
burn wound samples. The P. aeruginosa strain isolated from the patient was cultivated in LB 
medium and the planktonic control performed as for the other clinical strains. The 
microarray data analysis was performed on the duplicates of the clinical sample and 
duplicates of the planktonic growth sample. The same conditions and the same pfp value 
threshold were set at 0.05. Table 4-4 presents the list of those differentially regulated genes.  
Table 4-4: Differentially regulated genes (pfp < 0.05) during a CF pulmonary infection. 
PA Number Gene  Fold change Product Name 
PA0105 coxB -94.13 cytochrome c oxidase, subunit II 
PA0106 coxA -353.90 cytochrome c oxidase, subunit I 
PA0107  -274.10 conserved hypothetical protein 
PA0108 coIII -509.26 cytochrome c oxidase, subunit III 
PA0110  -80.38 hypothetical protein 
PA0111  -188.03 hypothetical protein 
PA0176 aer2 -79.93 aerotaxis transducer Aer2 
PA0179  -104.28 probable two-component response regulator 
PA0465 creD 120.48 inner membrane protein CreD 
PA0466  81.97 hypothetical protein 
PA0578  82.64 conserved hypothetical protein 
PA0672 hemO 142.86 heme oxygenase 
PA0866 aroP2 -281.13 aromatic amino acid transport protein AroP2 
PA0996 pqsA -717.41 probable coenzyme A ligase 
PA0997 pqsB -771.42 Homologous to beta-keto-acyl-acyl-carrier protein synthase 
PA0998 pqsC -1039.03 Homologous to beta-keto-acyl-acyl-carrier protein synthase 
PA0999 pqsD -300.62 3-oxoacyl-[acyl-carrier-protein] synthase III 
PA1000 pqsE -587.49 Quinolone signal response protein 
PA1001 phnA -331.43 anthranilate synthase component I 
PA1002 phnB -184.82 anthranilate synthase component II 
PA1027 pcd -72.66 probable aldehyde dehydrogenase 
PA1173 napB -70.45 cytochrome c-type protein NapB precursor 
PA1174 napA -195.49 periplasmic nitrate reductase protein NapA 
PA1176 napF -73.36 ferredoxin protein NapF 
PA1183 dctA 77.52 C4-dicarboxylate transport protein 
PA1300  88.50 probable sigma-70 factor, ECF subfamily 
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PA1922 feuA 100.00 probable TonB-dependent receptor 
PA1924  74.07 hypothetical protein 
PA1925  185.19 hypothetical protein 
PA1927 metE 263.16 5-methyltetrahydropteroyltriglutamate-homocysteine S-
methyltransferase 
PA2365  -190.18 conserved hypothetical protein 
PA2366  -114.98 conserved hypothetical protein 
PA2368  -87.25 hypothetical protein 
PA2386 pvdA 66.23 L-ornithine N5-oxygenase 
PA2397 pvdE 59.17 pyoverdine biosynthesis protein PvdE 
PA2398 fpvA 312.50 ferripyoverdine receptor 
PA2407  101.01 probable adhesion protein 
PA2409  46.73 probable permease of ABC transporter 
PA2426 pvdS 88.50 sigma factor PvdS 
PA2762  -140.54 hypothetical protein 
PA2840 deaD 54.35 probable ATP-dependent RNA helicase 
PA2911  51.02 probable TonB-dependent receptor 
PA2937  -85.07 hypothetical protein 
PA3236  -103.34 probable glycine betaine-binding protein precursor 
PA3281  52.08 hypothetical protein 
PA3407 hasAp 666.67 heme acquisition protein HasAp 
PA3416  -84.51 probable pyruvate dehydrogenase E1 component, beta chain 
PA3431 ywbG 79.37 conserved hypothetical protein 
PA3432  119.05 hypothetical protein 
PA3600 rpl36 1428.57 conserved hypothetical protein 
PA3601 ykgM 263.16 conserved hypothetical protein 
PA3922  -255.59 conserved hypothetical protein 
PA3923  -138.47 hypothetical protein 
PA4063  121.95 hypothetical protein 
PA4064  92.59 probable ATP-binding component of ABC transporter 
PA4296 pprB -84.09 two-component response regulator PprB 
PA4467  54.95 hypothetical protein 
PA4470 fumC1 63.69 fumarate hydratase 
PA4834  71.43 hypothetical protein 
PA4835  91.74 hypothetical protein 
PA4836  88.50 hypothetical protein 
PA4837  66.23 probable outer membrane protein precursor 
PA4838  99.01 hypothetical protein 
PA4913  -73.95 probable binding protein component of ABC transporter 
PA5373 betB 57.14 betaine aldehyde dehydrogenase 
PA5374 betI 285.71 transcriptional regulator BetI 
PA5396  -96.75 hypothetical protein 
PA5410 gbcA -125.86 GbcA 
Results 
 
78 
 
PA5504  59.17 probable permease of ABC transporter 
PA5535  51.81 conserved hypothetical protein 
PA5540  69.93 hypothetical protein 
PA5541 pyrQ 85.47 dihydroorotase 
 
The most striking result was the similarity of gene expression to the burn wound infection. 
More specifically, ribosomal proteins PA3600 and PA3601 were among the most 
upregulated in both infections (see Tables 4-2 and 4-4). There were also two other genes, 
PA4063 and PA4064, which encode a putative excretion system, as well as the whole operon 
of the putative novel siderophore system PA4834-38 described above. There are two genes 
which were reported to be involved in this process, betB and the regulator betI. The gene 
betB encodes betaine aldehyde dehydrogenase. It is important to mention that these two 
genes were upregulated as well in the burn wound infection. In addition, these genes have 
been reported to be involved in utilisation of the phosphatydylocholine as a carbon and 
nitrogen source for P. aeruginosa infecting CF patients lungs (Son et al., 2007). 
Another feature proven to be crucial for infection is iron acquisition. In the CF patient 
infection, there was overexpression of PvdS sigma factor together with genes responsible for 
pyoverdin synthesis and its receptor FpvA. There was also an overexpression of the probable 
sigma factor PA1300 as well as the putative TonB-dependent receptors PA1922 and PA2911. 
Again, similarly to the burn wound infection, there was high overexpression of hasAp, which 
encodes for a  heme acquisition protein.  
PQS system was downregulated in comparison to planktonic growth. A significant decrease 
was observed over the whole PQS synthesis system pqsA-E and phnAB (PA0996-PA1002). 
This downregulation could be explained by the elevated concentrations of PQS in the lung of 
CF patient with persistent chronic infection (pers. com. Dr. Susanne Haeussler). Also, the 
response regulator PprB belonging to the PprA-PprB two-component system was 
downregulated. This two-component system has been shown to modulate a broad range of 
QS-related genes in P. aeruginosa including those coding for PQS (Dong et al., 2005). The 
current list of differentially regulated genes shows similarities to the burn wound infection. 
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Genes PA3600, PA4835, pqsA and hasAp are further compared across all infection conditions 
later in this chapter (see Figure 4-13). To further elucidate the gene expression of CF patient 
infection additional samples will need to be collected. 
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4.3. P. aeruginosa infection models 
Infection models are important tools used to elucidate bacterial pathogenesis. Model are 
crucial to test novel hypotheses pertaining mechanisms underlying virulence, potential 
targets, the mode of action of anti-bacterial compounds and to screen possible new 
compounds or intervention strategies. In this work, both the plant infection model using 
lettuce leaves and the novel mouse tumour infection model were evaluated. It is proposed 
that the mouse tumour infection model can mimic the chronic infection of P. aeruginosa, 
which is a state of infection persistent in CF patients, as well as the long lasting infection of 
burn wounds. Firstly, the lettuce infection was tested for its resemblance of a real infection 
at the transcriptomic level. 
4.3.1. Lettuce infection model 
4.3.1.1. Lettuce infection 
Since P. aeruginosa is both a mammalian and a plant pathogen (Mahajan-Miklos et al., 2000, 
Rahme et al., 2000), the lettuce leaf infection model has been used to evaluate a number of 
aspects of pathogenicity by P. aeruginosa, namely the hierarchy of QS and virulence factors, 
as well as anaerobic growth (Aendekerk et al., 2005, Filiatrault et al., 2006, Wagner et al., 
2007). In the current work, the aim was to perform global expression profiling of P. 
aeruginosa infecting the lettuce to assess the potential usefulness of the lettuce as a model 
for mammalian infection. First, the level of infection of P. aeruginosa isolates PBCLOp10, 11, 
17 and P. putida KT2440 was measured. P. putida KT2440 was used as a non-infection 
control. Figure 4-3 shows the visual deterioration of the lettuce leaf after injection of 
different Pseudomonas strains at both day 0 and day 5. For the three P. aeruginosa clinical 
strains the necrosis and tissue maceration was visually similar after 5 days. P. putida KT2440 
strain did not produce such a marked change in the lettuce leaf as in comparison to those 
clinical strains.  
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 Day 0 Day 5 
P. putida 
KT2440 
Negative 
control 
  
P. 
aeruginosa 
PBCLOp10 
  
P. 
aeruginosa 
PBCLOp11 
  
P. 
aeruginosa 
PBCLOp17 
  
Figure 4-3:  Infection of lettuce mid-ribs by P. putida (as a non-infection control) and the 3 P. aeruginosa 
clinical strains PBCLOp10, 11 and 17 at days 0 and 5. 
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4.3.1.2. Transcription profiling of P. aeruginosa infecting lettuce 
Table 8-3 on page 177 shows all of the expression values obtained from comparison of the 
lettuce infection model with the planktonic and biofilm growth controls. Table 4-5 
summarises the expression levels of the genes discussed in this chapter. 
Table 4-5: Summary of genes from table 8-3 and those that are discussed in this section. 
PA Number Gene 
Fold change compared to 
Product Name Planktonic Biofilm 
PA0280 cysA 6.63 6.75 sulfate transport protein CysA 
PA0281 cysW 6.80 5.95 sulfate transport protein CysW 
PA0282 cysT 3.37 2.72 sulfate transport protein CysT 
PA0283 sbp 8.56 8.41 sulfate-binding protein precursor 
PA0298 spuB 2.94 2.46 probable glutamine synthetase 
PA0472 fiuI 2.43 9.38 probable sigma-70 factor, ECF subfamily 
PA0520 nirQ  2.64 regulatory protein NirQ 
PA0929 pirR 3.14 6.63 two-component response regulator 
PA1176 napF -3.83 3.26 ferredoxin protein NapF 
PA1177 napE  26.32 periplasmic nitrate reductase protein NapE 
PA1544 anr 2.32  transcriptional regulator anr 
PA1779 nasA 3.59 3.51 assimilatory nitrate reductase 
PA1780 nirD 7.32 5.99 assimilatory nitrite reductase small subunit 
PA1781 nirB 3.86 3.91 assimilatory nitrite reductase large subunit 
PA1783 nasA 4.05 4.02 nitrate transporter 
PA1838 cysI 3.46 2.85 sulfite reductase 
PA2426 pvdS 1.79 3.45 sigma factor PvdS 
PA2570 lecA 3.18 5.66 LecA 
PA2664 fhp 42.02 42.92 flavohemoprotein 
PA2718   2.44 probable transcriptional regulator 
PA2847  312.50 312.50 conserved hypothetical protein 
PA3479 rhlA 4.34  rhamnosyltransferase chain A 
PA3899  2.08 3.69 probable sigma-70 factor, ECF subfamily 
PA3914 moeA1 2.71 2.68 molybdenum cofactor biosynthetic protein A1 
PA3915 moaB1 7.01 5.88 molybdopterin biosynthetic protein B1 
PA3916 moaE 2.70 3.73 molybdopterin converting factor, large subunit 
PA3918 moaC 4.39 4.47 molybdopterin biosynthetic protein C 
PA4442 cysN 2.27 3.27 ATP sulfurylase GTP-binding subunit/APS kinase 
PA4443 cysD 3.94 3.64 ATP sulfurylase small subunit 
PA5240 trxA 3.80  thioredoxin 
PA5374 betI 13.48 3.45 transcriptional regulator BetI 
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The most upregulated gene during the infection of the lettuce was the PA2847 gene. 
According to the Pseudomonas Genome Database it encodes a conserved hypothetical 
protein, which has 8 predicted transmembrane helices and one domain of unknown 
function. The main features of the results of expression profiling in lettuce are addressed 
below. 
Anaerobic/aerobic respiration  
The gene anr encoding the anaerobic transcriptional regulator Anr was overexpressed in 
comparison with the planktonic control. Anr has been previously shown to be involved in the 
lettuce infection (Filiatrault et al., 2006). However, the border between aerobic and 
anaerobic respiration in the lettuce infection is not clear when analysing the transcriptomic 
data. In comparison to the biofilm control, the genes napF and napE encoding the ferredoxin 
protein NapF and the periplasmic nitrate reductase protein NapE were upregulated, while in 
comparison to the planktonic control, the whole nap system was downregulated. The nirQ 
gene has been shown to be essential for anaerobic growth in the lettuce infection (Filiatrault 
et al., 2006) and it was induced in this work. On the other hand, there was a clear induction 
of the assimilatory nitrate reductase (involving genes nasC, nirD, nirB and the transporter 
encoding gene nasA). These are responsible for nitrate reduction to NH3, which is used for L-
glutamine synthesis (PA0298 encoding for a probable glutamine synthase and was induced 
in the lettuce infection). Assimilatory reduction is not used for anaerobic respiration. 
Moreover, there was a strong overexpression of the fhp gene encoding flavohemoprotein, 
which has been reported to be involved in detoxification of nitric oxide under aerobic 
conditions. Together with nitrate reductase there was overexpression of molybdopterin, 
which acts as a cofactor for this enzyme. These genes were moeA1, moeB1, moaE and moaC.  
Quorum sensing 
The lettuce infection model has been also used to assess the hierarchy of the QS system in 
P. aeruginosa (Wagner et al., 2007). In the current work, there was an overexpression of the 
lasI gene encoding autoinducer synthesis protein LasI from the las QS system, (in comparison 
with biofilm growth). However, in comparison to planktonic growth, the genes directly 
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regulated by the rhl system: rhlA encoding for rahmnosyltransferase chain A and lecA coding 
for PA-I galactophilic lectin were upregulated. In comparison to the biofilm control the 
induction of a probable transcriptional regulator PA2718 was observed. It has been shown 
that the strain with mutation of this gene was unable to cause severe infection of the lettuce 
leaf (Wagner et al., 2007). Additionally, according to the Prodoric database, there were 50 
genes induced and 27 repressed, which have been previously known to be QS regulated 
(Schuster et al., 2003) in comparison with biofilm growth and only 10 upregulated and 67 
genes downregulated in comparison to the planktonic growth (Schuster et al., 2003). 
Sulfate reduction 
The pathway overexpressed during the lettuce infection and not in the other infection 
conditions was a sulfate reduction starting with the transport system, ABC transporter 
compounds cysA, cysW, cysT encoding sulfate transport proteins and sbp encoding sulfate-
binding protein precursor, finishing with those genes responsible for sulfate reduction: cysD, 
sulfate adenylyltransferase subunit 2, which condenses sulfate and adenosine 5’-
triphosphate (ATP) to form adenosine 5’-phosphosulfate (APS); cysN, bifunctional sulfate 
adenylyltransferase subunit 1 / adenylylsulfate kinase protein transforming APS to 3’-
phosphoadenosine 5’-phosphosulfate (PAPS); cysI, sulfite reductase reducing sulfite to H2S; 
and cysK, cysteine synthase A involved in cysteine synthesis from H2S and O3-acetyl-L-serine 
incorporating in this way acquired sulfur into metabolism of the bacterial cell 
(Hummerjohann et al., 1998). In the whole pathway of sulfate reduction there is only one 
enzyme missing in this expression data, cysH, PAPS reductase which forms sulfite from PAPS. 
Efficient reduction of sulfate requires protein reductant thioredoxin (Chartron et al., 2006), 
hence the overexpression of the trxA gene encoding this protein. 
Iron starvation 
Up-regulation of the sigma factor PvdS was reported in in vivo infection of the burn wound 
and the CF patients’ infection and was seen in the plant infection with P. aeruginosa. This 
suggests that during the lettuce infection, iron is at its limiting concentration. Most of the 
genes regulated by PvdS do not show differential expression with any of the controls. 
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However, further regulation of iron starvation is present as there are genes upregulated such 
as: pirR, a probable two-component response regulator (PA0929), PA3899, PA0472 and 
PA1912 all encoding a probable sigma-70 factor, ECF family responsible for iron uptake. All 
of these regulators are induced in comparison with both planktonic and biofilm growth. 
Additionally, in comparison to the biofilm control the ECF sigma factor PA2468 (foxI) was 
induced. 
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4.3.2. Tumour mouse infection model 
In order to assess the mouse tumour model as a possible real in vivo-like model of 
P. aeruginosa infection, three steps were taken. First, infection with the type strain 
P .aeruginosa PAO1 in comparison with the non-infectious Pseudomonas putida KT2440 
strain was evaluated. Second, transcription profiling of three clinical strains used in the 
current study (P. aeruginosa PBCLO10, 11 and 17) was performed and finally, the 
comparison of another sequenced strain P. aeruginosa PA14 and its mutants was done. 
4.3.2.1. Pseudomonas species in the tumour 
The P. putida KT2440 and P. aeruginosa PAO1 were transformed with plasmid pMC5-lite 
carriyng the whole luxCDABE operon from Photorhabdus luminescens (Winson et al., 1998). 
The lux is placed under the constitutive promoter. The advantage of the Lux operon is that it 
does not require any additional substrates to be given to the mice before measurement. The 
results derived from this experiment showed that P. putida KT2440 was not able to spread 
into the mouse’s body and also did not colonise the tumour (Fig 4-4a). Therefore, it was 
considered a good negative control. The P. aeruginosa PAO1 was highly virulent towards the 
mouse and after 48 hours following inoculation three of the five mice died. Nevertheless, 
the initial systemic spread and subsequent colonisation of the tumour can be clearly seen 
(Fig 4-4b).  
In addition, there was some evidence that P. aeruginosa can spread and colonise the gall 
bladder (Figures 4-4 and 4-6). In particular, P. aeruginosa PAO1 can be clearly observed to 
infect the gall blader of mice 2 and 3 at 24 h p.i. and mouse 1 at 48 h p.i. (Figure 4-4b), 
whereas P. aeruginosa PBCLOp10 infected the gall bladder of mice 1 and 5 at 48 h p.i. (Figure 
4-6e). Such a result has yet to be published and warrants further investigation, however 
while interesting is beyond the scope of this work here. 
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Figure 4-4: A) P. putida KT2440 bioluminescence with pBBRMCS5-LITE at 1 h, 12 h, 24 h, 48 h, B) P. 
aeruginosa PAO1 with pBBRMCS5-LITE at 1 h, 12 h, 24 h, 48 h. 
Tumour 
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4.3.2.2. Survival of P. aeruginosa clinical strains in mouse organs 
Figure 4-5 shows the number of colonies obtained from the tumour compared to the spleen 
and liver after 48 hours p.i. All 3 strains were 2-3 orders of magnitude greater in the tumour 
compared to the liver and 4-5 orders of magnitude greater than in the spleen. 
 
Figure 4-5: P. aeruginosa clinical strains in mice organs 3 days p.i. 
In order to observe the P. aeruginosa tumour infection in real time, the plasmid pHL320, 
carrying the luciferase gene with the constitutive promoter was introduced into the strain 
PBCLOp10. Figure 4-6 represents the signal from P. aeruginosa PBCLOp10 cells 3, 12, 24, 36 
and 48 hours p.i. In the first hours bacterial cells are present in the liver and in the spleen. 
Later, during the infection, bacterial cells were cleared from the mouse’s organs, and then 
clearly present in the tumour at 24 h p.i. and remained there with slight fluctuations over 36 
and 48 h p.i. (Figure 4-6). 
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Figure 4-6: Bioluminescence of PBCLOp10 with pHL320 reporter plasmid. A) 3 h p. i.; B) 12 h p. i.; C) 24 h p. i.; 
D) 36h p. i.; E) 48 h p. i. 
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4.3.2.3. Localisation and persistence 
The CT26 tumour is structured as a ring of the tumour cells with necrotic tissue inside. In the 
outer layer of the tumour, there is a rim of proliferating cells, while deeper in the quiescent 
cells and then in the centre, the necrotic tissue which is deprived from nutrients and oxygen 
(Sutherland, 1988). The localisation of the infection of P. aeruginosa was assessed by 
immune histology. As can be seen in Figure 4-7 viable bacterial cells were found in the ring. 
Low amounts of bacterial cells were found to penetrate the deeper layers into the quiescent 
cells or at the border with necrotic tissue. This observation makes the tumour infection very 
promising as a model, as microaerophilic conditions are believed to occur in the later stages 
of P. aeruginosa pulmonary infections in CF patients (Worlitzsch et al., 2002). 
  
Figure 4-7: Histology of tumours colonised by P. aeruginosa PBCLOp10. A) magnification 10x, B) 
magnification 100x. Green colour – P. aeruginosa cells, blue – DNA, red – Cytoplasm. 
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4.3.2.4. Evaluating the mouse tumour model 
4.3.2.4.1. Transcription profiling upon infection of tumour 
In order to obtain an insight into the behaviour of P. aeruginosa colonising the tumour, the 
transcription profiling of the three clinical strains used in this study was performed. The 
complete results of differentially expressed genes are given in the Appendix Table 8-2 on 
page 164. Table 4-6 provides a summarised version of the genes discussed in this section. 
Table 4-6: Summary of the genes discussed in the section 4.3.2. 
PA Number Gene 
Fold change compared to 
Product Name Planktonic Biofilm 
PA0044 exoT 6.51 10.52 exoenzyme T 
PA0510 nirE 4.12 3.24 probable uroporphyrin-III c-methyltransferase 
PA0515 nirD 4.63  probable transcriptional regulator 
PA0517 nirC 3.53  probable c-type cytochrome precursor 
PA0518 nirM 13.97 7.77 cytochrome c-551 precursor 
PA0519 nirS 6.35 8.83 nitrite reductase precursor 
PA0520 nirQ  4.14 regulatory protein NirQ 
PA0836 ackA 3.32 5.03 acetate kinase 
PA1580 gltA  -3.86 citrate synthase 
PA1692 pscS 2.46  probable translocation protein in type III secretion 
PA1695 pscP 2.93 2.81 translocation protein in type III secretion 
PA1696 pscO 3.22  translocation protein in type III secretion 
PA1699 pcr1 4.04  conserved hypothetical protein in type III secretion 
PA1700 pcr2 8.82 5.61 conserved hypothetical protein in type III secretion 
PA1701 pcr3 5.95  conserved hypothetical protein in type III secretion 
PA1704 pcrR 2.08 3.11 transcriptional regulator protein PcrR 
PA1706 pcrV 6.69 8.19 type III secretion protein PcrV 
PA1707 pcrH 7.03 7.28 regulatory protein PcrH 
PA1708 popB 5.57 7.43 translocator protein PopB 
PA1709 popD 5.75 7.14 Translocator outer membrane protein PopD precursor 
PA1711 exsE 4.26 5.81 ExsE 
PA1712 exsB 2.76  exoenzyme S synthesis protein B 
PA1714 exsD 5.52  ExsD 
PA1715 pscB 7.81 4.80 type III export apparatus protein 
PA1716 pscC 4.98 
 
Type III secretion outer membrane protein PscC 
precursor 
PA1717 pscD 5.64 5.47 type III export protein PscD 
PA1718 pscE 11.83 6.06 type III export protein PscE 
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PA1719 pscF 4.32 2.96 type III export protein PscF 
PA1720 pscG 3.94 3.58 type III export protein PscG 
PA1721 pscH 4.13 4.14 type III export protein PscH 
PA1722 pscI 4.61 4.38 type III export protein PscI 
PA1723 pscJ 2.59  type III export protein PscJ 
PA1724 pscK 2.41  type III export protein PscK 
PA2128 cupA1 16.61 10.25 fimbrial subunit CupA1 
PA2191 exoY 4.19 4.18 adenylate cyclase ExoY 
PA3147 wbpJ 3.05  probable glycosyl transferase WbpJ 
PA3148 wbpI 5.42 3.49 probable UDP-N-acetylglucosamine 2-epimerase WbpI 
PA3149 wbpH 3.30  probable glycosyltransferase WbpH 
PA3150 wbpG 4.08 4.51 LPS biosynthesis protein WbpG 
PA3153 wzx 2.69  O-antigen translocase 
PA3154 wzy 4.13 2.61 B-band O-antigen polymerase 
PA3155 wbpE 4.08  probable aminotransferase WbpE 
PA3156 wbpD 3.08  probable acetyltransferase WbpD 
PA3158 wbpB 2.68  probable oxidoreductase WpbB 
PA3159 wbpA 2.45 
 
probable UDP-glucose/GDP-mannose dehydrogenase 
WbpA 
PA3160 wzz 3.13  O-antigen chain length regulator 
PA3309 uspK 3.31 8.31 conserved hypothetical protein 
PA3407 hasAp 13.89 14.73 heme acquisition protein HasAp 
PA3415   2.62 probable dihydrolipoamide acetyltransferase 
PA3417 
  
4.84 probable pyruvate dehydrogenase E1 component, 
alpha subunit 
PA3476 rhlI -4.14 -4.52 autoinducer synthesis protein RhlI 
PA3477 rhlR -9.43 -4.84 transcriptional regulator RhlR 
PA3600 rpl36 17.30 37.88 conserved hypothetical protein 
PA3601 ykgM 13.16 10.03 conserved hypothetical protein 
PA3841 exoS 7.44 16.13 exoenzyme S 
PA4352  7.02 22.99 conserved hypothetical protein 
PA5170 arcD  14.77 arginine/ornithine antiporter 
PA5171 arcA 6.64 15.85 arginine deiminase 
PA5172 arcB 4.39 16.37 ornithine carbamoyltransferase, catabolic 
PA5173 arc  8.22 carbamate kinase 
PA5373 betB 4.91 3.92 betaine aldehyde dehydrogenase 
PA5374 betI 9.91 2.53 transcriptional regulator BetI 
PA5435 oadA  -3.05 probable transcarboxylase subunit 
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Type III secretion system 
When comparing the expression values of the tumour model to the burn wound infection, 
the CF patient infection and the lettuce leaf infection the most striking difference was the 
upregulation of the type III secretion system (T3SS). The upregulated operons were pscSPO, 
pcr123R, exsD-pscDEFGHIJK responsible for secretion apparatus, pcrVH-popBD involved in 
protein translocation and the regulators exsEB. The genes encoding exoenzymes secreted via 
the T3SS were also overexpressed: (i) exoenzymes ExoT and ExoS, which are ADP-
ribosyltransferases inhibiting phagocytosis by disrupting actin cytoskeletal rearrangement, 
focal adhesisns and signal transduction cascades important in phagocytic function and (ii) 
ExoY, a cytotoxin with adenylate cyclase activity.  
O-antigen 
Another interesting observation was the upregulation of most of the genes belonging to the 
cluster responsible for the B-band O-antigen. In comparison to the planktonic and biofilm 
controls, the induction of genes wzz, wbpABDE (only versus planktonic), wzx, wzy and 
wbpGHIJ (versus planktonic and biofilm) were upregulated. However, there was no 
significant difference in regulation of the A form of the O-antigen. P. aeruginosa possesses 
two of these forms, which are attached to core lipid A of Lipopolisaccharide (LPS) (Rocchetta 
et al., 1999).  Perhaps it is that the A form of the O-antigen is not present in these clinical 
strains or that they prefer to express only the B-band of the O-antigen. This fact requires 
further elucidation.  
Biofilm 
The cupA1 (PA2128) gene belonging to the operon cupA123 was also upregulated. This 
operon encodes the different components and assembly factors of a putative fimbrial 
structure required for biofilm formation (Vallet et al., 2001). The ability to form biofilms is 
one of the factors for successful infection by P. aeruginosa (Singh et al., 2000). Furthermore, 
the expression of the cupA1 gene was linked to anaerobiosis (Vallet-Gely et al., 2007). 
Results 
 
94 
 
Anaerobic respiration 
Analysis of the energy production in P. aeruginosa infecting mice tumours revealed that they 
grew anaerobically. The genes responsible for nitrite reduction, nirSMCDE and regulator nirQ 
were overexpressed. Other expressed genes indicating anaerobic growth were the encoding 
enzymes involved in pyruvate fermentation. In comparison to the biofilm control there was 
induction of the genes PA3417 and PA3415 responsible for conversion of pyruvate to acetyl-
CoA and in comparison to both controls gene ackA (PA0836) encoding acetate kinase. 
However, there was no significant result for gene pta (PA0835), encoding the phosphate 
acetyltransferase responsible for the conversion of acety-CoA to acetyl-phosphate, which is 
the one missing link in whole pyruvate fermentation system. However, when assessing the 
raw microarray data the signal intensity is similar to PA0836, therefore it can be assumed 
that the whole pyruvate fermentation pathway is induced during tumour infection. 
Additionally, the fermentation of arginine through the arginine deaminase pathway was 
induced. The arcDABC genes have been recently shown to be co-regulated with genes 
responsible for pyruvate fermentation (Schreiber et al., 2006). In the same report it is shown 
that there are two universal stress proteins linked to anaerobic survival with pyruvate 
fermentation (PA3309 and PA4352). Both of these were upregulated in the mouse tumour 
infection. Together with the overexpression of the pathways involved in anaerobic 
respiration there was inhibition of gene PA5435, encoding pyruvate carboxylase subunit B 
which is responsible for transformation of pyruvate to oxaloacetate and PA1580, encoding 
type II citrate synthase which transforms oxaloacetate to citrate, using acetyl-CoA. This 
clearly shows the direction of metabolism into pyruvate fermentation with the 
transformation, in the last instance, of acetyl-CoA to acetate recovering the ATP. Among the 
downregulated genes there were those involved in oxidative phosphorylation.  
Other factors 
Compared to the burn wound infection, ribosomal proteins PA3600 and PA3601 were highly 
overexpressed in a similar manner, but here there was no induction of the np20 gene or the 
genes encoding the zinc transporter system. Assessing the iron starvation response, there 
was overexpression of hasAp by 14-fold but not of the either siderophore systems. Another 
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similarity to the burn wound infection and the CF patient infection was the upregulation of 
the betB gene encoding betaine aldehyde dehydrogenase and the betI gene encoding a 
transcriptional regulator.  
4.3.2.4.2. Testing mutant strains 
To evaluate the use of the tumour infection as a model for P. aeruginosa infection, the 
following mutants were tested: (i) PA14 ∆anr, with the mutation in the global anaerobic 
regulator; (ii) PA14 ∆cupA1, to check if bacteria form biofilms similar to those isolates from a 
CF patient infection; and (iii) PA14 ∆pqsA, to analyse if PQS is necessary for the tumour 
infection. The analysis was based on the CFU obtained from a group of five mice per each 
strain and at each time point of infection. Figure 4-8 summarizes the survival of P. 
aeruginosa PA14 mutants and the wildtype strain in the tumour. At 24 hours p. i. there was 
no significant difference, but at 48 hours p. i. it was clear that the strain deficient in 
anaerobic regulation was unable to survive in the tumour. The strains with the mutation in 
the pqsA and cupA1 genes were also in reduced numbers of more than 2-fold in comparison 
to the wildtype.  
 
Figure 4-8: CFU of P. aeruginosa PA14 and mutants in the tumours of mice. 
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4.4. Comparing gene expression patterns across in vivo and in vitro 
settings 
Up until this point the analysis of the microarray data has focused on assessing individual 
genes that were differentially regulated. In this chapter, the transcriptomic data was 
analysed by an unsupervised approach in order to find any internal structure or relationships 
over the global data set. Two approaches were taken: (i) agglomerative hierarchical 
clustering, which is a widely used method to consider clusters in data, and (ii) ordination via 
non-metric multidimensional scaling (nMDS), which assesses the closeness between 
conditions based on similarity in global transcriptomic data. As for principal component 
analysis (PCA) non-metric MDS illustrates the similarity or difference across conditions in 
both magnitude and direction to each other. The gene expression from five conditions the 
burn wound infection, the tumour infection model, the lettuce infection model, planktonic 
growth and biofilm growth were compared. 
4.4.1. Hierarchical clustering 
Agglomerative hierarchical clustering was first used to assess the similarities in gene 
expression among duplicate independent clones at each condition. The five conditions are 
presented in Figure 4-9. This dendogram shows that duplicates from each of the three 
independent clones within each condition indeed cluster together. This indicates that the 
gene expression of each independent clone at each condition is more similar to the other 
two clones at the same condition rather than the same clone at under a different infection 
conditions. For example, the gene expression of clone PBCLOp11 always clusters with clones 
PBCLOp17 and PBCLOp10 irrespective of the infection condition. Although the same clones 
were used across the conditions, their gene expression is dependent upon the condition and 
not the clone itself. Interestingly, under the conditions of the lettuce infection model, the 
planktonic growth and the tumor infection model, clones PBCLOp17 and PBCLOp10 were 
always more similar than clone PBCLOp11. While under the conditions of the burn wound 
infection and biofilm growth, clones PBCLOp10 and PBCLOp11 were always more similar 
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than clone PBCLOp17. This is important as future analysis rely upon these three clones 
forming the predefined groups of each condition. This also shows that the gene expression 
profiling itself produces consistent and reliable data. 
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Figure 4-9: Hierarchical clustering of the conditions. 
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To extend upon the visualisation of the data, cluster analysis was also performed on the 
genes. Figure 4-10 shows the clustering of the genes connected with a heat map. Visually, it 
can be seen that there are specific clusters of genes unique for each conditions. 
Figure 4-10: Hierarchical clustering of genes presented with the heat map of expression values. 
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4.4.2. Finding patterns across different infection conditions using a global 
analysis approach 
Multidimensional scaling (MDS) is an ordination routine used to observe actual distances, 
patterns, degrees of similarity and dissimilarity between samples. That is, the distance in 
magnitude and direction between each condition on a MDS plot is equivalent to its 
difference and change in global gene expression respectively. Figure 4-11 shows how the five 
conditions relate to each other based on their similarity of gene expression (global 
transcriptomic pattern). After calculation of the Euclidean distance between each pair of 
samples (including duplicates of each clone and replicates of each condition), non 
parametric multi-dimensional scaling plots (nMDS) were generated and ANOSIM was used to 
test for statistically significant differences between each of the conditions. The stress value 
of the MDS plot is 0.15 and indicates a good ordination. 
Firstly, as observed in agglomerative hierarchical clustering, the duplicates of each clone 
within each condition group together. Secondly, clones from the tumour infection and 
clones from the burn wound infection ordinate together at the centre top of the MDS (red 
and dark blue dots representing tumour infection model and burn wound infection 
respectively), while clones from the planktonic growth (green) ordinate to the left of the 
plot, biofilm (light blue) ordinate to the lower right of the plot and lettuce infection model 
(brown) ordinate together at the bottom of the plot. This is confirmed with a one-way 
ANOSIM, where all conditions are significantly different to each other (p < 0.05). 
Furthermore, the R-statistic value of the pairwise comparison between the tumor infection 
and burn wound infection is 0.752 and is lower than all the of the other pairwise comparison 
indicating that these two conditions are more related to each other based on their global 
gene expression profiles (Table 4-7). 
The growth conditions can be regarded as clearly different, although there was some 
overlapping between burn wound infection and tumour infection clones. In this work the 
biofilm and planktonic growth conditions are used as controls. The infection conditions are 
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lettuce, tumour and burn wound. The lettuce infection was much more different than the  
burn wound and the tumour infection with R-statistics of 1 and 0.941 respectively. 
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Figure 4-11: Multidimensional scaling (nMDS) plot based on Euclidean distance of gene from different 
conditions. A stress value of 0.15 indicates good ordination. 
Table 4-7: The one-way ANOSIM pairwise comparisons of P. aeruginosa growth conditions. 
Pairwise comparison R statistic p - value 
• Burn/Tumour • 0.752 0.002 
• Planktonic/Lettuce • 0.881 0.002 
• Planktonic/Burn • 0.911 0.002 
• Biofilm/Tumour • 0.941 0.002 
• Tumour/Lettuce • 0.941 0.002 
• Planktonic/Tumour •  0.974 0.002 
• Planktonic/Biofilm • 0.985 0.002 
• Burn/Biofilm • 0.996 0.002 
• Biofilm/Lettuce • 1 0.002 
• Burn/Lettuce • 1 0.002 
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Thus, it is interesting that the two more realistic infection ordinate closer together while the 
other conditions are more distinctly separated. SIMPER analysis was used to assess those 
genes that contribute to the greatest differences between tumour infection and burn wound 
infection. Firstly, SIMPER was used to indicate which genes accounted the most for the 
difference between the tumour and burn wound conditions. Table 4-8 shows those genes 
that contribute more than 0.40 % (of 1677 genes analysed) to the dissimilarity between 
these conditions. The gene that shows the greatest difference was the bfd gene encoding for 
bacterioferritin-associated ferredoxin. The gene bfd was more highly expressed in the burn 
wound infection than the tumour infection (11.50 compared to 6.17, respectively). This 
confirms a strong iron starvation response present during the burn wound infection. The 
same gene has been found to be overexpressed by 200-fold in an iron starvation experiment 
of Ochsner and colleagues (2002). Another gene that had a higher expression level in the 
burn wound and is also involved in iron starvation was pvdS. Furthermore, the gene PA4570 
is also induced by iron. Other genes listed are PA3600, which encodes an alternative 
ribosomal protein, the gene PA4063 from the cluster of putative secretom system induced 
during burn wound infection. However, most of the genes encoded hypothetical and 
conserved hypothetical proteins. 
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Table 4-8: Similarity Percentage (SIMPER) analysis assessing those genes that account for the greatest 
dissimilarity between burn wound infection and tumour infection model. Genes having a contribution of 
more than 0.40 % are presented. 
Locus ID Gene Product Name 
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PA3530 bfd bacterioferritin-associated 
ferredoxin 
11.50 6.17 0.64 0.64 
PA3572  hypothetical protein 4.09 9.14 0.61 1.25 
PA2146 yciG conserved hypothetical protein 12.00 7.48 0.59 1.84 
PA3600 rpl36 conserved hypothetical protein 13.30 8.66 0.53 2.37 
PA2159  conserved hypothetical protein 10.40 5.97 0.51 2.87 
M57501 flaA flagellin type A 7.70 5.27 0.49 3.37 
PA0713  hypothetical protein 5.23 9.95 0.49 3.85 
PA1852  hypothetical protein 9.37 5.42 0.47 4.80 
PA4063  hypothetical protein 7.02 2.40 0.46 5.26 
PA4570  hypothetical protein 11.40 6.94 0.46 5.72 
PA4141  hypothetical protein 9.77 8.91 0.45 6.17 
PA2426 pvdS sigma factor PvdS 8.86 4.53 0.41 6.58 
PA3719  hypothetical protein 6.54 4.45 0.41 6.99 
 
4.4.3. Comparing the CF pulmonary infection to the other infection 
conditions 
This section takes a preliminary look at how different the CF patient infection is compared to 
the other infection conditions. This work is considered preliminary because only one isolate 
from one CF patient was analysed here, while all other conditions sort three independent 
isolates. The global gene expression of this one isolate was ordinated with the gene 
expression profiles of all of the in vivo and in vitro conditions. Figure 4-12 presents the new 
nMDS plot showing how the CF pulmonary infection compares to other conditions. The CF 
patient infection isolate is more closely related to the biofilm, burn and tumour infection 
settings than to the lettuce or planktonic growth. Also, it could be argued that there is a 
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gradient from the left to the right side of the plot, from planktonic to CF. Perhaps it can be 
hypothesised that this gradient represents the increase in virulence of P. aeruginosa across 
different growth conditions. If this is the case, then the biofilm growth condition is 
remarkable and strengthens the view that the ability for biofilm formation per se is a 
virulence factor responsible for successful infection. 
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Figure 4-12: Multidimensional scaling (nMDS) plot based on Euclidean distance of 1677 genes from different 
conditions. The stress value is 0.17 , which indicates a good ordination. 
“Virulence” 
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4.4.4. Overlaying the expression values of a single gene over the global 
pattern 
The relationship between the pattern in an MDS and a univariate variable (the gene 
expression value) can be visualised using “bubble plots”. This is achieved by presenting the 
value of the univariate variable as a symbol of different sizes and superimposing it onto the 
ordination of its corresponding sample. The genes previously discussed in the chapter 4.3 
were analysed with the MDS bubble plots. Figure 4-13 presents the 8 MDS plots which are 
based on the MDS from Figure 4-12, with the expression values from 8 given genes at each 
infection condition. The 8 genes are: rhlR, lasR, pqsA, hasAp, PA4835, PA3600, exoT and 
cupA1, and are representatives of an array of different processes within the cell, such as: QS, 
iron acquisition, zinc homeostasis, type III secretion system and biofilm formation potential, 
respectively. For example the genes cupA1 and exoT were visually most overexpressed in the 
mouse tumour infection model (Figure 4-13a and d), whereas las and rhl genes of the QS 
system seem to have no overall (Figure 4-13b and c). However, the pqsA gene (Figure 4-13h) 
is significantly downregulated in the CF patient infection. The genes hasAp, PA3600 and 
PA4835 are clearly overexpressed in mammalian infection conditions only, that is the burn 
wound, CF patient and mouse tumour infection but not in the lettuce infection model 
(Figure 4-13e, f and g). Except for the pqsA gene (Figure 4-13h), most values of these 
selected genes are equivalent between the CF and the burn wound infection. 
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Figure 4-13: 2D nMDS bubble plots showing all of the infection conditions and bubbles corresponding to the 
expression value of each gene: A) cupA1, B) lasR, C) rhlR, D) exoT, E) hasAp, F) PA3600, F) PA4835 and F) 
pqsA. On the first bubble plot the conditions are indicated and apply to all plots: Pl – Planktonic, Bi – Biofilm, 
Le – lettuce infection, Tu – mouse tumour infection, Bu – burn wound infection, CF – CF paitent infection 
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In summary, using these individual genes as indicators of the different processes within the 
P. aeruginosa cells, it can be confirmed that: 
• The QS systems las and rhl are generally unchanged across all conditions 
• The heme uptake is greatest in the burn wound infection, the CF patient infection 
and the mouse tumour infection 
• The gene encoding ribosomal protein, which expression is related to zinc 
homeostasis is overexpressed across the mammalian infections (burn wound, CF 
patient and mouse tumour infection) 
• Type III secretion system and gene cupA1 (involved in biofilm formation during 
infection) are most induced in the mouse tumour infection model 
Such unsupervised analysis approaches provide a valuable tool to visually and statistically 
evaluate the infection conditions, to find global patterns as well as similarities and 
dissimilarities across a broad range of in vivo and in vitro conditions. Then, information from 
a supervised approach (i.e. interesting individual genes), being the value of the individual 
gene can be superimposed with the unsupervised approach to further determine any 
specific patterns in the data. It is aimed that such an approach can better evaluate: (i) the 
comparison of infection models to the real infections, and (ii) similarities between the in vivo 
infections, to better understand global pathogen behaviour upon infection. 
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4.5. The quest for anti-pseudomonal compounds 
The number of multi-drug resistant Pseudomonas strains is constantly increasing, making the 
treatment of infections of those very difficult as antibiotic treatment may not be sufficient in 
such cases. Therefore, it is important to find novel prevention strategies that may act on 
bacterial cells by directly targeting the virulence of pathogens rather than (or in addition to) 
their growth. This approach helps to overcome the main problem occurring in antibiotic 
treatment, which is selectivity of resistant mutants that leads to selection of multiresistant 
clones (Hentzer et al., 2003). In case of P. aeruginosa a natural target is the QS system. There 
are extensive studies assessing natural and synthetic compounds with QS inhibitory activity 
(Rasmussen et al., 2005a, Bjarnsholt et al., 2005). 
Protoanemonin (4-methylenebut-2-en-4-olide) is one of the “dead end” products of the 
degradation of polychlorinated biphenyls (Bruckmann et al., 1998). It is formed by 
misrouting of chlorocatechol into the ordinary catechol pathway where muconate 
cycloisomerase forms protoanemonin from 3-chloromuconate as substrate. Protoanemonin 
is also a natural product from plants of the Ranunculaceae family and it possesses an 
antibiotic activity (Blasco et al., 1995).  
 
Figure 4-14: Comparing the chemical structures of furanone C30 and protoanemonin. 
 
Protoanemonin also has similar structure to furanone C30, which is known to inhibit QS 
(Hentzer et al., 2003). Figure 4-14 presents structures of both compounds. Protoanemonin 
was synthesised (Bobadilla, 2006) with the technique established by Crey and colleagues 
(2004) and analysed using the QS inhibitory screening system developed by Hentzer et al. 
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(2002). It uses the QS monitor strain P. aeruginosa MH602 consisting of a reporter gene (gfp 
(ASV)) fused to the promoter -including the lux box homologue - of lasB being controlled by 
quorum sensing in P. aeruginosa. The half-life of Gfp (ASV) is approximately 110 minutes 
allowing online monitoring of changes in gene expression to be seen over a time span of a 
few hours.  
When the gene encoding the modified Gfp (ASV) is fused to a promoter positively regulated 
by quorum sensing (such as the lasB promoter), elevated expression of the quorum sensing 
controlled gene can be measured as an increase in fluorescence. The addition of a quorum 
sensing inhibitor, to this construction will result in a lowered expression of Gfp (ASV) to an 
extent proportional to the efficiency of the inhibitor (Hentzer et al., 2002). Work performed 
by colleagues at DTU Biocentrum showed that this compound strongly inhibited QS at 
concentrations of protoanemonin in the range of 40µM to 174µM without impact on the 
growth (Figure 8-1 in the appendix).  
4.5.1. Transcriptional profiling of PAO1 in response to protoanemonin 
A QS-inhibition screening assay suggested that QS circuits are targeted by protoanemonin at 
a concentration range not inhibitory to bacterial growth. In order to investigate if this 
compound can target other factors in P. aeruginosa two approaches were followed: i) 
transcription profiling of P. aeruginosa PAO1 in response to protoanemonin and ii) 
proteomic analysis of secreted proteins in response to protoanemonin. The experiments 
were made using P. aeruginosa PAO1 for easy comparison to already published reports on 
QS inhibitors. 
During treatment with protoanemonin 84 genes were differentially expressed, whereby 46 
of these were induced and 38 were repressed by the action of protoanemonin. Table 4-9 
represents those genes that were significantly downregulated in response to 
protoanemonin. The majority of these repressed genes have been previously shown to be 
regulated by the las or rhl system (Schuster et al., 2003) or known to be regulated during 
different growth phases (Wagner et al., 2003). Genes lasA and lasB encoding LasA protease 
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precursor and elastase LasB are major effectors of the las QS system. Following the QS 
regulated pathways, the phenazine biosynthesis is also repressed in this current work. A 
total of 29 represed genes (76.3% of 38) have been previously reported to be QS regulated 
at the transcriptomic level and 13 (34.2% of 38) have been also repressed by furanone C30. 
Additionally, a gene encoding for catalase has been shown to be controlled by QS in 
response to hydrogen peroxide (Hassett et al., 1997).  
Surprisingly, the gene exoS encoding exoenzyme S secreted via the type III secretion system 
was dowregulated in response to protoanemonin. Previously, T3SS was reported to be 
negatively regulated by rhl system, where mutants of rhlR have showed upregulation of the 
T3SS (Hogardt et al., 2004, Bleves et al., 2005). 
Table 4-9: Genes downregulated in response to protoanemonin. Comparison with previously reported QS 
regulated genes:  * indicates those QS regulated genes in wild type versus lasR, rhlR mutant (Schuster et al., 
2003), # indicates those QS regulated genes in early stationary phase and ^ indicates  mid logarithmic phase 
(Wagner et al., 2003), – indicates those genes repressed by furanone C30 (Hentzer et al., 2003). 
PA Number Gene Fold change Product Name QS C30 
PA0795 prpC -9.44 citrate synthase 2   
PA0852 cbpD -13.04 chitin-binding protein CbpD precursor * - 
PA0865 hpd -5.24 4-hydroxyphenylpyruvate dioxygenase   
PA1174 napA -6.23 periplasmic nitrate reductase protein NapA   
PA1871 lasA -16.81 LasA protease precursor *# - 
PA1901 phzC2 -15.53 phenazine biosynthesis protein PhzC # - 
PA1902 phzD2 -16.86 phenazine biosynthesis protein PhzD # - 
PA1903 phzE2 -22.94 phenazine biosynthesis protein PhzE #^ - 
PA1904 phzF2 -24.57 probable phenazine biosynthesis protein #^ - 
PA1905 phzG2 -20.58 probable pyridoxamine 5'-phosphate oxidase #^  
PA1984 exaC1 -4.89 probable aldehyde dehydrogenase #  
PA1999 pcaI -11.30 probable CoA transferase, subunit A ^  
PA2007 maiA -13.48 maleylacetoacetate isomerase *  
PA2008 fahA -8.95 fumarylacetoacetase *  
PA2009 hmgA -6.38 homogentisate 1,2-dioxygenase *  
PA2067  -5.28 probable hydrolase *  
PA2068  -5.40 probable major facilitator superfamily (MFS) 
transporter 
*# - 
PA2069  -7.92 probable carbamoyl transferase *# - 
PA2302  -6.26 probable non-ribosomal peptide synthetase *# - 
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PA2565  -4.89 hypothetical protein *#  
PA3183 zwf -4.90 glucose-6-phosphate 1-dehydrogenase *  
PA3195 gapA -5.33 glyceraldehyde 3-phosphate dehydrogenase *  
PA3724 lasB -26.39 elastase LasB *#^ - 
PA3841 exoS -5.93 exoenzyme S   
PA4078  -8.67 probable nonribosomal peptide synthetase *  
PA4206 mexH -6.77 probable Resistance-Nodulation-Cell Division 
(RND) efflux membrane fusion protein precursor 
*  
PA4209 phzM -11.81 probable phenazine-specific methyltransferase *# - 
PA4210 phzA1 -19.12 probable phenazine biosynthesis protein *  
PA4211 phzB1 -24.57 probable phenazine biosynthesis protein *#^  
PA4217 phzS -35.59 flavin-containing monooxygenase *# - 
PA4236 katA -5.07 catalase   
PA4366 sodB -6.17 superoxide dismutase   
PA4587 ccpR -4.81 cytochrome c551 peroxidase precursor #  
PA4810 fdnI -5.18 nitrate-inducible formate dehydrogenase, 
gamma subunit 
  
PA4811 fdnH -10.32 nitrate-inducible formate dehydrogenase, beta 
subunit 
  
PA5172 arcB -5.16 ornithine carbamoyltransferase, catabolic   
PA5173 arcC -8.87 carbamate kinase   
PA5220  -5.14 hypothetical protein *#^ - 
 
While the response of the P. aeruginosa to furanone C-30 induces only 8 genes from a total 
of 93 differentially regulated genes (Hentzer et al., 2003), protoanemonin induced more 
than the 50% of all differentially regulated genes in the analysis. Interestingly, 68% of these 
genes are related to iron starvation (Table 4-10) previously reported by Ochsner et al., 
(2002). These genes include pyoverdine and pyochelin synthesis pathways involving genes 
pvd and pch respectively. Also, genes fumC-sodM encoding fumarase C and manganese-
cofactored superoxide dismutase which are controlled by the fur operon and are elevated in 
mucoid, alginate-producing bacteria (Hassett et al., 1997).  
 
Table 4-10: Genes upregulated in response to protoanemonin. * indicates those genes induced in iron 
starvation response by Ochsner et al., (2002). 
PA Number Gene Fold change Product Name Iron 
PA0201  12.35 hypothetical protein  
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PA0284  7.05 hypothetical protein  
PA0472 fiuI 6.97 probable sigma-70 factor, ECF subfamily * 
PA0672 hemO 13.15 heme oxygenase * 
PA0802  18.46 hypothetical protein  
PA1300  13.18 probable sigma-70 factor, ECF subfamily * 
PA2385 pvdQ 8.31 PvdQ * 
PA2386 pvdA 7.10 L-ornithine N5-oxygenase * 
PA2391 opmQ 9.31 probable outer membrane protein precursor * 
PA2392 pvdP 11.62 PvdP * 
PA2394 pvdN 8.48 PvdN * 
PA2395 pvdO 8.84 PvdO * 
PA2397 pvdE 7.54 pyoverdine biosynthesis protein PvdE * 
PA2399 pvdD 6.98 pyoverdine synthetase D * 
PA2402  9.35 probable non-ribosomal peptide synthetase * 
PA2412  7.46 conserved hypothetical protein * 
PA2413 pvdH 7.80 L-2,4-diaminobutyrate:2-ketoglutarate 4-
aminotransferase 
* 
PA2424 pvdL 12.09 PvdL * 
PA2425 pvdG 10.27 PvdG * 
PA2427  15.95 hypothetical protein * 
PA2486  10.16 hypothetical protein  
PA2663  10.01 hypothetical protein  
PA2664 fhp 34.31 flavohemoprotein  
PA2759  14.63 hypothetical protein  
PA3126 ibpA 9.65 heat-shock protein IbpA  
PA3446 ssuE; 9.69 conserved hypothetical protein  
PA3815  13.87 conserved hypothetical protein  
PA3899  8.13 probable sigma-70 factor, ECF subfamily * 
PA4218  10.54 probable transporter * 
PA4219 yfpB 17.91 hypothetical protein * 
PA4220 fptB 8.41 hypothetical protein * 
PA4224 pchG 8.76 pyochelin biosynthetic protein PchG * 
PA4225 pchF 6.97 pyochelin synthetase * 
PA4226 pchE 7.81 dihydroaeruginoic acid synthetase * 
PA4229 pchC 7.99 pyochelin biosynthetic protein PchC * 
PA4387 fxsA; 7.34 conserved hypothetical protein  
PA4467  18.96 hypothetical protein * 
PA4468 sodM 16.32 superoxide dismutase * 
PA4469  8.27 hypothetical protein * 
PA4470 fumC1 12.12 fumarate hydratase * 
PA4471 fagA 7.35 hypothetical protein * 
PA4570  18.65 hypothetical protein * 
PA4610  7.69 hypothetical protein  
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PA4623  10.62 hypothetical protein  
PA4881  7.14 hypothetical protein  
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4.5.2. Proteomic analysis of secreted proteins in response to 
protoanemonin 
In order to further elucidate the results obtained from the transcriptomic approach, 
proteomic analysis was also performed on the secreted proteins fraction of P. aeruginosa in 
response to protoanemonin. P. aeruginosa PAO1 was grown in ABT medium with casamino 
acids and the experiment performed with 125 µM of protoanemonin. Extracellular proteins 
from all replicates of P. aeruginosa cultures were solubilised and separated using two-
dimensional gel electrophoresis (2-DE) across a pH range 4-7 (Figure 4-15). Image and 
statistical analyses, using the Z3 software packages were performed to detect differences in 
protein expression between bacterial cells treated and untreated with protoanemonin. The 
list of identified proteins is given in Table 4-11. 
In comparison to the transcritpomic profiles there was consistency between two main 
groups of regulated genes in the las system and iron starvation response. Firstly, the elastase 
LasB protein was downregulated in protoanemonin treated samples while the PvdO protein 
(pyoverdine) was upregulated. Following are those proteins which were downregulated: (i) 
the probable bacteriophage protein (spot 1); (ii) the flagellin type B (spots 4.1, 4.2); (iii) 
additionally there are two proteins present only in the control, flagellin type B (spot 4.3) and 
probable aminopeptidase encoded by PA2939 (spots 12.1, 12.2). Among the upregulated 
genes were: (i) arginine/ornithine binding protein (spots 5.1, 5.2); (ii) sulfate binding protein 
of ABC transporter (spot 6); (iii) thiol:disulfide interchange protein DsbA (spot 7); (iv) the 
polyamine transport protein (spot 8); (v) the hypothetical protein encoded by PA0423 and 
(vi) a cation transport ATPase, which was identified with the best score from bacterium 
Listeria welshimeri serovar 6b str. SLCC5334 
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Table 4-11: Identification of extracellular proteins form PAO1 differentially expressed in response to 
protoanemonin. Proteins were identified by peptide mass mapping. Spot numbers refers to those shown in 
Fig. 4-15. # indicates those proteins present only on the control 2D gel, * indicates the identified as proteins 
from Listeria welshimeri serovar 6b str. SLCC5334 
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1 PA0622  Probable bacteriophage protein 8 28 5.80 20.66 -7.19 
2 PA3724 lasB Elastase 15 48 5.79 33.12 -5.85 
3 PA1094 fliD Flagellar capping protein FliD 10 35 6.52 43.42 -5.13 
4.1 PA1092 fliC Flagellin type B 21 38 5.40 49.22 -4.65 
4.2 PA1092 fliC Flagellin type B 17 36 5.40 49.22 -2.42 
4.3 PA1092 fliC Flagellin type B 15 27 5.40 49.22 # 
12.1 PA2939  Probable aminopeptidase 13 25 5.02 57.48 # 
12.2 PA2939  Probable aminopeptidase 13 22 5.02 57.48 # 
5.1 PA0888 aotJ Arginin/ornithine binding protein 11 54 6.43 27.99 2.40 
5.2 PA0888 aotJ Arginin/ornithine binding protein   6.43 27.99 4.61 
6 PA1493 cysP Sulfate-binding protein of ABC 
transporter 
13 32 7.77 36.50 2.64 
7 PA5489 dsbA Thiol:disulfide interchange protein 
DsbA 
11 46 5.98 23.36 2.76 
8 PA0300 spuD Polyamine transport protein 11 29 7.00 40.71 2.85 
9 PA2395 pvdO PvdO 10 38 5.41 31.05 5.32 
10 PA0423  Hypothetical protein 8 35 6.01 20.76 10.88 
11   Cation transport ATPase* 12 18 5.02 95.80 17.81 
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Figure 4-15: Extracellular proteins from P. aeruginosa PAO1. (A) control conditions, (B) protoanemonin at 125 µM. Proteins were separated by 2-DE using 
IPG ranges of pH 4-7. Proteins discussed in the text are highlighted and were identified by peptide mass mapping. Numbers represent the spot 
identifications listed in Table 4-11. 
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5. Discussion 
Pseudomonas aeruginosa is a threatening opportunistic pathogen and one of the major 
agents of nosocomial infections in immunosupressed patients. It is also a common 
environmental strain isolated from soil and wet niches. There are relatively small differences 
between strains cultivated from environmental and clinical samples and both of them may 
be similarly virulent (Alonso et al., 1999). In this work, a global transcription profiling 
approach was used to identify the factors that may be responsible for a switch from an 
environmental life style to a pathogenic state, in which P. aeruginosa cells have high impact 
on mortality of infected patients.  
Ideally such analyses are to be performed on in vivo samples taken from patients. However, 
it is usually very difficult to obtain from these samples enough RNA for global expression 
profiling. Furthermore, the amount of sample itself is often limited. By adapting and newly 
developing protocols and methods for sample collection, transportation, enrichment and 
microarray preparation in this work, we succeeded in profiling in vivo gene expression of P. 
aeruginosa infecting burn wounds, CF patients and different infection models.  
Having appropriate models that mimic closely the real infection are crucial to perform 
experiments for testing hypotheses on infection mechanisms or on the effect of potential 
novel drug targets. Two infection models were tested in this work: a recently reported 
lettuce infection model and a tumour mouse infection model specifically developed here.  
Planktonic and biofilm cultures grown in rich medium were used as control experiments. 
Planktonic cells were harvested in the early stationary phase, while biofilms were collected 
after 24 h of growth. These control conditions were chosen to mimic a nutrient richness 
similar to the infection sites, which is abundant in amino acids. The analyses provided the 
chance to pin-point differentially regulated genes involved in infection. The major changes 
observed in the analysis of the transcriptomic data were those involved in acquisition of 
trace elements such as iron and zinc, genes coding for proteins involved in alginate 
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production, anaerobic growth, type III secretion system and number of hypothetical operons 
not previously known to be connected with virulence. 
5.1. Minerals and trace elements 
The efficient infection of a host by bacteria requires that they develop appropriate survival 
strategies to overcome or bypass immune defences and to acquire essential nutrients such 
as iron and zinc.  Iron acquisition is illustrative of how bacteria overcome such limitations 
during host infection. Iron availability is strictly controlled in eukaryotes by metal binding 
proteins (e.g. ferritin, transferritin and lactoferin), which prevents its reactivity and limits the 
availability for uptake by pathogens (Payne, 1993, Ratledge & Dover, 2000, Schaible & 
Kaufmann, 2004). Since iron plays crucial catalytic roles in a large number of proteins in 
bacteria, they have developed sophisticated systems for iron acquisition (Poole & McKay, 
2003), which have been extensively studied and well reported. We propose in the current 
study that acquisition of another trace element, zinc, is important for bacterial cells during 
burn wound infections. 
Iron 
The study of iron acquisition systems in vitro by transcription profiling has been done in the 
past by assessing the response of cells under two main conditions, namely i) iron starvation 
(Ochsner et al., 2002) and ii) addition of iron to the medium with iron-starved cells (Palma et 
al., 2003). In this work, differentially regulated genes in response to iron starvation were 
observed in all of the in vivo infection conditions, with the most complex pattern being that 
of the burn wound infection setting, where 50% of the genes previously shown to be 
regulated by iron starvation were induced during the burn wound infection. These include 
the genes encoding for ECF sigma factors:  PvdS, FiuI, FemI, PA1300 and PA4896. The 
expression of these regulators and 46 other genes regulated by Fur regulator demonstrates 
that iron acquisition is crucial for survival of P. aeruginosa infecting a burn wound. The genes 
from PA4834-PA4837 were also consistently upregulated in both the burn wound infection 
and the CF patient infection. According to the Pseudomonas Genome Database and 
similarity searches, this operon putatively encodes for a probable novel siderophore system. 
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Thus, it may be a novel system involved in infection. A number of other reports in the 
literature support this hypothesis: i) this operon has been shown to be upregulated in P. 
aeruginosa PA14 growing on the artificial sputum medium as a carbon source (Palmer et al., 
2005); ii) the gene PA4837 has been reported to be expressed in P. aeruginosa clinical CF 
isolates in the early CF infection by phage display (Beckmann et al., 2005); and iii) PA4837 
was also reported to be upregulated in an in vivo peritoneal infection in rats (Mashburn et 
al., 2005). 
The ferric uptake regulator Fur was recently reported to have a broader role than previously 
expected. It has been shown to negatively regulate the small RNA (sRNA) PrrF1 and PrrF2, 
which are post-transcriptionally repressing a number of metabolic genes. As a result of the 
Fur activity, these genes are induced during iron starvation (Vasil, 2007). In the burn wound 
infection experiments, this was observed and will be discussed further in section 5.2. 
Iron starvation response genes are also upregulated in P. aeruginosa infecting lettuce. The 
main iron starvation response sigma factor PvdS is overexpressed together with the ECF 
sigma factors PA0472, PA1912, PA2486 and.  
In contrast to the other infection conditions tested, P. aeruginosa infecting mouse tumours 
did not exhibit strong iron starvation response and only a gene hasAp encoding for a heme 
acquisition protein was induced. This may be due to the presence of a necrotic compartment 
in the tumour, where degraded eukaryotic cells and debris may release sufficient amounts of 
iron so that there is no need for upregulation of the iron-starvation response genes. The 
heme acquisition protein encoding gene was upregulated in all mammalian infection settings 
and not in the plant model, as was expected and shows the careful regulation of such a 
complicated system as iron acquisition. Thus, in short, the global transcription analyses 
revealed the important role of iron acquisition among most of infection settings. The most 
severe iron limitation occurred in burn wound infections. 
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Zinc 
In comparison to the highly developed, complex and possibly not yet fully elucidated iron 
acquisition system, zinc acquisition seems to be simpler. A high-affinity ABC-type zinc 
transporter is encoded by the genes znuABC, which are regulated by the zinc uptake 
regulator encoded by the gene np20. In this report, the znuC was overexpressed in the burn 
wound infection, and the regulator encoded by np20 was also upregulated. The regulator 
np20 has been reported to be involved in P. aeruginosa virulence and PQS signalling (Wang 
et al., 1996, Gallagher et al., 2002).  
In E. coli the cellular requirement for zinc is similar as for iron and calcium (Outten & 
O'Halloran, 2001). The high affinity transport system for zinc ZnuABC was reported to be 
important for growth of pathogens in the host such as Salmonella enterica, Pasteurella 
multocida and Brucella abortus (Campoy et al., 2002, Garrido et al., 2003, Kim et al., 2004, 
Yang et al., 2006, Ammendola et al., 2007). 
The difference in the complexity of the machinery for iron and zinc uptake could be due to 
the elevated zinc levels in the host tissues (Walravens, 1979). However, particularly during 
the burn injury, the level of the zinc significantly decreases  in the wound, while 
concomitantly increasing its concentration in the urine (Berger et al., 1992). This event, 
together with a possible zinc limitation strategy employed by the host (Sohnle et al., 1991, 
Bryant et al., 2004) and overexpression of the eukaryotic matrix metalloprotease (MMP), a 
zinc containing enzyme involved in wound healing (Woessner, 1991) underscores the 
hypothesis that P. aeruginosa infecting the burn wound has to overcome zinc limitation. 
Furthermore, many P. aeruginosa proteins important for infection are zinc containing such 
as LasA protease, LasB elastase and present in clinical strains metallo-β-lactamase 
responsible for resistance to carbapenems. This raises the demand of zinc in the bacterial 
cells infecting the host. 
In addition to the np20 and znuC genes, also the PA3600 and PA3601 genes are 
overexpressed in the burn wound, lettuce and CF patient infection. As already described in 
the results section (4.2.1.1.) these genes encode alternative ribosomal proteins which 
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substitute proteins that would normally bind zinc. This system is believed to be regulated by 
zinc uptake regulators during the zinc limitation (Owen et al., 2007). These results agree with 
those reported recently for a CF-sputum analysis, in which np20 is strongly upregulated (Son 
et al., 2007). These results altogether lead to the hypothesis that the zinc uptake system may 
be a possible target for fighting infection. 
5.2. Aerobic versus anaerobic respiration 
P. aeruginosa cells infecting the host grow in the form of a biofilm (Singh et al., 2000). As a 
result, nutrient and population gradients develop and P. aeruginosa cells in the deeper 
layers of the biofilm (typically beyond a few hundreds micrometers at most) become 
exposed to anoxic conditions (Xu et al., 1998). Furthermore, in CF patients and other 
pulmonary infections, P. aeruginosa is embedded in the thickened airway mucus which 
reinforces these hypoxic gradients.  
Under anoxia P. aeruginosa is capable of respiration using an inorganic terminal electron 
acceptor such as nitrate, nitrite or nitric oxide (Hassett et al., 2002). They are also able to 
ferment arginine via the arginine deaminase pathway, albeit growth is very slow and  
requires rich medium (Mercenier et al., 1980). In the absence of other sources, P. aeruginosa 
also ferments  pyruvate, which is itself  not enough for growth, although it enables 
maintenance of basal metabolism (Eschbach et al., 2004). 
As shown in this work, P. aeruginosa cells grew abundantly in the mouse tumour, which is 
essentially anaerobic in deeper compartments (Sutherland, 1988). Genes encoding for 
enzymes involved in both fermentation strategies, arginine (arcDABC) and pyruvate 
(PA3417, PA3415 and ackA) were clearly overexpressed. Furthermore, the genes encoding 
for the universal stress proteins PA3309 and PA4352 (which are induced by pyruvate 
fermentation) were upregulated. Pyruvate fermentation is induced only when there is no 
nitrate and anaerobic oxidation cannot be performed (Eschbach et al., 2004). However, in 
the tumour mouse infection, the genes responsible for nitrite reduction, nirSMCDE and 
regulator nirQ were overexpressed. This possibly reflects the heterogeneity of the sample 
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from which the RNA was extracted, as it contains a mixture of cells from across the biofilms, 
both the deep anaerobic and the micro-aerophilic layers of the tumour. 
The lettuce infection model had been earlier used to identify those genes responsible for 
anaerobic growth of P. aeruginosa (Filiatrault et al., 2006). However, the transposon 
mutants of five of the twentyfour genes identified as essential for anaerobic growth on 
nitrate were attenuated in lettuce infection in this report and none of them were 
overexpressed in the current work. The genes induced in the lettuce infection model were 
the global anaerobic regulator Anr and that encoding for the regulatory protein NirQ, as well 
as the cofactor molybdopterin encoded by the genes moeA1, moeB1, moaE and moaC. This 
makes it difficult to assess whether P. aeruginosa cells infecting lettuce are really under 
anaerobic conditions. 
Interestingly, in the burn wound infection it was observed that the P. aeruginosa genes 
responsible for oxidative phosphorylation were mostly downregulated, with the exception of 
the part of the operon encoding for a succinate dehydrogenase. At the same time, the 
operon arcABCD, encoding for proteins involved in anaerobic arginine fermentation was 
upregulated. This is somewhat surprising as bacterial growth on burn wounds are not known 
to contain anaerobic environments, although it may be possible that some deeper layers in 
superficial biofilms become anoxic. Another reason for the inhibition of oxidative 
phosphorylation complexes could be due to iron limitation, and more specifically due to a 
novel, recently reported activity of the Fur regulator (Vasil, 2007, Oglesby et al., 2008). In 
that work, Vasil and colleagues have shown that Fur, acting via a negative regulation of the 
sRNA PrrF1 and PrrF2, induces a number of metabolic genes including those encoding 
enzymes involved in the TCA cycle with succinate dehydrogenase and aconitase B, which 
may be also involved in anaerobic metabolism. Furthermore, the PrrF1 and PrrF2 regulate 
periplasmic nitrate reductase. The acnB gene (encoding aconitase B) and genes sdhC and 
sdhD (encoding for succinate dehydrogenase C and D) were induced in the burn wound 
infection, however, there was no sign of anaerobic respiration with nitrate reduction. 
Nevertheless, it is tempting to hypothesise that the aerobic respiration during burn wound 
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infection is reduced due to limitation of iron, which is a crucial component of the enzymes 
involved in the oxidative phosphorylation complexes. This in turn, obliges bacterial cells to 
seek for alternative energy sources, which could be fermentation. Moreover, the anaerobic 
regulator Anr, which regulates the arcABCD operon is not induced during the burn wound 
infection (as seen on Figure 4-2) therefore, it can be postulated that some alternative 
regulation occurs, possibly correlated with the iron starvation response.   
5.3. Virulence of P. aeruginosa  
Pathogenicity of P. aeruginosa is combinatorial as there are many factors that, jointly, 
contribute to their virulence. The direct factors are either cell associated such as adhesins, 
alginate, pili, flagella and lipopolysaccharides, or extracellular such as elastase, exoenzyme S, 
exotoxin A, hemolysins, iron-binding proteins, leukocidins and proteases. Among the indirect 
factors, the most important are the availability to overcome stress conditions during host 
attack such as iron starvation, oxidative stress or the presence of antibacterial compounds. 
In this work, expression of a number of virulent factors under different conditions was 
observed. Some of these factors are discussed below. 
Alginate production 
 Alginate production and pathogenicity of P. aeruginosa strains is generally associated to 
conversion of to a mucoid phenotype (Schurr et al., 1996). The expression profiling done 
here revealed that the genes related to this phenotype were induced during burn wound 
infection of all three patients. In comparison with the biofilm control, the genes algU and 
mucA encoding for sigma and anti-sigma factors were overexpressed. These are important 
mechanisms for the initiation of alginate production (Boucher et al., 1997, Rowen & Deretic, 
2000), which starts with the induction of the gene algD encoding GDP-mannose 6-
dehydrogenase. The gene algD was overexpressed in the burn wound infection in 
comparison with both controls. The sigma factor algU also induces the transcriptional 
regulator algR, which activates positively algD and algC (overexpressed in burn wound in 
comparison to planctonic growth) encoding for phosphomannomutase. The regulator AlgR 
was induced in the burn wound infection, tumour infection and lettuce infection when 
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compared to the biofilm growth. The AlgR regulator has a more global function, regulating 
not only the alg genes but also inducing the genes encoding type IV fimbrial biogenesis 
proteins (Lizewski et al., 2004), which were induced in the lettuce infection model. Also the 
production of hydrogen cyanide and repression of the rhl QS system is regulated by AlgR 
(Morici et al., 2007). 
Toxins and secretion systems 
Another gene known to be involved in direct virulence is toxR, which encodes for the 
regulator of exotoxin A. This gene was clearly upregulated in the three P. aeruginosa strains 
infecting the respective burn wound patients. Higher levels of expression of exotoxin A are 
related to low iron concentration and regulation by PvdS (Gaines et al., 2007). The other 
direct virulence factors secreted during iron starvation were protease IV (gene piv) and the 
insulin-cleaving metalloproteinase (gene icmP). The genes of both proteins were 
upregulated in the burn wound infection, whereas the piv gene was induced in the lettuce 
infection model. 
Secretion of various toxins is a major mechanism allowing P. aeruginosa to thrive within the 
infected host. Exotoxin A is secreted via a type II secretion system encoded by genes from 
the operon xcp (Nunn & Lory, 1992). The gene xcpY was overexpressed in the lettuce 
infection. The second secretion system possessed by P. aeruginosa is type III secretion 
system (T3SS), which is involved in direct injection of the effector proteins into the contact 
host cell (Yahr et al., 1996). This complete system was overexpressed only in the tumour 
mouse infection. The presence of T3SS is usually recognised as an acute type of infection 
with high levels of cytotoxity of the infecting P. aeruginosa cells (Finck-Barbançon et al., 
1997).  
It is not clear if the T3SS is induced during prolonged chronic pulmonary infection of CF 
patients. The report of Lee et al., (2005) has shown that P. aeruginosa strains from CF 
patients isolated shortly after infection and about a decade later, exhibit lower cytotoxity, 
which may the result from mutations in T3SS apparatus or regulatory networks. On the 
contrary, burn wound infections are often regarded as acute P. aeruginosa infections 
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(Church et al., 2006). The strains PBCLOp10, PBCLOp11 and PBCLOp17 were isolated from 
burn wound infections and, accordingly, have a fully active T3SS, which were consistently 
active in the mouse tumour infection model. However, during the burn wound infection 
there is no clear overexpression of this system in any of the three strains. This finding, 
together with other transcriptomic results presented in this thesis, such as the inhibition of 
oxidative phosporylation (which results in lowered energy production) seem to suggest that 
burn wound infection represents, in reality, a non-acute state of infection. This may be less 
surprising than anticipated if one takes into account that the immune system in burn 
wounds is extremely compromised, thus diminishing the need of bacterial cells to employ 
such damaging weapons. 
 Glycine betaine production 
The gene betB encoding betaine aldehyde dehydrogenase, which transforms betaine 
aldehyde into glycine betaine was cleary overexpressed, together with its regulator in all of 
the infection conditions tested in this work; burn wound infection, CF patient infection and 
lettuce and mouse tumour infection models. This is a very interesting result as the 
production of glycine betaine is a feature not yet fully understood in connection with 
virulence. Glycine betaine is an effective osmoprotectant and most likely act as such in 
P. aeruginosa cells growing in the hyperosmotic environment of infected tissues (D'Souza-
Ault et al., 1993). The genes from the bet pathway can play the dual role of producing the 
glycine betaine as osmoprotectant but also of utilising its precursors (such as choline and 
phosphadytylocholin) as carbon and nitrogen sources during infection (Son et al., 2007). 
Both of these features make the enzyme betaine aldehyde dehydrogenase another potential 
drug target (Velasco-Garcia et al., 2006).  
Quorum sensing  
Quorum sensing is the mechanism that allows bacteria to “sense” the density of a bacterial 
population and to respond to it in an organised manner, regulating thereby a large battery of 
genes, including those encoding for virulence factors like elastase LasB and rhamnolipid 
(Schuster & Peter, 2006). The regulon of the QS systems las and rhl was extensively studied 
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in vitro. Table 5-1 shows the amount of genes regulated under the different conditions in the 
work carried out here and which are compared to in vitro studies of las and rhl QS system 
from the report of Schuster and colleagues, where a wildtype P. aeruginosa strain was 
compared to the double lasI rhlI mutant (2003). The results clearly show that a large number 
of genes reported as QS regulated are both induced and repressed under various infection 
conditions. In the case of planktonic growth most of the genes are downregulated. These 
observations underscore the notion that regulation of gene expression is much more 
complex under in vivo than in vitro conditions.  
Table 5-1: Comparison of QS regulated genes, up and downregulated in different infection settings in this 
work. 
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Burn wound 482 55 37 568 37 81 
Tumour 520 27 37 468 9 81 
Lettuce 627 50 27 616 10 67 
CF patient - - - 73 2 20 
 
The direct effector of the las system, elastase LasB, was downregulated in comparison with 
planktonic growth and did not significantly change in comparison to biofilm growth. The 
gene rhlA, encoding a rhamnosyltransferase involved in rhamnolipid production, was 
induced in the lettuce infection model and did not change in other conditions tested in this 
work. The third QS system in P. aeruginosa, which is based on PQS signalling molecule, was 
mainly downregulated under the various conditions, with the highest decrease in expression 
in the CF infection. This could be due to the high concentration of PQS in the patient’s lung 
(S. Häussler, personal communication). 
In the case of the burn wound infection the downregulation of the PQS synthesis pathway 
may be also due to the regulation of vfr, which encodes a virulence factor regulator. The Vfr 
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activates the ToxR regulator of Exotoxin A production and the synthesis of Protease IV (gene 
piv) (West et al., 1994a), which are both overexpressed in the burn wound infection. Vfr also 
activates the QS regulator LasR, but has been shown to negatively regulate PQS (Whitchurch 
et al., 2005). These results show the complexity of gene regulation in various infection 
conditions and usefulness of direct in vivo gene expression profiling in order to reveal these 
various interplays.  
Overall, this work demonstrates that there is likely a sub-set of core genes/regulators that 
are commonly upregulated across many different infection conditions.  
5.4. Real infection settings versus models of infection 
Owing the multifactorial and combinatorial nature of P. aeruginosa’s virulence, the 
availability of realistic infection models is crucial for the testing of novel hypotheses 
regarding both the understanding of its pathogenicity and the development of prevention 
and therapeutic strategies. Global transcription profiling allowed comparisons between the 
expression patterns of various in vivo and in vitro conditions, and among different infection 
models proposed. The comparison was performed at two levels. Firstly, by comparing the 
overall global expression patterns (ordination patterns such as MDS) and secondly, by 
comparing the individual features of virulence present among the different in vivo and in 
vitro conditions.  
Ordination (using multidimensional scaling) of the global expression profiles obtained from 
all conditions revealed that, at statistical level, each of the conditions is significantly different 
from the other. However, the burn wound infection and the tumour infection models are 
more closely related to each other than to any other condition. The CF patient infection was 
not considered in the statistical analysis because, apart from being only one isolate from one 
patient, it was a strain different from that of the three used for the comparative analyses. 
However, owing to its relevance, the data from this experiment was used for qualitative 
comparisons. It would certainly be very relevant to continue collecting data on CF to 
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compare it with the tumour mouse model infection. The relevance of the two infection 
models tested is discussed briefly below. 
Lettuce infection model 
Lettuce infection has been used in the past as a model for P. aeruginosa infection and the 
study of QS and anaerobic growth (Filiatrault et al., 2006, Wagner et al., 2007). However, 
even in these reports only two or three genes proposed to be crucial for either QS or 
anaerobic growth were shown to be crucial for lettuce infection. The data collected in this 
study show certain similarities to those reported, namely, the overexpression of QS system 
las or iron starvation response with sigma factor PvdS, but the multivariate statistical 
analysis shows that the model is far from the other infection conditions and to be closer to 
the planktonic control growth (see Figure 4-11 and Table 4-7). This shows that the lettuce 
infection model can be used for the study of particular factors like the already reported QS. 
However, it is not suitable as a model mimicking mammalian infections by P. aeruginosa. 
Tumour infection model 
The mouse tumour infection model exhibits overexpression of the T3SS together with 
exotoxins secreted via this system, anaerobic growth in similarity to CF pulmonary infection 
conditions, heme acquisition system and expression of proteases like PfpL. The gene cupA1, 
which is involved in biofilm formation during lung infection of CF patients was also 
overexpressed in the tumour. To test this hypothesis, further tests were performed on the P. 
aeruginosa infecting mouse tumour, namely: (i) an histological analysis, which showed that 
bacteria form a layer, most likely, on the border between anaerobic and microaerofilic 
compartment of the tumour; (ii) testing the mutants of the genes involved CF patient 
infection, which revealed that the mutant in gene encoding for anaerobic regulator Anr is 
highly attenuated and mutants of genes cupA1 and pqsA were much less viable in tumour; 
and (iii) statistical analysis of transcriptomic data showed that mouse tumour infection is 
more related to the burn wound infection than non-mammalian lettuce infection or 
planktonic and biofilm growth. These results altogether suggest the mouse tumour infection 
model may be a realistic model for the study of P. aeruginosa mammalian infections. Further 
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analysis is needed in order to more accurately appraise in how far it resembles chronic 
infection. 
5.5. The quest for novel anti-bacterial compounds: Protoanemonin 
The QS inhibitory potential of protanemonin was tested with the bioassay based on the 
fluorescent reporter fused with lasB promoter. The gene lasB is directly regulated by the las 
QS system. The inhibition of the las QS system proved the anti-pseudomonal potential of 
protoanemonin. To further assess the mode of action of this compound, a transcriptomic 
and proteomic approaches were taken. 
The response of P. aeruginosa cells to protonamemonin at the transcriptional level showed 
the differential expression of 84 genes. More than half were repressed. Most of these were 
QS-regulated. Interestingly, the iron starvation response was induced. Iron starvation is 
believed to be interconnected with the QS circuit, especially in biofilm grown bacteria 
(Hentzer et al., 2005), and that PvdS may be AHL-dependent (Juhas et al., 2004). However, 
previous reports on the QS regulon using transcriptomic approaches have not shown that 
iron response is coregulated by QS  (Hentzer et al., 2003, Schuster et al., 2003, Wagner et al., 
2003).  
The proteomic data obtained were consistent with transcriptomic results. Among the 
secreted proteins, downregulation of elastases B (encoded by gene lasB) and overexpression 
of pyoverdine was observed. Only one report, based on a proteomic approach, showed a 
likely link between QS and iron starvation, where pyoverdine and pyochelin receptors FpvA 
and FptA were increased in the lasIrhlI mutant suggesting that the mutant strains 
experienced iron limitation despite the presence of excess iron in the medium (Ferro et al., 
2003). 
This finding shows that the impact and, possibly, the mode of action of protoanemonin, on 
the P. aeruginosa cells differ from furanone C30. The compound furanone C30 did not 
induce almost any gene in the experimental setting for measurement of QS inhibition. The 
reason of the induction of iron stress response by protoanemonin needs to be further 
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investigated in order to elucidate if this is an indirect action via quorum sensing, which is not 
yet fully understood, or if this compound influences directly the regulation of iron. In either 
way, the findings show that protoanemonin may be a promising anti-pseudomonal 
compound. 
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6. Conclusions and Outlook 
In this thesis, the transcriptomic analysis of P. aeruginosa in various infection settings was 
performed. The in vivo gene expression was successfully carried out by developing the 
technical procedures for sample collection, transportation and microarray preparation, 
which provided a basis to answer the questions stated in the rationale. The main conclusions 
are thus the following: 
• According to the transcriptomic analysis, the main factors underlying burn wound 
infection by P. aeruginosa were iron and zinc acquisition as well as alginate 
production. The bacterial state during burn wound infection was not fully acute. 
Bacterial cells undergo serious iron limitation and are slower in metabolism. 
• Iron acquisition and alginate production are important mechanisms common among 
the infection settings studied, namely burn wound, CF patient and tumour model.  
• The tumour mouse model is a promising mammalian infection model and, unto a 
large extent, it mimics the growth conditions of a CF lung. It should be tested further 
in a wider range of conditions to assess if it can be used as a chronic infection model.  
• Plant infection models using lettuce infection may be useful for the study of certain 
factors such as QS systems, but yielded different results as compared to the real 
mammalian infections and therefore cannot be used as a reliable infection model. 
• The multivariate statistical approach of the global expression data shows that the 
tumour infection model is the most closely related to the burn wound infection 
among all conditions. All tested infection and control conditions are statistically 
different from each other. 
• The data analysis techniques, demonstrates that there is a sub-set of core genes that 
are commonly expressed across many different infection conditions, which shows 
that the mechanisms of infections are generally common for different conditions. 
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• Global transcriptomic studies revealed that iron acquisition plays a crucial role in the 
infection by P. aeruginosa. Following leads that have shown that protoanemonin 
inhibited QS in P. aeruginosa, in this thesis, the effect of this compound on the 
proteomic and transcriptomic profiles of P. aeruginosa was tested. It was shown that 
protoanemonin inhibited QS-related genes and proteins while inducing iron 
starvation of the cell. The exact mechanism is as yet unknown. This compound thus 
should be further tested for its potential as anti-infective 
• The features observed and the results reported here on the mechanisms and 
processes used by P. aeruginosa during infection provide a wealth of insights that 
should be explored further in the future. The effect of zinc and the regulation of the 
zinc response may be a promising new path to understand and combat the virulence 
of P. aeruginosa. Together with the proposed targets like glycine betaine production 
enzymes, there are a number of hypothetical unknown factors which may play a 
crucial role in infection. Examples are the proteins encoded by the cluster PA4063-65 
and PA4834-37, putatively encoding for a novel siderophore system.  
The insights and conclusions obtained in the work presented here provide a foundation for 
future work directed at the understanding of P. aeruginosa infection and finding new 
prevention and treatment strategies. 
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8. Appendix 
Table 8-1: Differentially regulated genes (pfp < 0.05) in burn wound infection in comparison with planktonic 
and biofilm growth controls. 
PA Number Gene 
Fold change compared to 
Product Name Planktonic Biofilm 
PA0007  -4.72  hypothetical protein 
PA0020  2.23  hypothetical protein 
PA0038   3.72 hypothetical protein 
PA0050  -2.75 -5.24 hypothetical protein 
PA0052  -4.76  hypothetical protein 
PA0059 osmC 3.70 21.69 osmotically inducible protein OsmC 
PA0060  3.56 7.14 conserved hypothetical protein 
PA0085   -4.40 conserved hypothetical protein 
PA0102  7.46 12.11 probable carbonic anhydrase 
PA0103   2.20 probable sulfate transporter 
PA0104  2.66 2.75 hypothetical protein 
PA0105 coxB -12.23  cytochrome c oxidase, subunit II 
PA0106 coax -35.41  cytochrome c oxidase, subunit I 
PA0107  -34.07  conserved hypothetical protein 
PA0108 coIII -69.43 -3.09 cytochrome c oxidase, subunit III 
PA0109  -3.88  hypothetical protein 
PA0110  -19.82  hypothetical protein 
PA0111  -13.65  hypothetical protein 
PA0112  -4.36  hypothetical protein 
PA0113  -8.76  probable cytochrome c oxidase assembly factor 
PA0122  -46.03 -6.99 conserved hypothetical protein 
PA0128 phnA  -3.02 conserved hypothetical protein 
PA0160   -4.13 hypothetical protein 
PA0161   -3.15 hypothetical protein 
PA0173  -2.99  probable methylesterase 
PA0175 cheR2 -10.86  probable chemotaxis protein methyltransferase 
PA0176 aer2 -8.41  aerotaxis transducer Aer2 
PA0177  -8.59  probable purine-binding chemotaxis protein 
PA0178  -10.71  probable two-component sensor 
PA0179  -26.10  probable two-component response regulator 
PA0180  -6.75  probable chemotaxis transducer 
PA0215 madL  -7.23  probable transporter 
PA0249  -3.38  probable acetyltransferase 
PA0250  -3.80  conserved hypothetical protein 
PA0256  -3.29  hypothetical protein 
PA0263 hcpC  -54.00 secreted protein Hcp 
PA0291 oprE 
 
-3.69 Anaerobically-induced outer membrane porin OprE 
precursor 
PA0312  -6.50  conserved hypothetical protein 
PA0315   2.55 hypothetical protein 
PA0320  3.70 3.64 conserved hypothetical protein 
PA0329  -4.10  conserved hypothetical protein 
PA0332  -3.35  hypothetical protein 
PA0354  3.47  conserved hypothetical protein 
Appendix 
 
148 
 
PA0355 pfpI  7.42 protease PfpI 
PA0363 coaD  -3.00 phosphopantetheine adenylyltransferase 
PA0365  -5.00  hypothetical protein 
PA0376 rpoH  3.65 sigma factor RpoH 
PA0384  -3.81  hypothetical protein 
PA0385   -2.88 hypothetical protein 
PA0408 pilG  -4.09 twitching motility protein PilG 
PA0409 pilH  -4.59 twitching motility protein PilH 
PA0410 pilI  -2.65 twitching motility protein PilI 
PA0411 pilJ  -2.55 twitching motility protein PilJ 
PA0423 pasP 3.85  PasP 
PA0424 mexR 2.53  multidrug resistance operon repressor MexR 
PA0456   -4.61 probable cold-shock protein 
PA0460   2.65 hypothetical protein 
PA0472 fiuI   3.93 probable sigma-70 factor, ECF subfamily 
PA0484  -4.50  conserved hypothetical protein 
PA0490   4.87 hypothetical protein 
PA0505  -4.34  hypothetical protein 
PA0506   -4.00 probable acyl-CoA dehydrogenase 
PA0520 nirQ -3.05  regulatory protein NirQ 
PA0532  3.87 2.68 hypothetical protein 
PA0541   -3.49 hypothetical protein 
PA0553   4.07 hypothetical protein 
PA0563   -4.39 conserved hypothetical protein 
PA0567 yqaE   7.62 conserved hypothetical protein 
PA0578  9.19 -3.93 conserved hypothetical protein 
PA0579 rpsU 3.89 -2.82 30S ribosomal protein S21 
PA0581 ygiH   -3.17 conserved hypothetical protein 
PA0586 ycgB  -4.22  conserved hypothetical protein 
PA0588 yeaG   2.43 conserved hypothetical protein 
PA0589 glpE   -3.51 conserved hypothetical protein 
PA0608 gph   -2.74 probable phosphoglycolate phosphatase 
PA0610 prtN -3.43  transcriptional regulator PrtN 
PA0612 ptrB -3.55  repressor, PtrB 
PA0623  -2.51  probable bacteriophage protein 
PA0624  -4.58  hypothetical protein 
PA0652 vfr 2.36  transcriptional regulator Vfr 
PA0654 speD  -3.95 S-adenosylmethionine decarboxylase proenzyme 
PA0655   -3.13 hypothetical protein 
PA0656 ycfF  -4.38  probable HIT family protein 
PA0667 yebA   -2.84 conserved hypothetical protein 
PA0672 hemO  6.84 heme oxygenase 
PA0707 toxR 4.34 4.16 transcriptional regulator ToxR 
PA0713   -3.44 hypothetical protein 
PA0745  -2.94  probable enoyl-CoA hydratase/isomerase 
PA0762 algU  2.75 sigma factor AlgU 
PA0763 mucA  4.78 anti-sigma factor MucA 
PA0764 mucB 2.61  negative regulator for alginate biosynthesis MucB 
PA0766 mucD 2.42  serine protease MucD precursor 
PA0767 lepA  -5.51 GTP-binding protein LepA 
PA0768 lepB  -3.25 signal peptidase I 
PA0778 icp 2.31  inhibitor of cysteine peptidase 
PA0779  2.33  probable ATP-dependent protease 
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PA0781  3.14 3.22 hypothetical protein 
PA0805   -5.12 hypothetical protein 
PA0852 cbpD -3.44  chitin-binding protein CbpD precursor 
PA0856  2.73  hypothetical protein 
PA0857 bolA 2.19  morphogene protein BolA 
PA0865 hpd -7.05  4-hydroxyphenylpyruvate dioxygenase 
PA0866 aroP2 -4.69  aromatic amino acid transport protein AroP2 
PA0870 phhC -5.41  aromatic amino acid aminotransferase 
PA0871 phhB -4.55  pterin-4-alpha-carbinolamine dehydratase 
PA0887 acsA  3.73 acetyl-coenzyme A synthetase 
PA0890 aotM  -3.06 arginine/ornithine transport protein AotM 
PA0915 yehS   -3.45 conserved hypothetical protein 
PA0917 kup  -2.57 potassium uptake protein Kup 
PA0921  -3.89  hypothetical protein 
PA0925  2.44  hypothetical protein 
PA0934 relA -2.57  GTP pyrophosphokinase 
PA0945 purM  -3.18 phosphoribosylaminoimidazole synthetase 
PA0952   -3.88 hypothetical protein 
PA0954  -3.19  probable acylphosphatase 
PA0955   -4.80 hypothetical protein 
PA0959  -3.58  hypothetical protein 
PA0960  -5.58  hypothetical protein 
PA0962   4.25 probable dna-binding stress protein 
PA0965 ruvC  -4.03 Holliday junction resolvase RuvC 
PA0981   -2.53 hypothetical protein 
PA0998 pqsC 
 
-4.45 Homologous to beta-keto-acyl-acyl-carrier protein 
synthase 
PA1000 pqsE  -2.51 Quinolone signal response protein 
PA1001 phnA -2.51 -3.69 anthranilate synthase component I 
PA1002 phnB -3.72  anthranilate synthase component II 
PA1029   2.67 hypothetical protein 
PA1034   -2.86 hypothetical protein 
PA1041  -33.52  probable outer membrane protein precursor 
PA1042  -3.39  conserved hypothetical protein 
PA1048  -3.34  probable outer membrane protein precursor 
PA1080 flgE  -2.67 flagellar hook protein FlgE 
PA1092 fliC  -3.86 flagellin type B 
PA1102 fliG -2.91  flagellar motor switch protein FliG 
PA1118   2.62 hypothetical protein 
PA1121  -5.21  conserved hypothetical protein 
PA1123   -15.42 hypothetical protein 
PA1132   -2.87 hypothetical protein 
PA1134  3.67 3.69 hypothetical protein 
PA1137  3.65 3.92 probable oxidoreductase 
PA1151 imm2 -2.71  pyocin S2 immunity protein 
PA1168  -5.35 -59.91 hypothetical protein 
PA1172 napC -4.25  cytochrome c-type protein NapC 
PA1173 napB -4.03  cytochrome c-type protein NapB precursor 
PA1174 napA -10.94  periplasmic nitrate reductase protein NapA 
PA1175 napD -8.01 -2.82 NapD protein of periplasmic nitrate reductase 
PA1176 napF -14.21  ferredoxin protein NapF 
PA1177 napE -29.71  periplasmic nitrate reductase protein NapE 
PA1178 oprH -40.86  PhoP/Q and low Mg2+ inducible outer membrane 
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protein H1 precursor 
PA1179 phoP -10.24  two-component response regulator PhoP 
PA1180 phoQ -5.74  two-component sensor PhoQ 
PA1181 yegE  -4.98  conserved hypothetical protein 
PA1183 dctA  -15.66 C4-dicarboxylate transport protein 
PA1190 yohC  -8.88  conserved hypothetical protein 
PA1198   -2.96 conserved hypothetical protein 
PA1199   -3.32 probable lipoprotein 
PA1202 ycaC  -2.80  probable hydrolase 
PA1283  -2.90  probable transcriptional regulator 
PA1289  -10.93  hypothetical protein 
PA1300   5.49 probable sigma-70 factor, ECF subfamily 
PA1301   4.22 probable transmembrane sensor 
PA1306   -2.63 probable HIT family protein 
PA1323   5.48 hypothetical protein 
PA1324  3.65 6.73 hypothetical protein 
PA1327  -2.77  probable protease 
PA1340  -6.04 -4.13 probable permease of ABC transporter 
PA1342 
 
-4.83 
 
probable binding protein component of ABC 
transporter 
PA1348  -7.26  hypothetical protein 
PA1353  -3.55  hypothetical protein 
PA1404  2.41 24.10 hypothetical protein 
PA1414  -2.86  hypothetical protein 
PA1431 rsaL -6.20  regulatory protein RsaL 
PA1439 ybaN   -2.61 conserved hypothetical protein 
PA1444 fliN -3.48  flagellar motor switch protein FliN 
PA1454 fleN -3.06  flagellar synthesis regulator FleN 
PA1455 fliA -3.35  sigma factor FliA 
PA1456 cheY -3.34  two-component response regulator CheY 
PA1458 cheA  -2.97  probable two-component sensor 
PA1462  -4.28  probable plasmid partitioning protein 
PA1464 cheW  -2.84  probable purine-binding chemotaxis protein 
PA1465  -3.16  hypothetical protein 
PA1476 ccmB  -2.60 heme exporter protein CcmB 
PA1477 ccmC  -2.79 heme exporter protein CcmC 
PA1478 ccmD  -2.99 hypothetical protein 
PA1479 ccmE  -4.15 cytochrome C-type biogenesis protein CcmE 
PA1480 ccmF  -4.64 cytochrome C-type biogenesis protein CcmF 
PA1482 ccmH  -5.22 cytochrome C-type biogenesis protein CcmH 
PA1511   -2.56 conserved hypothetical protein 
PA1515 alc 2.43 2.78 allantoicase 
PA1517  2.09 3.78 conserved hypothetical protein 
PA1518  4.43 3.61 conserved hypothetical protein 
PA1540  2.29  conserved hypothetical protein 
PA1543 apt  -3.21 adenine phosphoribosyltransferase 
PA1545  -3.68  hypothetical protein 
PA1546 hemN  -3.13 oxygen-independent coproporphyrinogen III oxidase 
PA1551 fixG  -3.07 probable ferredoxin 
PA1555 ccoP  -4.30 probable cytochrome c 
PA1556 ccoO 2.61 -4.92 probable cytochrome c oxidase subunit 
PA1557 ccoN  -5.60 probable cytochrome oxidase subunit (cbb3-type) 
PA1579   2.77 hypothetical protein 
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PA1581 sdhC 3.13  succinate dehydrogenase (C subunit) 
PA1582 sdhD 3.10  succinate dehydrogenase (D subunit) 
PA1584 sdhB  -2.59 succinate dehydrogenase (B subunit) 
PA1592  2.50  hypothetical protein 
PA1596 htpG 2.17  heat shock protein HtpG 
PA1610 fabA  -3.56 beta-hydroxydecanoyl-ACP dehydrase 
PA1617  -6.60  probable AMP-binding enzyme 
PA1641  -3.68  hypothetical protein 
PA1656   -12.65 hypothetical protein 
PA1657   -4.36 conserved hypothetical protein 
PA1658   -8.61 conserved hypothetical protein 
PA1659   -7.13 hypothetical protein 
PA1660   -10.06 hypothetical protein 
PA1661   -6.99 hypothetical protein 
PA1668   -3.07 hypothetical protein 
PA1669   -2.69 hypothetical protein 
PA1677  -3.08  conserved hypothetical protein 
PA1701 pcr3   -3.34 conserved hypothetical protein in type III secretion 
PA1710 exsC -3.65  ExsC, exoenzyme S synthesis protein C precursor. 
PA1713 exsA  -3.52 transcriptional regulator ExsA 
PA1714 exsD  -2.68 ExsD 
PA1728  -10.56  hypothetical protein 
PA1733  -2.63  conserved hypothetical protein 
PA1751  -3.95  hypothetical protein 
PA1752  -3.04  hypothetical protein 
PA1753  -2.74  conserved hypothetical protein 
PA1760  -4.15  probable transcriptional regulator 
PA1761  -2.86  hypothetical protein 
PA1767   -3.41 hypothetical protein 
PA1768  2.01 -2.71 hypothetical protein 
PA1775 cmpX 2.48 
 
conserved cytoplasmic membrane protein, CmpX 
protein 
PA1784  -7.93  hypothetical protein 
PA1787 acnB 2.07  aconitate hydratase 2 
PA1812 mltD 3.36 -3.39 membrane-bound lytic murein transglycosylase D 
precursor 
PA1819 yjdE  -2.82  probable amino acid permease 
PA1830   -3.78 hypothetical protein 
PA1847 yhgI  2.45  conserved hypothetical protein 
PA1862 modB 2.28  molybdenum transport protein ModB 
PA1869   -2.81 probable acyl carrier protein 
PA1870  3.73 7.84 hypothetical protein 
PA1874  -5.13  hypothetical protein 
PA1875 opmL  -16.57  probable outer membrane protein precursor 
PA1876 
 
-3.90 
 
probable ATP-binding/permease fusion ABC 
transporter 
PA1887  -9.08  hypothetical protein 
PA1888  -4.95  hypothetical protein 
PA1912  2.53 3.23 probable sigma-70 factor, ECF subfamily 
PA1914 hvn  -5.17  conserved hypothetical protein 
PA1931  -2.77 2.59 probable ferredoxin 
PA1959 bacA 2.57  bacitracin resistance protein 
PA1985 pqqA  2.61 pyrroloquinoline quinone biosynthesis protein A 
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PA1988 pqqD  3.06 pyrroloquinoline quinone biosynthesis protein D 
PA2000 atoA 2.39 2.65 probable CoA transferase, subunit B 
PA2006 
 
-3.60 
 
probable major facilitator superfamily (MFS) 
transporter 
PA2007 maiA -2.84 6.08 maleylacetoacetate isomerase 
PA2008 fahA -3.30  fumarylacetoacetase 
PA2015 liuA 2.84  putative isovaleryl-CoA dehydrogenase 
PA2016 liuR 2.96  regulator of liu genes 
PA2020 amrR -4.00  probable transcriptional regulator 
PA2021   5.66 hypothetical protein 
PA2023 galU 3.19  UTP--glucose-1-phosphate uridylyltransferase 
PA2024  -6.20 3.47 probable ring-cleaving dioxygenase 
PA2027  -47.94  hypothetical protein 
PA2030  -4.14  hypothetical protein 
PA2033   3.03 hypothetical protein 
PA2034  -1.29 4.14 hypothetical protein 
PA2071 fusA2 -2.61  elongation factor G 
PA2108  2.88 3.13 probable decarboxylase 
PA2134  4.79 30.40 hypothetical protein 
PA2135  3.82 6.70 probable transporter 
PA2140  3.90 3.50 probable metallothionein 
PA2141  5.67 8.02 hypothetical protein 
PA2142 yhxC  5.00 7.15 probable short-chain dehydrogenase 
PA2143  2.33 34.48 hypothetical protein 
PA2144 glgP 3.35 7.38 glycogen phosphorylase 
PA2145  2.35 3.65 hypothetical protein 
PA2146 yciG  3.40 86.21 conserved hypothetical protein 
PA2147 katE 3.44 3.37 catalase HPII 
PA2148  3.42 7.13 conserved hypothetical protein 
PA2149  3.09 8.99 hypothetical protein 
PA2150  2.64 2.88 conserved hypothetical protein 
PA2151  3.65 4.01 conserved hypothetical protein 
PA2152  2.89 5.23 probable trehalose synthase 
PA2153 glgB 2.60 4.34 1,4-alpha-glucan branching enzyme 
PA2157  4.63 5.29 hypothetical protein 
PA2158  6.30 14.25 probable alcohol dehydrogenase (Zn-dependent) 
PA2159  6.31 52.08 conserved hypothetical protein 
PA2160 glgX  3.44 4.19 probable glycosyl hydrolase 
PA2161  3.14 5.41 hypothetical protein 
PA2164  3.73 4.19 probable glycosyl hydrolase 
PA2165 glgA  4.37 6.33 probable glycogen synthase 
PA2166  -5.44 3.92 hypothetical protein 
PA2167   3.54 hypothetical protein 
PA2168  3.15 5.98 hypothetical protein 
PA2169  4.06 22.99 hypothetical protein 
PA2170  3.24 32.57 hypothetical protein 
PA2171  4.67 18.87 hypothetical protein 
PA2172  1.97 7.78 hypothetical protein 
PA2173   9.88 hypothetical protein 
PA2174   2.61 hypothetical protein 
PA2175  2.53 2.99 hypothetical protein 
PA2176  2.34 2.69 hypothetical protein 
PA2178  3.66 5.45 hypothetical protein 
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PA2180  4.85 4.97 hypothetical protein 
PA2181  3.05 3.92 hypothetical protein 
PA2182   3.44 hypothetical protein 
PA2183  3.51 5.08 hypothetical protein 
PA2184 yciE   5.82 conserved hypothetical protein 
PA2186  2.14  hypothetical protein 
PA2187  2.98 4.56 hypothetical protein 
PA2189   2.87 hypothetical protein 
PA2190  4.38 44.25 conserved hypothetical protein 
PA2192  4.00 7.91 conserved hypothetical protein 
PA2199   2.24 probable dehydrogenase 
PA2231 pslA  -3.28 PslA 
PA2233 pslC -3.44  probable glycosyl transferase 
PA2240 pslJ  -2.54 hypothetical protein 
PA2247 bkdA1 -4.74  2-oxoisovalerate dehydrogenase (alpha subunit) 
PA2248 bkdA2 -3.43  2-oxoisovalerate dehydrogenase (beta subunit) 
PA2249 bkdB -4.80 
 
branched-chain alpha-keto acid dehydrogenase 
(lipoamide component) 
PA2250 lpdV -7.46  lipoamide dehydrogenase-Val 
PA2364  -4.74  hypothetical protein 
PA2365  -4.11 -3.29 conserved hypothetical protein 
PA2367  -3.38  hypothetical protein 
PA2368  -3.11  hypothetical protein 
PA2375  -5.10  hypothetical protein 
PA2381  -2.79  hypothetical protein 
PA2383  2.69 4.24 probable transcriptional regulator 
PA2384  3.09 12.29 hypothetical protein 
PA2385 pvdQ 5.70 5.47 PvdQ 
PA2386 pvdA 4.16 4.36 L-ornithine N5-oxygenase 
PA2393  2.84 3.47 probable dipeptidase precursor 
PA2395 pvdO 3.79 3.90 PvdO 
PA2404  2.94 4.19 hypothetical protein 
PA2405  4.01 4.63 hypothetical protein 
PA2406  3.51  hypothetical protein 
PA2407  2.57 2.50 probable adhesion protein 
PA2411  6.05 15.46 probable thioesterase 
PA2412  5.76 13.16 conserved hypothetical protein 
PA2413 pvdH 3.69 4.69 L-2,4-diaminobutyrate:2-ketoglutarate 4-
aminotransferase, PvdH 
PA2414   7.89 L-sorbosone dehydrogenase 
PA2422  -3.04  hypothetical protein 
PA2423  -2.70  hypothetical protein 
PA2424 pvdL 3.23 4.57 PvdL 
PA2425 pvdG 2.34 3.78 PvdG 
PA2426 pvdS 5.42 10.43 sigma factor PvdS 
PA2433   10.20 hypothetical protein 
PA2456   -3.12 hypothetical protein 
PA2485  2.07  hypothetical protein 
PA2486  4.01 6.33 hypothetical protein 
PA2501  -27.00 -4.44 hypothetical protein 
PA2504  -6.18  hypothetical protein 
PA2531  2.33  probable aminotransferase 
PA2562  -3.15  hypothetical protein 
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PA2564 tam  -23.36  hypothetical protein 
PA2565  -32.01  hypothetical protein 
PA2566  -28.00  conserved hypothetical protein 
PA2569   3.15 hypothetical protein 
PA2570 lecA -5.73 -3.22 LecA 
PA2571  -6.29  probable two-component sensor 
PA2573  -4.59  probable chemotaxis transducer 
PA2584 pgsA  -3.98 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase 
PA2591  -9.04 -4.62 probable transcriptional regulator 
PA2593   -8.45 hypothetical protein 
PA2605 yheN  -3.74  conserved hypothetical protein 
PA2618  -3.28  hypothetical protein 
PA2619 infA 2.44 -4.83 initiation factor 
PA2620 clpA -3.34  ATP-binding protease component ClpA 
PA2621  -3.02  conserved hypothetical protein 
PA2622 cspD -8.84 -3.38 cold-shock protein CspD 
PA2624 idh 5.28  isocitrate dehydrogenase 
PA2629 purB  -3.89 adenylosuccinate lyase 
PA2634 aceA 3.44  isocitrate lyase 
PA2637 nuoA  -3.33 NADH dehydrogenase I chain A 
PA2640 nuoE -4.48 -4.59 NADH dehydrogenase I chain E 
PA2643 nuoH -5.17 -4.35 NADH dehydrogenase I chain H 
PA2646 nuoK -3.44 -3.24 NADH dehydrogenase I chain K 
PA2647 nuoL -2.63 -2.53 NADH dehydrogenase I chain L 
PA2657   3.05 probable two-component response regulator 
PA2658  3.16 8.14 hypothetical protein 
PA2659  2.18 3.72 hypothetical protein 
PA2666 ptpS   -2.82 probable 6-pyruvoyl tetrahydrobiopterin synthase 
PA2667  2.33  conserved hypothetical protein 
PA2694  2.46 2.73 probable thioredoxin 
PA2709 cysK  2.38 cysteine synthase A 
PA2738 himA -3.38  integration host factor, alpha subunit 
PA2741 rplT 2.50  50S ribosomal protein L20 
PA2746  -10.88  hypothetical protein 
PA2747  -4.41  hypothetical protein 
PA2748 mapB   2.64 probable methionine aminopeptidase 
PA2754   5.66 conserved hypothetical protein 
PA2755 eco 2.27  ecotin precursor 
PA2756  -3.37  hypothetical protein 
PA2762  -2.74  hypothetical protein 
PA2765  -2.55  hypothetical protein 
PA2771  -4.29  conserved hypothetical protein 
PA2779  -3.70  hypothetical protein 
PA2840 deaD  2.93 -2.97 probable ATP-dependent RNA helicase 
PA2849  -4.24  probable transcriptional regulator 
PA2851 efp 2.71  translation elongation factor P 
PA2883   2.80 hypothetical protein 
PA2899  -2.76  probable transcriptional regulator 
PA2915  -2.83  hypothetical protein 
PA2937  -7.59  hypothetical protein 
PA2939 pepB  -5.76  probable aminopeptidase 
PA2953   -3.39 electron transfer flavoprotein-ubiquinone 
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oxidoreductase 
PA2955   -2.53 hypothetical protein 
PA2957   -3.15 probable transcriptional regulator 
PA2966 acpP  -3.01 acyl carrier protein 
PA2970 rpmF 2.17 -2.84 50S ribosomal protein L32 
PA2971 yceD   -5.10 conserved hypothetical protein 
PA2992   -2.68 hypothetical protein 
PA3009   -3.26 hypothetical protein 
PA3017  -5.04 2.93 conserved hypothetical protein 
PA3022  -4.73 -2.83 hypothetical protein 
PA3032 snr1 -3.95  cytochrome c Snr1 
PA3040 yqjD   5.96 conserved hypothetical protein 
PA3041 yqjE   5.00 hypothetical protein 
PA3042   5.69 hypothetical protein 
PA3049 rmf  2.61 ribosome modulation factor 
PA3057   -2.70 hypothetical protein 
PA3068 gdhB -2.83  NAD-dependent glutamate dehydrogenase 
PA3069  2.47  hypothetical protein 
PA3096 xcpY -2.88  general secretion pathway protein L 
PA3100 xcpU -3.75 -3.10 General secretion pathway outer membrane protein H 
precursor 
PA3101 xcpT -2.92  general secretion pathway protein G 
PA3114 truA  -2.80 tRNA-pseudouridine synthase I 
PA3123  -5.04  conserved hypothetical protein 
PA3126 ibpA 4.13  heat-shock protein IbpA 
PA3186 oprB -6.10 
 
Glucose/carbohydrate outer membrane porin OprB 
precursor 
PA3187 gltK  -7.19  probable ATP-binding component of ABC transporter 
PA3188 gltG  -6.07  probable permease of ABC sugar transporter 
PA3189 gltF  -3.50  probable permease of ABC sugar transporter 
PA3190 gltB  -7.27 -5.11 probable binding protein component of ABC sugar 
transporter 
PA3216  -6.71  hypothetical protein 
PA3217 cyaB  -3.99 CyaB 
PA3231   21.65 hypothetical protein 
PA3234  -4.54  probable sodium:solute symporter 
PA3235  -4.37  conserved hypothetical protein 
PA3245 minE  -2.81 cell division topological specificity factor MinE 
PA3260  -3.20  probable transcriptional regulator 
PA3262  2.35  probable peptidyl-prolyl cis-trans isomerase, FkbP-type 
PA3266 capB 9.76  cold acclimation protein B 
PA3274  3.33 13.19 hypothetical protein 
PA3278   -3.31 hypothetical protein 
PA3280 oprO 
 
-2.55 Pyrophosphate-specific outer membrane porin OprO 
precursor 
PA3283  4.49 5.78 conserved hypothetical protein 
PA3284  2.58 4.50 hypothetical protein 
PA3292   -6.98 hypothetical protein 
PA3299 fadD1  -2.70 long-chain-fatty-acid--CoA ligase 
PA3316  -3.23  probable permease of ABC transporter 
PA3326  -4.65  probable Clp-family ATP-dependent protease 
PA3332   -4.37 conserved hypothetical protein 
PA3343  -2.81  hypothetical protein 
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PA3345  -2.68  hypothetical protein 
PA3346  -6.68  probable two-component response regulator 
PA3347  -4.60  hypothetical protein 
PA3349  -6.57  probable chemotaxis protein 
PA3353  -2.97  hypothetical protein 
PA3354  -3.30  hypothetical protein 
PA3361 lecB -6.99 -24.70 fucose-binding lectin PA-IIL 
PA3385 amrZ -3.64  alginate and motility regulator Z 
PA3397 fpr 2.93  ferredoxin--NADP+ reductase 
PA3407 hasAp 31.45 33.33 heme acquisition protein HasAp 
PA3415  -6.02  probable dihydrolipoamide acetyltransferase 
PA3416  -5.59 
 
probable pyruvate dehydrogenase E1 component, beta 
chain 
PA3417  -4.50 
 
probable pyruvate dehydrogenase E1 component, 
alpha subunit 
PA3418 ldh -9.77  leucine dehydrogenase 
PA3431 ywbG  10.11 7.82 conserved hypothetical protein 
PA3432  6.32 6.66 hypothetical protein 
PA3451  -4.51  hypothetical protein 
PA3459 asnB  4.66 21.98 probable glutamine amidotransferase 
PA3460  4.69 13.02 probable acetyltransferase 
PA3461 yhfE  3.82 20.16 conserved hypothetical protein 
PA3465 yfiS  -3.37  conserved hypothetical protein 
PA3472  2.21  hypothetical protein 
PA3477 rhlR -3.15  transcriptional regulator RhlR 
PA3489 rnfA   -4.99 conserved hypothetical protein 
PA3496  -4.21 -5.18 hypothetical protein 
PA3520  -4.08 -3.73 hypothetical protein 
PA3525 argG  -2.68 argininosuccinate synthase 
PA3526 motY  -2.85  probable outer membrane protein precursor 
PA3530 bfd   2.67 conserved hypothetical protein 
PA3531 bfrB  -5.36 bacterioferritin 
PA3540 algD 3.96 3.90 GDP-mannose 6-dehydrogenase AlgD 
PA3568 ymmS  -14.46  probable acetyl-coa synthetase 
PA3569 mmsB -5.29 2.50 3-hydroxyisobutyrate dehydrogenase 
PA3570 mmsA -3.89 2.67 methylmalonate-semialdehyde dehydrogenase 
PA3572  -13.37 -2.61 hypothetical protein 
PA3576  -3.55  hypothetical protein 
PA3584 glpD 15.38  glycerol-3-phosphate dehydrogenase 
PA3598 ypqQ  6.94 6.69 conserved hypothetical protein 
PA3600 rpl36  434.78 1000.00 conserved hypothetical protein 
PA3601 ykgM  232.56 175.44 conserved hypothetical protein 
PA3611  3.78  hypothetical protein 
PA3612 ypeB  2.72  conserved hypothetical protein 
PA3618 ygaD   2.86 conserved hypothetical protein 
PA3621 fdxA  -5.95 ferredoxin I 
PA3622 rpoS -5.33  sigma factor RpoS 
PA3635 eno 3.75  enolase 
PA3645 fabZ 
 
-3.13 (3R)-hydroxymyristoyl-[acyl carrier protein] 
dehydratase 
PA3646 lpxD 
 
-3.40 UDP-3-O-[3-hydroxylauroyl] glucosamine N-
acyltransferase 
PA3648   -2.99 probable outer membrane protein precursor 
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PA3652 uppS  -3.02 undecaprenyl pyrophosphate synthetase 
PA3653 frr  -2.61 ribosome recycling factor 
PA3654 pyrH  -4.78 uridylate kinase 
PA3655 tsf 2.60  elongation factor Ts 
PA3656 rpsB 2.37  30S ribosomal protein S2 
PA3662  -9.09  hypothetical protein 
PA3684  -31.76 -8.32 hypothetical protein 
PA3688  -3.96 2.52 hypothetical protein 
PA3691  2.66 16.42 hypothetical protein 
PA3692  4.61 14.04 probable outer membrane protein precursor 
PA3698  -3.44  hypothetical protein 
PA3703 wspF -2.54  probable methylesterase 
PA3719  2.31  hypothetical protein 
PA3722   -3.82 hypothetical protein 
PA3723 yqjM  -6.44  probable FMN oxidoreductase 
PA3724 lasB -5.68  elastase LasB 
PA3731 yjfJ  2.32 4.02 conserved hypothetical protein 
PA3732 yjfI   3.78 conserved hypothetical protein 
PA3741   -3.31 hypothetical protein 
PA3742 rplS 2.28 -4.58 50S ribosomal protein L19 
PA3762  2.63 4.21 hypothetical protein 
PA3784  -4.41  hypothetical protein 
PA3785  -4.32  conserved hypothetical protein 
PA3786  -3.35  hypothetical protein 
PA3792 leuA -2.87  2-isopropylmalate synthase 
PA3795  2.72 4.67 probable oxidoreductase 
PA3796  -3.28  hypothetical protein 
PA3804   -2.53 hypothetical protein 
PA3805 pilF  -3.12 type 4 fimbrial biogenesis protein PilF 
PA3806 yfgB   -2.98 conserved hypothetical protein 
PA3809 fdx2 2.10  ferredoxin [2Fe-2S] 
PA3811 hscB 2.32  heat shock protein HscB 
PA3812 iscA 2.46  probable iron-binding protein IscA 
PA3814 iscS 4.68 
 
L-cysteine desulfurase (pyridoxal phosphate-
dependent) 
PA3815  6.89  conserved hypothetical protein 
PA3819 ycfJ   5.15 conserved hypothetical protein 
PA3824 queA 
 
-3.64 S-adenosylmethionine:trna ribosyltransferase-
isomerase 
PA3833  -2.67  hypothetical protein 
PA3846  -2.74  hypothetical protein 
PA3847  -3.32  conserved hypothetical protein 
PA3848  -2.80  hypothetical protein 
PA3854  -2.79  hypothetical protein 
PA3858 aapJ  -7.32  probable amino acid-binding protein 
PA3891  2.50 2.62 probable ATP-binding component of ABC transporter 
PA3905   -3.50 hypothetical protein 
PA3906   -3.90 hypothetical protein 
PA3908   -5.14 hypothetical protein 
PA3922  -7.91  conserved hypothetical protein 
PA3923  -2.87  hypothetical protein 
PA3941   -3.05 hypothetical protein 
PA3945  -3.10  conserved hypothetical protein 
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PA3951  3.20 2.47 conserved hypothetical protein 
PA3952   2.63 hypothetical protein 
PA3957  -6.91  probable short-chain dehydrogenase 
PA3966  2.53 -2.99 hypothetical protein 
PA3967   -4.90 hypothetical protein 
PA3973  -2.69  probable transcriptional regulator 
PA3979   -2.98 hypothetical protein 
PA3986  -18.49  hypothetical protein 
PA4012  -4.05  hypothetical protein 
PA4028  2.40  hypothetical protein 
PA4031 ppa 3.04  inorganic pyrophosphatase 
PA4034 aqpZ 2.64  aquaporin Z 
PA4049  -2.65  hypothetical protein 
PA4061 ybbN   2.43 probable thioredoxin 
PA4063  29.07 24.75 hypothetical protein 
PA4064  5.04 4.56 probable ATP-binding component of ABC transporter 
PA4065  3.92 3.97 hypothetical protein 
PA4079  -2.65  probable dehydrogenase 
PA4090  3.15 5.95 hypothetical protein 
PA4108  -2.70  hypothetical protein 
PA4112  -3.39  probable sensor/response regulator hybrid 
PA4129  -9.44 -11.65 hypothetical protein 
PA4130  -3.63 -6.63 probable sulfite or nitrite reductase 
PA4131   -4.71 probable iron-sulfur protein 
PA4132   -4.51 conserved hypothetical protein 
PA4133 ccoN -5.09 -12.14 cytochrome c oxidase subunit (cbb3-type) 
PA4134  -7.53 -29.56 hypothetical protein 
PA4139  -3.29 -26.42 hypothetical protein 
PA4140   -7.14 hypothetical protein 
PA4141   -3.63 hypothetical protein 
PA4142   -6.95 probable secretion protein 
PA4170  5.90 6.16 hypothetical protein 
PA4171  6.31 26.18 probable protease 
PA4172  18.15 23.70 probable nuclease 
PA4175 piv  5.62 protease IV 
PA4218  -1.97  probable transporter 
PA4219 yfpB  -3.53  hypothetical protein 
PA4220 fptB  -2.67 7.49 hypothetical protein 
PA4221 fptA -1.40 3.72 Fe(III)-pyochelin outer membrane receptor precursor 
PA4222 pchI -4.86  probable ATP-binding component of ABC transporter 
PA4223 pchH -3.51 2.93 probable ATP-binding component of ABC transporter 
PA4224 pchG -3.41 3.83 pyochelin biosynthetic protein PchG 
PA4225 pchF -4.28  pyochelin synthetase 
PA4226 pchE -3.58  dihydroaeruginoic acid synthetase 
PA4227 pchR  5.21 transcriptional regulator PchR 
PA4228 pchD -3.17  pyochelin biosynthesis protein PchD 
PA4229 pchC -4.80  pyochelin biosynthetic protein PchC 
PA4230 pchB -1.31 4.32 salicylate biosynthesis protein PchB 
PA4231 pchA -3.88  salicylate biosynthesis isochorismate synthase 
PA4239 rpsD 2.09  30S ribosomal protein S4 
PA4240 rpsK 3.62  30S ribosomal protein S11 
PA4241 rpsM 2.60 -3.74 30S ribosomal protein S13 
PA4242 rpmJ  -3.90 50S ribosomal protein L36 
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PA4247 rplR 2.29  50S ribosomal protein L18 
PA4248 rplF 2.32  50S ribosomal protein L6 
PA4250 rpsN  -2.94 30S ribosomal protein S14 
PA4251 rplE  -2.56 50S ribosomal protein L5 
PA4254 rpsQ  -2.79 30S ribosomal protein S17 
PA4261 rplW  -3.01 50S ribosomal protein L23 
PA4264 rpsJ  -5.12 30S ribosomal protein S10 
PA4268 rpsL  -2.81 30S ribosomal protein S12 
PA4269 rpoC  -2.61 DNA-directed RNA polymerase beta* chain 
PA4270 rpoB  -2.93 DNA-directed RNA polymerase beta chain 
PA4271 rplL 2.65  50S ribosomal protein L7 / L12 
PA4272 rplJ 2.59 -2.92 50S ribosomal protein L10 
PA4273 rplA 2.35  50S ribosomal protein L1 
PA4274 rplK 2.56 -4.07 50S ribosomal protein L11 
PA4275 nusG 3.18 -2.62 transcription antitermination protein NusG 
PA4276 secE 3.16 -2.74 secretion protein SecE 
PA4293 pprA -2.87  two-component sensor PprA 
PA4294  -10.99  hypothetical protein 
PA4296 pprB -13.69  two-component response regulator, PprB 
PA4297 tadG -9.63  TadG 
PA4298  -9.90  hypothetical protein 
PA4299 tadD -5.54  TadD 
PA4300 tadC -13.21  TadC 
PA4301 tadB -5.59  TadB 
PA4302 tadA -20.34  TadA ATPase 
PA4303 tadZ -14.24  TadZ 
PA4304 rcpA -30.58  RcpA 
PA4305 rcpC -32.02  RcpC 
PA4306 flp -109.86 -4.40 Type IVb pilin, Flp 
PA4317   -3.46 hypothetical protein 
PA4318   -2.57 hypothetical protein 
PA4324  -3.59 -2.75 hypothetical protein 
PA4328  -2.48  hypothetical protein 
PA4344   2.73 probable hydrolase 
PA4345   4.18 hypothetical protein 
PA4352   2.88 conserved hypothetical protein 
PA4362  -2.67  hypothetical protein 
PA4370 icmP 
 
2.92 Insulin-cleaving metalloproteinase outer membrane 
protein precursor 
PA4377  -8.26  hypothetical protein 
PA4385 groEL 2.18  GroEL protein 
PA4390  7.59 6.76 hypothetical protein 
PA4394 yggB  2.82 6.79 conserved hypothetical protein 
PA4405   -3.93 hypothetical protein 
PA4419 ftsL -3.68  cell division protein FtsL 
PA4424 yraN   -2.82 conserved hypothetical protein 
PA4426 yraP   -2.88 conserved hypothetical protein 
PA4427 sspB  -8.62 stringent starvation protein B 
PA4428 sspA  -8.01 stringent starvation protein A 
PA4429   -5.23 probable cytochrome c1 precursor 
PA4430   -6.78 probable cytochrome b 
PA4431   -5.61 probable iron-sulfur protein 
PA4432 rpsI 2.70 -4.46 30S ribosomal protein S9 
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PA4433 rplM 2.69 -4.51 50S ribosomal protein L13 
PA4458 yrbI   -2.78 conserved hypothetical protein 
PA4459 yrbK   -2.64 conserved hypothetical protein 
PA4461 yhbG  2.21  probable ATP-binding component of ABC transporter 
PA4463 yhbH  -2.69  conserved hypothetical protein 
PA4467   10.06 hypothetical protein 
PA4468 sodM 3.57 16.95 superoxide dismutase 
PA4469   9.95 hypothetical protein 
PA4470 fumC1  15.70 fumarate hydratase 
PA4471 fagA  3.22 7.59 hypothetical protein 
PA4474 tldD   2.48 conserved hypothetical protein 
PA4479 mreD 3.12  rod shape-determining protein MreD 
PA4480 mreC  -3.44 rod shape-determining protein MreC 
PA4481 mreB 5.87  rod shape-determining protein MreB 
PA4494   -4.60 probable two-component sensor 
PA4495   2.52 hypothetical protein 
PA4507  -9.29  hypothetical protein 
PA4528 pilD  -3.14 type 4 prepilin peptidase PilD 
PA4530   -2.71 conserved hypothetical protein 
PA4542 clpB 4.66 4.30 ClpB protein 
PA4563 rpsT 5.19 -11.03 30S ribosomal protein S20 
PA4565 proB  -2.91 glutamate 5-kinase 
PA4567 rpmA  -3.54 50S ribosomal protein L27 
PA4568 rplU 2.63 -2.57 50S ribosomal protein L21 
PA4569 ispB  -2.56 octaprenyl-diphosphate synthase 
PA4570   14.01 hypothetical protein 
PA4572 fklB -8.69  peptidyl-prolyl cis-trans isomerase FklB 
PA4573  -27.56  hypothetical protein 
PA4575   2.45 hypothetical protein 
PA4590 pra -8.54  protein activator 
PA4602 glyA3  -4.94 serine hydroxymethyltransferase 
PA4606 cstA  -3.23  conserved hypothetical protein 
PA4607  -10.48  hypothetical protein 
PA4608  -10.60  hypothetical protein 
PA4611  -4.63  hypothetical protein 
PA4625   -4.78 hypothetical protein 
PA4633  -2.75  probable chemotaxis transducer 
PA4641  -4.80  still frameshift hypothetical protein 
PA4648  -25.57  hypothetical protein 
PA4651  -3.14  probable pili assembly chaperone 
PA4657   3.67 hypothetical protein 
PA4661 pagL  3.11 Lipid A 3-O-deacylase 
PA4670 prs 7.79 -2.86 ribose-phosphate pyrophosphokinase 
PA4671 rplY  3.05  probable ribosomal protein L25 
PA4672 pth   -6.47 peptidyl-tRNA hydrolase 
PA4673 ychF  2.59 -3.14 conserved hypothetical protein 
PA4678 rimI  -2.63 peptide n-acetyltransferase RimI 
PA4702  -2.93  hypothetical protein 
PA4703  -4.24  hypothetical protein 
PA4713  -2.58  hypothetical protein 
PA4717  -4.53  conserved hypothetical protein 
PA4733 acsB -2.63  acetyl-coenzyme A synthetase 
PA4735  -2.57  hypothetical protein 
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PA4736  -3.22  hypothetical protein 
PA4741 rpsO  -3.28 30S ribosomal protein S15 
PA4743 rbfA  -5.34 ribosome-binding factor A 
PA4745 nusA 2.37  N utilization substance protein A 
PA4746 yhbC  4.76 -4.12 conserved hypothetical protein 
PA4747 secG  -3.64 secretion protein SecG 
PA4753 yhbY   -3.74 conserved hypothetical protein 
PA4757 yeaS   -3.44 conserved hypothetical protein 
PA4759 dapB 3.05  dihydrodipicolinate reductase 
PA4761 dnaK 4.07 3.57 DnaK protein 
PA4765 omlA 2.08 -2.88 Outer membrane lipoprotein OmlA precursor 
PA4767 yfjG  -3.62  conserved hypothetical protein 
PA4768 smpB  -3.32 SmpB protein 
PA4778 ybbI  -3.47  probable transcriptional regulator 
PA4780  -2.75  conserved hypothetical protein 
PA4781  -11.59  probable two-component response regulator 
PA4782  -4.19  hypothetical protein 
PA4787  -5.85  probable transcriptional regulator 
PA4810 fdnI -2.91 
 
nitrate-inducible formate dehydrogenase, gamma 
subunit 
PA4811 fdnH -4.66  nitrate-inducible formate dehydrogenase, beta subunit 
PA4812 fdnG -3.33  formate dehydrogenase-O, major subunit 
PA4833   5.77 conserved hypothetical protein 
PA4834  6.45 6.07 hypothetical protein 
PA4835  14.31 13.40 hypothetical protein 
PA4836  22.42 20.24 hypothetical protein 
PA4837  24.15 22.17 probable outer membrane protein precursor 
PA4838  3.91 3.92 hypothetical protein 
PA4842   3.26 hypothetical protein 
PA4846 aroQ1  -2.83 3-dehydroquinate dehydratase 
PA4853 fis  -4.14 DNA-binding protein Fis 
PA4854 purH 
 
-2.80 phosphoribosylaminoimidazolecarboxamide 
formyltransferase 
PA4874 psiF  -3.00  conserved hypothetical protein 
PA4876 osmE  5.56 osmotically inducible lipoprotein OsmE 
PA4877   8.05 hypothetical protein 
PA4896  3.43 3.54 probable sigma-70 factor, ECF subfamily 
PA4913 
 
-4.23 
 
probable binding protein component of ABC 
transporter 
PA4915  -5.62  probable chemotaxis transducer 
PA4925  -9.23  conserved hypothetical protein 
PA4929  -11.81  hypothetical protein 
PA4932 rplI 3.47  50S ribosomal protein L9 
PA4934 rpsR  -2.72 30S ribosomal protein S18 
PA4935 rpsF 2.64 -2.53 30S ribosomal protein S6 
PA4936 spoU  2.68 probable rRNA methylase 
PA4940 yjeT   -3.88 conserved hypothetical protein 
PA4947 amiB -3.42  N-acetylmuramoyl-L-alanine amidase 
PA4962 ybcI   -3.12 conserved hypothetical protein 
PA4971 aspP  3.01 adenosine diphosphate sugar pyrophosphatase 
PA5030 ynfM  4.26 
 
probable major facilitator superfamily (MFS) 
transporter 
PA5033   -2.99 hypothetical protein 
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PA5040 pilQ 
 
-2.95 Type 4 fimbrial biogenesis outer membrane protein 
PilQ precursor 
PA5041 pilP -2.84 -5.53 type 4 fimbrial biogenesis protein PilP 
PA5042 pilO -2.92 -4.28 type 4 fimbrial biogenesis protein PilO 
PA5045 ponA  -2.63 penicillin-binding protein 1A 
PA5049 rpmE  -7.40 50S ribosomal protein L31 
PA5053 hslV 2.35  heat shock protein HslV 
PA5054 hslU 3.34  heat shock protein HslU 
PA5055  2.54  hypothetical protein 
PA5058 phaC2 -5.36  poly(3-hydroxyalkanoic acid) synthase 2 
PA5060 phaF  3.05 polyhydroxyalkanoate synthesis protein PhaF 
PA5101  -7.40 -2.51 hypothetical protein 
PA5111 gloA3  2.69 lactoylglutathione lyase 
PA5117 typA 2.40 -3.33 regulatory protein TypA 
PA5118 thiI  -3.94 thiazole biosynthesis protein ThiI 
PA5128 secB 2.57  secretion protein SecB 
PA5129 grx 4.28  glutaredoxin 
PA5139   -3.65 hypothetical protein 
PA5150   3.58 probable short-chain dehydrogenase 
PA5153  -3.73  probable periplasmic binding protein 
PA5170 arcD  3.84 arginine/ornithine antiporter 
PA5171 arcA  3.65 arginine deiminase 
PA5172 arcB  3.60 ornithine carbamoyltransferase, catabolic 
PA5173 arcC  4.14 carbamate kinase 
PA5194  2.08  hypothetical protein 
PA5200 ompR  2.83 two-component response regulator OmpR 
PA5208  -5.37  conserved hypothetical protein 
PA5212   5.31 hypothetical protein 
PA5213 gcvP1 -4.78  glycine cleavage system protein P1 
PA5214 gcvH1 -2.49  glycine cleavage system protein H1 
PA5217 
  
2.71 probable binding protein component of ABC iron 
transporter 
PA5239 rho 3.79 -2.95 transcription termination factor Rho 
PA5255 algQ -3.98  Alginate regulatory protein AlgQ 
PA5261 algR -3.10 3.68 alginate biosynthesis regulatory protein AlgR 
PA5288 glnK -5.19  nitrogen regulatory protein P-II 2 
PA5296 rep  -2.76 ATP-dependent DNA helicase Rep 
PA5298 xpt ; 3.66  xanthine phosphoribosyltransferase 
PA5300 cycB  -4.16 cytochrome c5 
PA5301 ycjC  -2.93  probable transcriptional regulator 
PA5315 rpmG 2.15 -6.43 50S ribosomal protein L33 
PA5316 rpmB  -4.34 50S ribosomal protein L28 
PA5322 algC 2.73  phosphomannomutase AlgC 
PA5338 spoT 2.19 
 
guanosine-3',5'-bis(diphosphate) 3'-
pyrophosphohydrolase 
PA5340  3.50  hypothetical protein 
PA5348  -16.26  probable DNA-binding protein 
PA5350 rubA2 -4.04  Rubredoxin 2 
PA5351 rubA1  -3.40 Rubredoxin 1 
PA5359  -3.55  hypothetical protein 
PA5366 pstB  -2.82 ATP-binding component of ABC phosphate transporter 
PA5367 pstA 
 
-3.70 membrane protein component of ABC phosphate 
transporter 
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PA5369 pstS 
 
-2.77 phosphate ABC transporter, periplasmic phosphate-
binding protein, PstS 
PA5373 betB 4.85 3.87 betaine aldehyde dehydrogenase 
PA5374 betI 28.01 7.17 transcriptional regulator BetI 
PA5380 gbdR -3.79  GbdR 
PA5388  13.68 13.16 hypothetical protein 
PA5408   2.93 hypothetical protein 
PA5409  -3.66  hypothetical protein 
PA5424 yeaQ ; -3.00  conserved hypothetical protein 
PA5429 aspA  -1.68 aspartate ammonia-lyase 
PA5479 gltP 2.97 -2.84 proton-glutamate symporter 
PA5481   9.56 hypothetical protein 
PA5482   8.40 hypothetical protein 
PA5490 cc4  -6.53 cytochrome c4 precursor 
PA5491   -3.65 probable cytochrome 
PA5492   -2.55 conserved hypothetical protein 
PA5494  -2.74  hypothetical protein 
PA5499 np20 4.18 5.68 transcriptional regulator np20 
PA5500 znuC 2.39  zinc transport protein ZnuC 
PA5504   -2.92 probable permease of ABC transporter 
PA5505   -2.97 probable TonB-dependent receptor 
PA5527  -6.15  hypothetical protein 
PA5531 tonB  3.06 TonB protein 
PA5534  2.49  hypothetical protein 
PA5535  9.98 10.28 conserved hypothetical protein 
PA5536  6.45 7.07 conserved hypothetical protein 
PA5537  2.86 4.07 hypothetical protein 
PA5538 amiA 5.27 5.38 N-acetylmuramoyl-L-alanine amidase 
PA5539  5.12 5.20 hypothetical protein 
PA5540  18.35 16.45 hypothetical protein 
PA5541 pyrQ 11.20 10.70 dihydroorotase 
PA5543  -3.49  hypothetical protein 
PA5546  -2.59 2.86 conserved hypothetical protein 
PA5553 atpC  -2.81 ATP synthase epsilon chain 
PA5555 atpG  -2.95 ATP synthase gamma chain 
PA5560 atpB 2.36 -3.10 ATP synthase A chain 
PA5568  2.52 -4.05 conserved hypothetical protein 
PA5569 rnpA 2.39  ribonuclease P protein component 
AF035937cds6 wbpO 
 
-2.91 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds8 wbpQ 
 
-2.48 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF241171cds39   2.29 first half of finger motif 
Pae_orfC_at 
 
-2.92 
 
putative 3-oxoacyl (acyl carrier protein ) synthase - 
fatty acid biosnthesis, from glycosylation island genes 
in strain PAK 
Pae_tRNA_Ala   -6.75 tRNA_Alanine 
Pae_tRNA_Arg  2.77 6.64 tRNA_Arginine 
Pae_tRNA_Asn   -2.86 tRNA_Asparagine 
Pae_tRNA_Gln   -4.79 tRNA_Glutamine 
Pae_tRNA_Gly   -7.38 tRNA_Glycine 
Pae_tRNA_His   -4.34 tRNA_Histidine 
Pae_tRNA_Ile   -5.32 tRNA_Isoleucine 
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Pae_tRNA_Leu   -2.83 tRNA_Leucine 
Pae_tRNA_Lys  2.12  tRNA_Lysine 
Pae_tRNA_Ser  -10.41  tRNA_Serine 
Pae_tRNA_Trp   -3.73 tRNA_Tryptophan 
Pae_tRNA_Tyr   -3.32 tRNA_Tyrosine 
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Table 8-2: Differentially regulated genes (pfp < 0.05) in mouse tumour infection in comparison with 
planktonic and biofilm growth controls. 
PA Number Gene 
Fold change compared 
to 
Product Name Planktonic Biofilm 
PA0001 dnaA  -3.12 chromosomal replication initiator protein DnaA 
PA0020  3.27  hypothetical protein 
PA0044 exoT 6.51 10.52 exoenzyme T 
PA0059 osmC  3.57 osmotically inducible protein OsmC 
PA0061   3.23 hypothetical protein 
PA0067 prlC  2.83 oligopeptidase A 
PA0093  2.38 2.83 hypothetical protein 
PA0102  3.96 6.44 probable carbonic anhydrase 
PA0122  -45.85 -6.96 conserved hypothetical protein 
PA0128 phnA   -3.31 conserved hypothetical protein 
PA0130  2.45 2.96 probable aldehyde dehydrogenase 
PA0132 oapT  8.00 6.51 beta-alanine--pyruvate transaminase 
PA0141  4.16 3.04 conserved hypothetical protein 
PA0145  2.49  hypothetical protein 
PA0160   -4.27 hypothetical protein 
PA0161   -4.99 hypothetical protein 
PA0168 yigZ  2.48  conserved hypothetical protein 
PA0179  -69.65 -3.59 probable two-component response regulator 
PA0197  2.63 2.37 hypothetical protein 
PA0200   10.05 hypothetical protein 
PA0257   -2.39 hypothetical protein 
PA0263 hcpC  -74.45 secreted protein Hcp 
PA0271   2.44 hypothetical protein 
PA0276  5.47 3.51 hypothetical protein 
PA0291 oprE 
 
-2.81 Anaerobically-induced outer membrane porin OprE 
precursor 
PA0297 spuA  -3.19 probable glutamine amidotransferase 
PA0312  -3.33 2.67 conserved hypothetical protein 
PA0320  3.22 3.17 conserved hypothetical protein 
PA0332   3.97 hypothetical protein 
PA0355 pfpI  3.12 protease PfpI 
PA0363 coaD  -3.09 phosphopantetheine adenylyltransferase 
PA0385   -3.92 hypothetical protein 
PA0388   4.55 hypothetical protein 
PA0408 pilG  -3.66 twitching motility protein PilG 
PA0409 pilH  -3.78 twitching motility protein PilH 
PA0410 pilI  -3.15 twitching motility protein PilI 
PA0415 chpC 2.61 2.59 probable chemotaxis protein 
PA0424 mexR  -5.69 multidrug resistance operon repressor MexR 
PA0432 sahH  -3.25 S-adenosyl-L-homocysteine hydrolase 
PA0433  2.43 2.51 hypothetical protein 
PA0447 gcdH  -4.34 glutaryl-CoA dehydrogenase 
PA0456   -14.44 probable cold-shock protein 
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PA0505  -15.99 -2.86 hypothetical protein 
PA0506  2.53  probable acyl-CoA dehydrogenase 
PA0510 nirE  4.12 3.24 probable uroporphyrin-III c-methyltransferase 
PA0515 nirD  4.63  probable transcriptional regulator 
PA0517 nirC 3.53  probable c-type cytochrome precursor 
PA0518 nirM 13.97 7.77 cytochrome c-551 precursor 
PA0519 nirS 6.35 8.83 nitrite reductase precursor 
PA0520 nirQ  4.14 regulatory protein NirQ 
PA0526  2.58 3.31 hypothetical protein 
PA0541   -2.55 hypothetical protein 
PA0545  6.83 8.39 hypothetical protein 
PA0546 metK  -5.17 methionine adenosyltransferase 
PA0563   -4.60 conserved hypothetical protein 
PA0572  2.80  hypothetical protein 
PA0576 rpoD  -7.08 sigma factor RpoD 
PA0578   -28.77 conserved hypothetical protein 
PA0579 rpsU  -14.96 30S ribosomal protein S21 
PA0581 ygiH   -3.88 conserved hypothetical protein 
PA0589 glpE   -3.52 conserved hypothetical protein 
PA0595 ostA  -3.96 organic solvent tolerance protein OstA precursor 
PA0610 prtN  3.94 transcriptional regulator PrtN 
PA0614   2.81 hypothetical protein 
PA0647   2.92 hypothetical protein 
PA0654 speD  -4.30 S-adenosylmethionine decarboxylase proenzyme 
PA0655   -2.55 hypothetical protein 
PA0665 yadR   -3.66 conserved hypothetical protein 
PA0667 yebA   -4.74 conserved hypothetical protein 
PA0713  9.69 7.63 hypothetical protein 
PA0747   3.19 probable aldehyde dehydrogenase 
PA0767 lepA  -10.50 GTP-binding protein LepA 
PA0768 lepB  -7.95 signal peptidase I 
PA0781  3.02 3.09 hypothetical protein 
PA0805  -7.83 -41.61 hypothetical protein 
PA0836 ackA 3.32 5.03 acetate kinase 
PA0864  3.37 3.27 probable transcriptional regulator 
PA0890 aotM  -3.96 arginine/ornithine transport protein AotM 
PA0915 yehS   -3.48 conserved hypothetical protein 
PA0916 yliG   -2.48 conserved hypothetical protein 
PA0929 pirR  -5.61 -2.66 two-component response regulator 
PA0936 lpxO2  -3.22 lipopolysaccharide biosynthetic protein LpxO2 
PA0942   4.18 probable transcriptional regulator 
PA0944 purN  -3.31 phosphoribosylaminoimidazole synthetase 
PA0945 purM  -5.08 phosphoribosylaminoimidazole synthetase 
PA0952  7.69  hypothetical protein 
PA0955   -5.13 hypothetical protein 
PA0962   3.99 probable dna-binding stress protein 
PA0965 ruvC  -3.43 Holliday junction resolvase RuvC 
PA0969 tolQ  -4.25 TolQ protein 
PA0974   -5.73 conserved hypothetical protein 
PA0984  2.34  colicin immunity protein 
PA0996 pqsA -3.71 -5.30 probable coenzyme A ligase 
PA0998 pqsC -3.41 -5.01 Homologous to beta-keto-acyl-acyl-carrier protein 
synthase 
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PA1000 pqsE -2.54 -2.72 Quinolone signal response protein 
PA1001 phnA  -3.07 anthranilate synthase component I 
PA1006 yrkI   -3.21 conserved hypothetical protein 
PA1029  11.24 29.33 hypothetical protein 
PA1030   2.99 hypothetical protein 
PA1034   -3.69 hypothetical protein 
PA1077 flgB  -3.00 flagellar basal-body rod protein FlgB 
PA1080 flgE  -3.19 flagellar hook protein FlgE 
PA1118   2.71 hypothetical protein 
PA1123   -13.29 hypothetical protein 
PA1126  2.67  hypothetical protein 
PA1127 gsp69   3.24 probable oxidoreductase 
PA1131 
  
-2.30 probable major facilitator superfamily (MFS) 
transporter 
PA1132   -2.88 hypothetical protein 
PA1151 imm2 -9.51 -6.17 pyocin S2 immunity protein 
PA1168  -3.98 -44.61 hypothetical protein 
PA1177 napE -7.98 5.95 periplasmic nitrate reductase protein NapE 
PA1183 dctA  -16.72 C4-dicarboxylate transport protein 
PA1193   -3.12 hypothetical protein 
PA1195  9.06 7.13 hypothetical protein 
PA1199   -4.32 probable lipoprotein 
PA1305  -5.71 -13.65 hypothetical protein 
PA1306   -2.66 probable HIT family protein 
PA1323   3.78 hypothetical protein 
PA1337 ansB  2.54 glutaminase-asparaginase 
PA1340  -5.08 -3.47 probable permease of ABC transporter 
PA1388  2.29 2.82 hypothetical protein 
PA1404   3.98 hypothetical protein 
PA1414   7.30 hypothetical protein 
PA1429  3.86 4.03 probable cation-transporting P-type ATPase 
PA1431 rsaL -11.28 -4.03 regulatory protein RsaL 
PA1439 ybaN   -4.20 conserved hypothetical protein 
PA1457 cheZ -5.42 -3.47 chemotaxis protein CheZ 
PA1477 ccmC  -4.28 heme exporter protein CcmC 
PA1479 ccmE  -3.66 cytochrome C-type biogenesis protein CcmE 
PA1480 ccmF  -2.55 cytochrome C-type biogenesis protein CcmF 
PA1482 ccmH  -6.01 cytochrome C-type biogenesis protein CcmH 
PA1493 cysP -3.97 -4.21 sulfate-binding protein of ABC transporter 
PA1506  2.23  hypothetical protein 
PA1517   3.85 conserved hypothetical protein 
PA1533  -3.49 -3.07 conserved hypothetical protein 
PA1540   -2.41 conserved hypothetical protein 
PA1543 apt  -4.69 adenine phosphoribosyltransferase 
PA1544 anr  -4.74 transcriptional regulator Anr 
PA1546 hemN 2.36  oxygen-independent coproporphyrinogen III oxidase 
PA1553 fixO  -3.32 -5.48 probable cytochrome c oxidase subunit 
PA1555 ccoP 17.06  probable cytochrome c 
PA1556 ccoO 5.68  probable cytochrome c oxidase subunit 
PA1557 ccoN 11.35  probable cytochrome oxidase subunit (cbb3-type) 
PA1564   -5.26 conserved hypothetical protein 
PA1580 gltA  -3.86 citrate synthase 
PA1581 sdhC  -4.38 succinate dehydrogenase (C subunit) 
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PA1583 sdhA  -3.31 succinate dehydrogenase (A subunit) 
PA1584 sdhB  -6.58 succinate dehydrogenase (B subunit) 
PA1610 fabA -5.81 -23.50 beta-hydroxydecanoyl-ACP dehydrase 
PA1656   -11.00 hypothetical protein 
PA1657   -3.36 conserved hypothetical protein 
PA1658   -6.27 conserved hypothetical protein 
PA1659   -5.27 hypothetical protein 
PA1660   -8.35 hypothetical protein 
PA1661   -6.42 hypothetical protein 
PA1662  2.27  probable ClpA/B-type protease 
PA1673  4.00 7.12 hypothetical protein 
PA1692 pscS  2.46  probable translocation protein in type III secretion 
PA1695 pscP 2.93 2.81 translocation protein in type III secretion 
PA1696 pscO 3.22  translocation protein in type III secretion 
PA1699 pcr1  4.04  conserved hypothetical protein in type III secretion 
PA1700 pcr2  8.82 5.61 conserved hypothetical protein in type III secretion 
PA1701 pcr3  5.95  conserved hypothetical protein in type III secretion 
PA1704 pcrR 2.08 3.11 transcriptional regulator protein PcrR 
PA1706 pcrV 6.69 8.19 type III secretion protein PcrV 
PA1707 pcrH 7.03 7.28 regulatory protein PcrH 
PA1708 popB 5.57 7.43 translocator protein PopB 
PA1709 popD 5.75 7.14 Translocator outer membrane protein PopD 
precursor 
PA1711 exsE 4.26 5.81 ExsE 
PA1712 exsB 2.76  exoenzyme S synthesis protein B 
PA1714 exsD 5.52  ExsD 
PA1715 pscB 7.81 4.80 type III export apparatus protein 
PA1716 pscC 4.98 
 
Type III secretion outer membrane protein PscC 
precursor 
PA1717 pscD 5.64 5.47 type III export protein PscD 
PA1718 pscE 11.83 6.06 type III export protein PscE 
PA1719 pscF 4.32 2.96 type III export protein PscF 
PA1720 pscG 3.94 3.58 type III export protein PscG 
PA1721 pscH 4.13 4.14 type III export protein PscH 
PA1722 pscI 4.61 4.38 type III export protein PscI 
PA1723 pscJ 2.59  type III export protein PscJ 
PA1724 pscK 2.41  type III export protein PscK 
PA1728  -16.46 1.47 hypothetical protein 
PA1734  2.11  hypothetical protein 
PA1742  3.09 3.29 probable amidotransferase 
PA1746  11.07 15.29 hypothetical protein 
PA1767   -4.50 hypothetical protein 
PA1768   -4.45 hypothetical protein 
PA1774 cfrX -3.01 -8.29 CfrX protein 
PA1776 sigX -4.29 -3.42 ECF sigma factor SigX 
PA1789   3.23 hypothetical protein 
PA1801 clpP  -3.38 ATP-dependent Clp protease proteolytic subunit 
PA1812 mltD  -7.87 membrane-bound lytic murein transglycosylase D 
precursor 
PA1833 yhfP   3.49 probable oxidoreductase 
PA1847 yhgI   -3.39 conserved hypothetical protein 
PA1852  -9.58 -17.22 hypothetical protein 
PA1869   -3.63 probable acyl carrier protein 
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PA1879  3.02  hypothetical protein 
PA1925  2.51  hypothetical protein 
PA2007 maiA -5.30 3.26 maleylacetoacetate isomerase 
PA2021   3.71 hypothetical protein 
PA2031   3.15 hypothetical protein 
PA2042 ygjU   -2.76 probable transporter (membrane subunit) 
PA2119 adh  3.28 2.95 alcohol dehydrogenase (Zn-dependent) 
PA2127  4.14  conserved hypothetical protein 
PA2128 cupA1 16.61 10.25 fimbrial subunit CupA1 
PA2134   2.81 hypothetical protein 
PA2143   4.68 hypothetical protein 
PA2146 yciG  -6.54 3.86 conserved hypothetical protein 
PA2168   2.61 hypothetical protein 
PA2169   3.26 hypothetical protein 
PA2170   4.40 hypothetical protein 
PA2171   5.53 hypothetical protein 
PA2172   3.26 hypothetical protein 
PA2173   4.87 hypothetical protein 
PA2190   7.45 conserved hypothetical protein 
PA2191 exoY 4.19 4.18 adenylate cyclase ExoY 
PA2231 pslA  -3.67 PslA 
PA2242 pslL  -3.62 hypothetical protein 
PA2249 bkdB -3.04 3.30 branched-chain alpha-keto acid dehydrogenase 
(lipoamide component) 
PA2273 soxR   2.59 probable transcriptional regulator 
PA2321 gntV   -3.50 gluconokinase 
PA2365  -5.40 -4.32 conserved hypothetical protein 
PA2392 pvdP 4.02 4.41 PvdP 
PA2411   3.26 probable thioesterase 
PA2412   3.29 conserved hypothetical protein 
PA2436  3.00 2.78 hypothetical protein 
PA2442 gcvT2  3.24 glycine cleavage system protein T2 
PA2453  4.24  hypothetical protein 
PA2460  2.36 2.41 hypothetical protein 
PA2573   2.93 probable chemotaxis transducer 
PA2576  2.46 2.90 hypothetical protein 
PA2584 pgsA 
 
-6.05 CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase 
PA2591  -16.12 -8.25 probable transcriptional regulator 
PA2592 potF5  
 
-3.05 probable periplasmic spermidine/putrescine-binding 
protein 
PA2593   -8.91 hypothetical protein 
PA2619 infA  -15.58 initiation factor 
PA2627 ycfC   -3.37 conserved hypothetical protein 
PA2629 purB  -3.89 adenylosuccinate lyase 
PA2637 nuoA  -4.26 NADH dehydrogenase I chain A 
PA2640 nuoE -3.80 -3.89 NADH dehydrogenase I chain E 
PA2643 nuoH -5.10 -4.30 NADH dehydrogenase I chain H 
PA2658   3.92 hypothetical protein 
PA2659  1.66 2.83 hypothetical protein 
PA2662  3.26 3.16 conserved hypothetical protein 
PA2709 cysK  2.93 cysteine synthase A 
PA2741 rplT  -4.62 50S ribosomal protein L20 
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PA2753  4.22 4.40 hypothetical protein 
PA2754   5.78 conserved hypothetical protein 
PA2769   -3.48 hypothetical protein 
PA2797  -8.21 -8.84 hypothetical protein 
PA2826   4.04 probable glutathione peroxidase 
PA2827 yeaA   3.00 conserved hypothetical protein 
PA2840 deaD   -5.68 probable ATP-dependent RNA helicase 
PA2851 efp  -4.74 translation elongation factor P 
PA2864  -3.95 -4.50 conserved hypothetical protein 
PA2899  -4.82 -2.53 probable transcriptional regulator 
PA2931  7.45 9.59 probable transcriptional regulator 
PA2957   -4.68 probable transcriptional regulator 
PA2960 pilZ  -2.54 type 4 fimbrial biogenesis protein PilZ 
PA2966 acpP  -8.93 acyl carrier protein 
PA2970 rpmF  -11.43 50S ribosomal protein L32 
PA2971 yceD   -7.80 conserved hypothetical protein 
PA3006 psrA 2.29  transcriptional regulator PsrA 
PA3009   -8.62 hypothetical protein 
PA3017  -4.21 3.51 conserved hypothetical protein 
PA3031   -5.53 hypothetical protein 
PA3040 yqjD   5.90 conserved hypothetical protein 
PA3041 yqjE   3.36 hypothetical protein 
PA3056  2.82 2.98 hypothetical protein 
PA3092 fadH1 2.55  2,4-dienoyl-CoA reductase FadH1 
PA3104 xcpP  -2.83 secretion protein XcpP 
PA3112 accD  -5.83 acetyl-CoA carboxylase beta subunit 
PA3115 fimV 2.25  Motility protein FimV 
PA3123   4.30 conserved hypothetical protein 
PA3126 ibpA 2.92  heat-shock protein IbpA 
PA3144   3.34 hypothetical protein 
PA3147 wbpJ 3.05  probable glycosyl transferase WbpJ 
PA3148 wbpI 5.42 3.49 probable UDP-N-acetylglucosamine 2-epimerase 
WbpI 
PA3149 wbpH 3.30  probable glycosyltransferase WbpH 
PA3150 wbpG 4.08 4.51 LPS biosynthesis protein WbpG 
PA3151 hisF2 4.23 2.65 imidazoleglycerol-phosphate synthase, cyclase 
subunit 
PA3152 hisH2 3.81 4.38 glutamine amidotransferase 
PA3153 wzx 2.69  O-antigen translocase 
PA3154 wzy 4.13 2.61 B-band O-antigen polymerase 
PA3155 wbpE 4.08  probable aminotransferase WbpE 
PA3156 wbpD 3.08  probable acetyltransferase WbpD 
PA3158 wbpB 2.68  probable oxidoreductase WpbB 
PA3159 wbpA 2.45 
 
probable UDP-glucose/GDP-mannose dehydrogenase 
WbpA 
PA3160 wzz 3.13  O-antigen chain length regulator 
PA3162 rpsA  -6.98 30S ribosomal protein S1 
PA3166 pheA  -3.24 chorismate mutase 
PA3173 yciK   -2.94 probable short-chain dehydrogenase 
PA3190 gltB  -7.78 -5.46 probable binding protein component of ABC sugar 
transporter 
PA3202 yciI  2.83  conserved hypothetical protein 
PA3204   -3.47 probable two-component response regulator 
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PA3217 cyaB  -3.90 CyaB 
PA3225   2.71 probable transcriptional regulator 
PA3231   6.34 hypothetical protein 
PA3237  2.29  hypothetical protein 
PA3244 minD  -4.15 cell division inhibitor MinD 
PA3245 minE  -6.45 cell division topological specificity factor MinE 
PA3256   2.67 probable oxidoreductase 
PA3266 capB  -17.32 cold acclimation protein B 
PA3273  2.92 3.78 hypothetical protein 
PA3274   2.75 hypothetical protein 
PA3278  9.75 4.21 hypothetical protein 
PA3284  2.21 3.86 hypothetical protein 
PA3292   -5.12 hypothetical protein 
PA3308 hepA  -2.86 RNA helicase HepA 
PA3309 uspK  3.31 8.31 conserved hypothetical protein 
PA3332   -3.72 conserved hypothetical protein 
PA3337 rfaD 2.45 2.86 ADP-L-glycero-D-mannoheptose 6-epimerase 
PA3341   -2.94 probable transcriptional regulator 
PA3361 lecB -15.39 -54.35 fucose-binding lectin PA-IIL 
PA3385 amrZ -12.48 -3.83 alginate and motility regulator Z 
PA3389  2.23  probable ring-cleaving dioxygenase 
PA3397 fpr  -3.49 ferredoxin--NADP+ reductase 
PA3407 hasAp 13.89 14.73 heme acquisition protein HasAp 
PA3415   2.62 probable dihydrolipoamide acetyltransferase 
PA3417 
  
4.84 probable pyruvate dehydrogenase E1 component, 
alpha subunit 
PA3431 ywbG  23.70 18.32 conserved hypothetical protein 
PA3432  31.75 33.44 hypothetical protein 
PA3459 asnB   3.46 probable glutamine amidotransferase 
PA3461 yhfE   4.76 conserved hypothetical protein 
PA3472   -3.55 hypothetical protein 
PA3476 rhlI -4.14 -4.52 autoinducer synthesis protein RhlI 
PA3477 rhlR -9.43 -4.84 transcriptional regulator RhlR 
PA3478 rhlB  -3.35 rhamnosyltransferase chain B 
PA3480 dcd   -4.10 probable deoxycytidine triphosphate deaminase 
PA3489 rnfA   -9.37 conserved hypothetical protein 
PA3491 rnfC   2.41 probable ferredoxin 
PA3496  -3.86 -4.75 hypothetical protein 
PA3509  3.08 3.15 probable hydrolase 
PA3525 argG  -4.17 argininosuccinate synthase 
PA3529 tsaA   2.99 probable peroxidase 
PA3530 bfd  -42.81 -15.35 conserved hypothetical protein 
PA3531 bfrB  -3.61 bacterioferritin 
PA3533 ydhD  -2.83 -3.78 conserved hypothetical protein 
PA3572  2.48 12.69 hypothetical protein 
PA3578  2.78 2.81 conserved hypothetical protein 
PA3581 glpF 2.91  glycerol uptake facilitator protein 
PA3584 glpD 40.00  glycerol-3-phosphate dehydrogenase 
PA3600 rpl36  17.30 37.88 conserved hypothetical protein 
PA3601 ykgM  13.16 10.03 conserved hypothetical protein 
PA3613  3.68 4.36 hypothetical protein 
PA3621 fdxA  -5.47 ferredoxin I 
PA3636 kdsA  -4.10 2-dehydro-3-deoxyphosphooctonate aldolase 
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PA3637 pyrG  -3.52 CTP synthase 
PA3645 fabZ 
 
-6.46 (3R)-hydroxymyristoyl-[acyl carrier protein] 
dehydratase 
PA3646 lpxD 
 
-6.09 UDP-3-O-[3-hydroxylauroyl] glucosamine N-
acyltransferase 
PA3648   -3.65 probable outer membrane protein precursor 
PA3652 uppS  -3.56 undecaprenyl pyrophosphate synthetase 
PA3654 pyrH  -3.71 uridylate kinase 
PA3655 tsf  -4.48 elongation factor Ts 
PA3656 rpsB  -5.15 30S ribosomal protein S2 
PA3684  -35.87 -9.39 hypothetical protein 
PA3686 adk  -6.99 adenylate kinase 
PA3687 ppc  2.55 phosphoenolpyruvate carboxylase 
PA3689 yhdM   2.93 probable transcriptional regulator 
PA3691   5.57 hypothetical protein 
PA3722   -4.80 hypothetical protein 
PA3732 yjfI  2.97 5.82 conserved hypothetical protein 
PA3741   -3.55 hypothetical protein 
PA3742 rplS  -12.99 50S ribosomal protein L19 
PA3743 trmD  -5.73 tRNA (guanine-N1)-methyltransferase 
PA3744 rimM  -3.18 16S rRNA processing protein 
PA3745 rpsP  -4.23 30S ribosomal protein S16 
PA3747   -3.60 conserved hypothetical protein 
PA3770 guaB  -4.23 inosine-5'-monophosphate dehydrogenase 
PA3796   5.72 hypothetical protein 
PA3804   -2.99 hypothetical protein 
PA3805 pilF  -3.97 type 4 fimbrial biogenesis protein PilF 
PA3806 yfgB   -8.95 conserved hypothetical protein 
PA3808 yfhJ  -4.80 -3.62 conserved hypothetical protein 
PA3812 iscA -3.18 -3.64 probable iron-binding protein IscA 
PA3815   -11.22 conserved hypothetical protein 
PA3818 suhB   -3.44 extragenic suppressor protein SuhB 
PA3824 queA 
 
-5.40 S-adenosylmethionine:trna ribosyltransferase-
isomerase 
PA3828 yjgP   -9.96 conserved hypothetical protein 
PA3841 exoS 7.44 16.13 exoenzyme S 
PA3842 orf1  4.79 3.82 probable chaperone 
PA3843  4.19 3.09 hypothetical protein 
PA3866   2.27 pyocin protein 
PA3880  2.41 2.88 conserved hypothetical protein 
PA3905   -3.18 hypothetical protein 
PA3906   -3.19 hypothetical protein 
PA3908   -4.89 hypothetical protein 
PA3916 moaE  2.42 molybdopterin converting factor, large subunit 
PA3940  -2.72 -6.70 probable DNA binding protein 
PA3941   -3.40 hypothetical protein 
PA3966   -4.73 hypothetical protein 
PA3967   -6.58 hypothetical protein 
PA3968 ymfC  2.65 2.95 probable pseudouridine synthase 
PA3979   -5.30 hypothetical protein 
PA3982   -3.89 conserved hypothetical protein 
PA3986  -18.81 1.90 hypothetical protein 
PA3989 holA  -2.99 DNA polymerase III, delta subunit 
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PA3996 lis  -3.55 lipoate synthase 
PA4028  2.38  hypothetical protein 
PA4031 ppa  -3.68 inorganic pyrophosphatase 
PA4049  -4.38 -3.22 hypothetical protein 
PA4067 oprG 3.30  Outer membrane protein OprG precursor 
PA4108   2.66 hypothetical protein 
PA4117  -6.23 -3.67 probable bacteriophytochrome 
PA4129  -3.19 -3.93 hypothetical protein 
PA4130   -3.33 probable sulfite or nitrite reductase 
PA4133 ccoN  -3.90 cytochrome c oxidase subunit (cbb3-type) 
PA4134   -9.02 hypothetical protein 
PA4139  -5.21 -41.79 hypothetical protein 
PA4140   -7.00 hypothetical protein 
PA4141   -6.62 hypothetical protein 
PA4142   -6.44 probable secretion protein 
PA4211 phzB1 3.34  probable phenazine biosynthesis protein 
PA4217 phzS 3.11  flavin-containing monooxygenase 
PA4220 fptB  -4.07 4.92 hypothetical protein 
PA4237 rplQ  -7.58 50S ribosomal protein L17 
PA4238 rpoA  -5.00 DNA-directed RNA polymerase alpha chain 
PA4239 rpsD  -5.24 30S ribosomal protein S4 
PA4240 rpsK  -5.02 30S ribosomal protein S11 
PA4241 rpsM  -8.17 30S ribosomal protein S13 
PA4242 rpmJ  -4.31 50S ribosomal protein L36 
PA4243 secY  -3.71 secretion protein SecY 
PA4245 rpmD  -3.68 50S ribosomal protein L30 
PA4246 rpsE  -4.03 30S ribosomal protein S5 
PA4247 rplR  -8.99 50S ribosomal protein L18 
PA4248 rplF  -3.87 50S ribosomal protein L6 
PA4249 rpsH  -4.45 30S ribosomal protein S8 
PA4250 rpsN  -5.22 30S ribosomal protein S14 
PA4254 rpsQ  -3.75 30S ribosomal protein S17 
PA4258 rplV  -3.44 50S ribosomal protein L22 
PA4261 rplW  -6.19 50S ribosomal protein L23 
PA4263 rplC  -3.32 50S ribosomal protein L3 
PA4264 rpsJ  -5.72 30S ribosomal protein S10 
PA4265 tufA 1.93  elongation factor Tu 
PA4270 rpoB  -3.18 DNA-directed RNA polymerase beta chain 
PA4271 rplL  -4.95 50S ribosomal protein L7 / L12 
PA4273 rplA  -5.62 50S ribosomal protein L1 
PA4274 rplK  -5.04 50S ribosomal protein L11 
PA4275 nusG  -5.11 transcription antitermination protein NusG 
PA4276 secE  -5.58 secretion protein SecE 
PA4315 mvaT -3.71 -4.55 transcriptional regulator MvaT, P16 subunit 
PA4318   -2.87 hypothetical protein 
PA4324  -6.10 -4.68 hypothetical protein 
PA4325  -3.76 -2.76 hypothetical protein 
PA4348  3.58  conserved hypothetical protein 
PA4352  7.02 22.99 conserved hypothetical protein 
PA4385 groEL 3.90 2.73 GroEL protein 
PA4386 groES 3.19 3.06 GroES protein 
PA4405   -4.65 hypothetical protein 
PA4406 lpxC  -4.85 UDP-3-O-acyl-N-acetylglucosamine deacetylase 
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PA4424 yraN   -3.86 conserved hypothetical protein 
PA4426 yraP   -5.07 conserved hypothetical protein 
PA4427 sspB  -5.13 stringent starvation protein B 
PA4428 sspA  -8.51 stringent starvation protein A 
PA4429   -3.70 probable cytochrome c1 precursor 
PA4430   -6.26 probable cytochrome b 
PA4431   -6.21 probable iron-sulfur protein 
PA4432 rpsI  -15.10 30S ribosomal protein S9 
PA4433 rplM  -12.20 50S ribosomal protein L13 
PA4440  2.36  hypothetical protein 
PA4449 hisG  -3.58 ATP-phosphoribosyltransferase 
PA4458 yrbI   -4.11 conserved hypothetical protein 
PA4459 yrbK   -4.03 conserved hypothetical protein 
PA4460 yhbN   -3.29 conserved hypothetical protein 
PA4461 yhbG   -7.68 probable ATP-binding component of ABC transporter 
PA4466   -3.79 probable phosphoryl carrier protein 
PA4475   2.92 conserved hypothetical protein 
PA4479 mreD 3.90  rod shape-determining protein MreD 
PA4480 mreC  -4.02 rod shape-determining protein MreC 
PA4481 mreB  -3.10 rod shape-determining protein MreB 
PA4494   -4.13 probable two-component sensor 
PA4523   5.48 hypothetical protein 
PA4528 pilD  -2.80 type 4 prepilin peptidase PilD 
PA4542 clpB 3.48 3.22 ClpB protein 
PA4545 comL  -4.68 competence protein ComL 
PA4563 rpsT  -52.87 30S ribosomal protein S20 
PA4567 rpmA -2.11 -15.74 50S ribosomal protein L27 
PA4568 rplU  -7.27 50S ribosomal protein L21 
PA4569 ispB  -3.26 octaprenyl-diphosphate synthase 
PA4575   2.83 hypothetical protein 
PA4577  3.99 8.31 hypothetical protein 
PA4587 ccpR 6.96 2.46 cytochrome c551 peroxidase precursor 
PA4602 glyA3  -4.33 serine hydroxymethyltransferase 
PA4608  -6.99 3.00 hypothetical protein 
PA4610  3.61 4.04 hypothetical protein 
PA4625   -5.40 hypothetical protein 
PA4670 prs  -10.97 ribose-phosphate pyrophosphokinase 
PA4671 rplY   -5.12 probable ribosomal protein L25 
PA4672 pth   -8.69 peptidyl-tRNA hydrolase 
PA4673 ychF   -5.27 conserved hypothetical protein 
PA4674 vapI   3.06 conserved hypothetical protein 
PA4678 rimI  -4.16 peptide n-acetyltransferase RimI 
PA4691   2.88 hypothetical protein 
PA4697  2.41  hypothetical protein 
PA4699  2.31 2.60 hypothetical protein 
PA4728 folK 
 
-2.52 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
pyrophosphokinase 
PA4741 rpsO  -6.58 30S ribosomal protein S15 
PA4743 rbfA  -7.73 ribosome-binding factor A 
PA4746 yhbC   -18.43 conserved hypothetical protein 
PA4747 secG  -4.28 secretion protein SecG 
PA4753 yhbY   -5.31 conserved hypothetical protein 
PA4757 yeaS   -5.60 conserved hypothetical protein 
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PA4761 dnaK 5.20 4.56 DnaK protein 
PA4762 grpE 3.00 2.64 heat shock protein GrpE 
PA4765 omlA  -8.86 Outer membrane lipoprotein OmlA precursor 
PA4768 smpB  -3.53 SmpB protein 
PA4778 ybbI  -17.15 -7.45 probable transcriptional regulator 
PA4833   4.21 conserved hypothetical protein 
PA4846 aroQ1  -4.32 3-dehydroquinate dehydratase 
PA4853 fis  -12.18 DNA-binding protein Fis 
PA4876 osmE  3.66 osmotically inducible lipoprotein OsmE 
PA4877   4.21 hypothetical protein 
PA4881  2.70 3.51 hypothetical protein 
PA4932 rplI  -5.61 50S ribosomal protein L9 
PA4933  2.21  hypothetical protein 
PA4934 rpsR  -3.92 30S ribosomal protein S18 
PA4935 rpsF  -3.91 30S ribosomal protein S6 
PA4940 yjeT  -11.03 -23.64 conserved hypothetical protein 
PA4943 hflX   -4.30 probable GTP-binding protein 
PA4962 ybcI   -3.04 conserved hypothetical protein 
PA4971 aspP  2.71 adenosine diphosphate sugar pyrophosphatase 
PA5010 waaG 2.47 
 
UDP-glucose:(heptosyl) LPS alpha 1,3-
glucosyltransferase WaaG 
PA5027  4.30 7.02 hypothetical protein 
PA5030 ynfM 3.22 
 
probable major facilitator superfamily (MFS) 
transporter 
PA5033   -2.83 hypothetical protein 
PA5045 ponA  -6.07 penicillin-binding protein 1A 
PA5046   -4.26 malic enzyme 
PA5049 rpmE  -12.29 50S ribosomal protein L31 
PA5051 argS 3.45  arginyl-tRNA synthetase 
PA5054 hslU 2.67  heat shock protein HslU 
PA5055   -2.96 hypothetical protein 
PA5105 hutC 2.87 2.72 histidine utilization repressor HutC 
PA5106  8.55 8.78 conserved hypothetical protein 
PA5117 typA  -4.40 regulatory protein TypA 
PA5118 thiI  -3.71 thiazole biosynthesis protein ThiI 
PA5129 grx  -4.06 glutaredoxin 
PA5130 yibN   -2.48 conserved hypothetical protein 
PA5139   -3.03 hypothetical protein 
PA5163 rmlA -5.53 -3.24 glucose-1-phosphate thymidylyltransferase 
PA5170 arcD  14.77 arginine/ornithine antiporter 
PA5171 arcA 6.64 15.85 arginine deiminase 
PA5172 arcB 4.39 16.37 ornithine carbamoyltransferase, catabolic 
PA5173 arcC  8.22 carbamate kinase 
PA5202  2.28  hypothetical protein 
PA5212   3.54 hypothetical protein 
PA5232 yhiI  2.75 4.38 conserved hypothetical protein 
PA5239 rho  -12.11 transcription termination factor Rho 
PA5261 algR  3.66 alginate biosynthesis regulatory protein AlgR 
PA5263 argH  -2.46 argininosuccinate lyase 
PA5271   2.53 hypothetical protein 
PA5276 lppL  -3.71 Lipopeptide LppL precursor 
PA5300 cycB  -4.18 cytochrome c5 
PA5301 ycjC ; -4.88 -3.01 probable transcriptional regulator 
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PA5315 rpmG 1.15 -12.03 50S ribosomal protein L33 
PA5316 rpmB -2.32 -17.01 50S ribosomal protein L28 
PA5338 spoT 
 
-5.70 guanosine-3',5'-bis(diphosphate) 3'-
pyrophosphohydrolase 
PA5348  -32.19 -3.67 probable DNA-binding protein 
PA5355 glcD 2.12  glycolate oxidase subunit GlcD 
PA5366 pstB 
 
-4.19 ATP-binding component of ABC phosphate 
transporter 
PA5367 pstA 
 
-3.52 membrane protein component of ABC phosphate 
transporter 
PA5373 betB 4.91 3.92 betaine aldehyde dehydrogenase 
PA5374 betI 9.91 2.53 transcriptional regulator BetI 
PA5388  2.75 2.65 hypothetical protein 
PA5408   5.51 hypothetical protein 
PA5409   4.87 hypothetical protein 
PA5427 adhA 15.46 17.95 alcohol dehydrogenase 
PA5435 oadA   -3.05 probable transcarboxylase subunit 
PA5461  -11.46 -7.21 hypothetical protein 
PA5475  5.59 6.98 hypothetical protein 
PA5479 gltP  -5.20 proton-glutamate symporter 
PA5490 cc4  -8.03 cytochrome c4 precursor 
PA5491  -4.38 -19.91 probable cytochrome 
PA5494   6.36 hypothetical protein 
PA5504   -2.98 probable permease of ABC transporter 
PA5505   -5.24 probable TonB-dependent receptor 
PA5546   2.46 conserved hypothetical protein 
PA5560 atpB  -7.49 ATP synthase A chain 
PA5561 atpI -3.26 -5.89 ATP synthase protein I 
PA5563 soj -3.29 -7.82 chromosome partitioning protein Soj 
PA5568 yidC   -7.11 conserved hypothetical protein 
PA5569 rnpA  -8.68 ribonuclease P protein component 
PA5570 rpmH  -3.84 50S ribosomal protein L34 
5S rRNA  -3.10 -3.23 5S ribosomal RNA 
AF035937cds3 wbpV 
 
-4.65 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds6 wbpO 
 
-3.82 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF043558cds 
  
-3.09 Pseudomonas aeruginosa beta-lactamase OXA-13-1 
gene, complete cds. 
AF191564cds4 sul1  -3.29 metallo beta-lactamase 
AF241171cds1  4.01 4.98 No significant similarity 
AF241171cds39  2.41 2.79 first half of finger motif 
J05162cds   -4.31 P .aeruginosa carbenicillinase gene, complete cds. 
L81176cds6  -4.48 -5.03 P. aeruginosa flagellin (fliC) gene, partial cds 
M21651cds  4.18 3.18 P. aeruginosa K122-4 type IV pilin precursor 
M57501cds flaA -4.53 -3.44 Pseudomonas aeruginosa flagellin (flaA) gene 
Pae_orfB 
 
-5.20 -4.44 putative acyl carrier protein - fatty acid biosynthesis, 
from glycosylation island genes in strain PAK 
Pae_orfC 
 
-7.35 -3.99 putative 3-oxoacyl (acyl carrier protein ) synthase - 
fatty acid biosnthesis, from glycosylation island genes 
in strain PAK 
Pae_tRNA_Ala   -13.35 tRNA_Alanine 
Pae_tRNA_Arg  -7.84 -3.26 tRNA_Arginine 
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Pae_tRNA_Asn  -3.14 -18.45 tRNA_Asparagine 
Pae_tRNA_Cys  -9.16 -8.16 tRNA_Cysteine 
Pae_tRNA_Gln   -13.88 tRNA_Glutamine 
Pae_tRNA_Gly  -3.52 -20.35 tRNA_Glycine 
Pae_tRNA_His   -6.85 tRNA_Histidine 
Pae_tRNA_Leu  -12.87 -35.11 tRNA_Leucine 
Pae_tRNA_Lys   -4.53 tRNA_Lysine 
Pae_tRNA_Phe   -9.47 tRNA_Phenylalanine 
Pae_tRNA_Pro   -3.21 tRNA_Proline 
Pae_tRNA_Trp   -5.77 tRNA_Tryptophan 
Pae_tRNA_Tyr   -3.63 tRNA_Tyrosine 
Pae_tRNA_Val  -5.31 -11.82 tRNA_Valine 
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Table 8-3: Differentially regulated genes (pfp < 0.05) in lettuce leaf infection in comparison with planktonic 
and biofilm growth controls. 
PA Number Gene 
Fold change compared to 
Product Name Planktonic Biofilm 
PA0007  -2.86  hypothetical protein 
PA0011  2.25  probable 2-OH-lauroyltransferase 
PA0035 trpA 2.22 2.69 tryptophan synthase alpha chain 
PA0038  -3.67  hypothetical protein 
PA0050   -4.04 hypothetical protein 
PA0052   7.28 hypothetical protein 
PA0059 osmC  3.04 osmotically inducible protein OsmC 
PA0085  3.49  conserved hypothetical protein 
PA0089   -2.51 hypothetical protein 
PA0102  3.04 4.93 probable carbonic anhydrase 
PA0105 coxB -4.13 3.83 cytochrome c oxidase, subunit II 
PA0106 coxA -10.50  cytochrome c oxidase, subunit I 
PA0107  -8.70 2.79 conserved hypothetical protein 
PA0108 coIII -22.22  cytochrome c oxidase, subunit III 
PA0109   3.97 hypothetical protein 
PA0110  -5.95  hypothetical protein 
PA0111  -8.81  hypothetical protein 
PA0112  -2.61  hypothetical protein 
PA0113  -6.29  probable cytochrome c oxidase assembly factor 
PA0122  -5.99  conserved hypothetical protein 
PA0128 phnA   -2.77 conserved hypothetical protein 
PA0140 ahpF  -3.16 alkyl hydroperoxide reductase subunit F 
PA0156 triA -3.76 
 
Resistance-Nodulation-Cell Division (RND) triclosan 
efflux membrane fusion protein, TriA 
PA0157 triB -2.99 
 
Resistance-Nodulation-Cell Division (RND) triclosan 
efflux membrane fusion protein, TriB 
PA0160   -2.64 hypothetical protein 
PA0161   -2.96 hypothetical protein 
PA0172   -2.59 hypothetical protein 
PA0173  -3.20  probable methylesterase 
PA0175 cheR2  -5.18  probable chemotaxis protein methyltransferase 
PA0176 aer2 -8.64  aerotaxis transducer Aer2 
PA0177  -8.41  probable purine-binding chemotaxis protein 
PA0178  -5.33  probable two-component sensor 
PA0179  -5.57 3.49 probable two-component response regulator 
PA0180  -4.13  probable chemotaxis transducer 
PA0200   9.62 hypothetical protein 
PA0201  2.84 3.59 hypothetical protein 
PA0226  2.89  probable CoA transferase, subunit A 
PA0249  -3.69  probable acetyltransferase 
PA0250   2.41 conserved hypothetical protein 
PA0256  -3.53  hypothetical protein 
PA0257   -3.26 hypothetical protein 
PA0258   -3.89 hypothetical protein 
PA0261   -2.93 hypothetical protein 
PA0263 hcpC 3.41 -24.45 secreted protein Hcp 
PA0276  10.09 6.49 hypothetical protein 
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PA0280 cysA 6.63 6.75 sulfate transport protein CysA 
PA0281 cysW 6.80 5.95 sulfate transport protein CysW 
PA0282 cysT 3.37 2.72 sulfate transport protein CysT 
PA0283 sbp 8.56 8.41 sulfate-binding protein precursor 
PA0284  5.99 7.22 hypothetical protein 
PA0286 desA 11.07 8.54 delta-9 fatty acid desaturase, DesA 
PA0291 oprE 
 
-3.97 Anaerobically-induced outer membrane porin OprE 
precursor 
PA0297 spuA 3.57  probable glutamine amidotransferase 
PA0298 spuB 2.94 2.46 probable glutamine synthetase 
PA0312   4.83 conserved hypothetical protein 
PA0315  -3.64  hypothetical protein 
PA0329  -5.75  conserved hypothetical protein 
PA0332   4.05 hypothetical protein 
PA0355 pfpI -3.90  protease PfpI 
PA0359   -2.78 hypothetical protein 
PA0363 coaD  -2.80 phosphopantetheine adenylyltransferase 
PA0365  -5.55  hypothetical protein 
PA0366  -3.30  probable aldehyde dehydrogenase 
PA0377  2.75  hypothetical protein 
PA0385  3.98  hypothetical protein 
PA0386 yggW  2.61  probable oxidase 
PA0395 pilT -2.28  twitching motility protein PilT 
PA0408 pilG  -4.53 twitching motility protein PilG 
PA0409 pilH  -5.16 twitching motility protein PilH 
PA0410 pilI  -2.77 twitching motility protein PilI 
PA0411 pilJ  -2.98 twitching motility protein PilJ 
PA0424 mexR  -2.95 multidrug resistance operon repressor MexR 
PA0432 sahH -3.09 -3.08 S-adenosyl-L-homocysteine hydrolase 
PA0436  2.81  probable transcriptional regulator 
PA0439  2.55 3.14 probable oxidoreductase 
PA0441 dht 4.15 5.15 dihydropyrimidinase 
PA0444  2.87  N-carbamoyl-beta-alanine amidohydrolase 
PA0447 gcdH  -7.56 glutaryl-CoA dehydrogenase 
PA0451  4.11 10.32 conserved hypothetical protein 
PA0452 slp   3.65 probable stomatin-like protein 
PA0456  22.78 3.57 probable cold-shock protein 
PA0459 clpC  -3.49  probable ClpA/B protease ATP binding subunit 
PA0460  -3.27  hypothetical protein 
PA0469   3.56 hypothetical protein 
PA0472 fiuI  2.43 9.38 probable sigma-70 factor, ECF subfamily 
PA0484   4.65 conserved hypothetical protein 
PA0485 rarD  2.90  conserved hypothetical protein 
PA0490   3.15 hypothetical protein 
PA0505  2.54 14.22 hypothetical protein 
PA0506   -3.09 probable acyl-CoA dehydrogenase 
PA0520 nirQ  2.64 regulatory protein NirQ 
PA0536  -2.39  hypothetical protein 
PA0538 dsbB 2.55 2.48 disulfide bond formation protein 
PA0540  -2.79  hypothetical protein 
PA0541   -3.39 hypothetical protein 
PA0546 metK  -2.57 methionine adenosyltransferase 
PA0553  -4.86  hypothetical protein 
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PA0555 fda -3.35  fructose-1,6-bisphosphate aldolase 
PA0563  2.61  conserved hypothetical protein 
PA0566  2.51  hypothetical protein 
PA0567 yqaE  -4.84  conserved hypothetical protein 
PA0576 rpoD  -2.67 sigma factor RpoD 
PA0578  4.53 -7.98 conserved hypothetical protein 
PA0579 rpsU 7.62  30S ribosomal protein S21 
PA0580 gcp 2.67  O-sialoglycoprotein endopeptidase 
PA0581 ygiH   -2.56 conserved hypothetical protein 
PA0586 ycgB  -5.65  conserved hypothetical protein 
PA0588 yeaG  -3.28  conserved hypothetical protein 
PA0589 glpE   -3.79 conserved hypothetical protein 
PA0595 ostA  -3.50 organic solvent tolerance protein OstA precursor 
PA0608 gph  3.23  probable phosphoglycolate phosphatase 
PA0610 prtN -2.61  transcriptional regulator PrtN 
PA0612 ptrB -4.30  repressor, PtrB 
PA0614  -2.72  hypothetical protein 
PA0616  -2.84  hypothetical protein 
PA0619  -2.82  probable bacteriophage protein 
PA0623  -2.78  probable bacteriophage protein 
PA0624  -5.33  hypothetical protein 
PA0631  -3.17  hypothetical protein 
PA0635  -3.29  hypothetical protein 
PA0636  -2.70  hypothetical protein 
PA0648  -2.81  hypothetical protein 
PA0652 vfr  -3.42 transcriptional regulator Vfr 
PA0654 speD  -3.84 S-adenosylmethionine decarboxylase proenzyme 
PA0655   -2.32 hypothetical protein 
PA0656 ycfF   3.06 probable HIT family protein 
PA0665 yadR  2.98  conserved hypothetical protein 
PA0667 yebA   -2.75 conserved hypothetical protein 
PA0676  3.18  probable transmembrane sensor 
PA0713   -2.77 hypothetical protein 
PA0730  3.19  probable transferase 
PA0734  24.45 12.76 hypothetical protein 
PA0745  -4.34  probable enoyl-CoA hydratase/isomerase 
PA0746  -2.76  probable acyl-CoA dehydrogenase 
PA0747  -2.96  probable aldehyde dehydrogenase 
PA0762 algU -2.90  sigma factor AlgU 
PA0766 mucD  -3.24 serine protease MucD precursor 
PA0767 lepA  -5.09 GTP-binding protein LepA 
PA0768 lepB  -2.96 signal peptidase I 
PA0776  -2.66  hypothetical protein 
PA0801   2.47 hypothetical protein 
PA0802  1.92 2.83 hypothetical protein 
PA0805  3.39  hypothetical protein 
PA0810   2.29 probable haloacid dehalogenase 
PA0814  3.90 4.25 conserved hypothetical protein 
PA0815  6.47 11.42 probable transcriptional regulator 
PA0817  2.60 2.68 probable ring-cleaving dioxygenase 
PA0837 slyD 2.62 3.17 peptidyl-prolyl cis-trans isomerase SlyD 
PA0838 btuE   2.62 probable glutathione peroxidase 
PA0851  2.67 2.74 hypothetical protein 
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PA0856  2.75  hypothetical protein 
PA0859   2.74 hypothetical protein 
PA0862   2.97 hypothetical protein 
PA0865 hpd -7.16  4-hydroxyphenylpyruvate dioxygenase 
PA0866 aroP2 -3.19  aromatic amino acid transport protein AroP2 
PA0870 phhC -5.86  aromatic amino acid aminotransferase 
PA0871 phhB -6.65  pterin-4-alpha-carbinolamine dehydratase 
PA0872 phhA -3.32  phenylalanine-4-hydroxylase 
PA0892 aotP -2.36  arginine/ornithine transport protein AotP 
PA0900  -3.11  hypothetical protein 
PA0909   2.63 hypothetical protein 
PA0915 yehS   -2.66 conserved hypothetical protein 
PA0921  -6.15  hypothetical protein 
PA0929 pirR  3.14 6.63 two-component response regulator 
PA0936 lpxO2 3.56  lipopolysaccharide biosynthetic protein LpxO2 
PA0942   2.37 probable transcriptional regulator 
PA0944 purN  -3.94 phosphoribosylaminoimidazole synthetase 
PA0952   -4.89 hypothetical protein 
PA0954   2.49 probable acylphosphatase 
PA0955   -3.98 hypothetical protein 
PA0959  -3.38  hypothetical protein 
PA0961   -2.87 probable cold-shock protein 
PA0962  -2.81  probable dna-binding stress protein 
PA0964 yebC   -3.06 conserved hypothetical protein 
PA0969 tolQ  -4.03 TolQ protein 
PA0974   -3.02 conserved hypothetical protein 
PA0981   -3.44 hypothetical protein 
PA0988   2.95 hypothetical protein 
PA0995 ogt 2.50 3.04 methylated-DNA--protein-cysteine methyltransferase 
PA0998 pqsC 
 
-2.93 Homologous to beta-keto-acyl-acyl-carrier protein 
synthase 
PA1001 phnA  -3.19 anthranilate synthase component I 
PA1011   -2.71 hypothetical protein 
PA1027 pcd  -2.96  probable aldehyde dehydrogenase 
PA1029   2.69 hypothetical protein 
PA1034   -2.77 hypothetical protein 
PA1035  -3.62  hypothetical protein 
PA1041  -6.80 2.52 probable outer membrane protein precursor 
PA1048  -4.22  probable outer membrane protein precursor 
PA1060  3.14 4.04 hypothetical protein 
PA1075   3.24 hypothetical protein 
PA1080 flgE -2.61 -3.47 flagellar hook protein FlgE 
PA1097 fleQ -4.45  transcriptional regulator FleQ 
PA1118   4.79 hypothetical protein 
PA1121  -3.61  conserved hypothetical protein 
PA1123   -25.40 hypothetical protein 
PA1132   -3.24 hypothetical protein 
PA1151 imm2 -3.66  pyocin S2 immunity protein 
PA1159  5.35 3.24 probable cold-shock protein 
PA1160  2.84 3.11 hypothetical protein 
PA1168  -5.54 -62.11 hypothetical protein 
PA1174 napA -4.68  periplasmic nitrate reductase protein NapA 
PA1175 napD -2.78  NapD protein of periplasmic nitrate reductase 
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PA1176 napF -3.83 3.26 ferredoxin protein NapF 
PA1177 napE  26.32 periplasmic nitrate reductase protein NapE 
PA1178 oprH -56.76 
 
PhoP/Q and low Mg2+ inducible outer membrane 
protein H1 precursor 
PA1179 phoP -11.64  two-component response regulator PhoP 
PA1180 phoQ -6.58  two-component sensor PhoQ 
PA1183 dctA 10.38 -2.67 C4-dicarboxylate transport protein 
PA1190 yohC  5.41 35.09 conserved hypothetical protein 
PA1192 ydaO  2.84  conserved hypothetical protein 
PA1193   -2.77 hypothetical protein 
PA1198   -3.28 conserved hypothetical protein 
PA1199   -4.45 probable lipoprotein 
PA1202 ycaC  -4.67  probable hydrolase 
PA1245 aprX  -3.41  hypothetical protein 
PA1246 aprD -3.43  alkaline protease secretion protein AprD 
PA1247 aprE -2.83  alkaline protease secretion protein AprE 
PA1249 aprA -3.30  alkaline metalloproteinase precursor 
PA1283  -3.19  probable transcriptional regulator 
PA1287   2.53 probable glutathione peroxidase 
PA1289  -6.34  hypothetical protein 
PA1296  2.50  probable 2-hydroxyacid dehydrogenase 
PA1300  -1.81  probable sigma-70 factor, ECF subfamily 
PA1305  3.07  hypothetical protein 
PA1306  2.81  probable HIT family protein 
PA1323   2.41 hypothetical protein 
PA1327  -2.68  probable protease 
PA1340  -4.20 -2.87 probable permease of ABC transporter 
PA1342 
 
-2.99 
 
probable binding protein component of ABC 
transporter 
PA1348  -9.99  hypothetical protein 
PA1377 yhhY   4.05 conserved hypothetical protein 
PA1404   10.60 hypothetical protein 
PA1414   3.35 hypothetical protein 
PA1430 lasR -2.36  transcriptional regulator LasR 
PA1432 lasI  3.41 autoinducer synthesis protein LasI 
PA1440   2.74 hypothetical protein 
PA1457 cheZ -2.28  chemotaxis protein CheZ 
PA1464 cheW   5.12 probable purine-binding chemotaxis protein 
PA1476 ccmB  -2.34 heme exporter protein CcmB 
PA1478 ccmD  -3.14 hypothetical protein 
PA1480 ccmF  -2.90 cytochrome C-type biogenesis protein CcmF 
PA1482 ccmH  -5.76 cytochrome C-type biogenesis protein CcmH 
PA1505 moaA2 2.95 5.79 molybdopterin biosynthetic protein A2 
PA1511   -3.26 conserved hypothetical protein 
PA1517  2.60 4.71 conserved hypothetical protein 
PA1533  -3.01 -2.65 conserved hypothetical protein 
PA1540   -2.92 conserved hypothetical protein 
PA1544 anr 2.32  transcriptional regulator Anr 
PA1545   3.95 hypothetical protein 
PA1550   -3.95 hypothetical protein 
PA1551 fixG   -4.05 probable ferredoxin 
PA1552   -2.71 probable cytochrome c 
PA1553 fixO -3.45 -5.69 probable cytochrome c oxidase subunit 
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PA1555 fixP   -19.20 probable cytochrome c 
PA1556 ccoO  -17.85 probable cytochrome c oxidase subunit 
PA1557 ccoN  -7.13 probable cytochrome oxidase subunit (cbb3-type) 
PA1580 gltA  -4.84 citrate synthase 
PA1581 sdhC 3.63  succinate dehydrogenase (C subunit) 
PA1582 sdhD 2.38  succinate dehydrogenase (D subunit) 
PA1584 sdhB  -2.74 succinate dehydrogenase (B subunit) 
PA1586 sucB -3.41 -3.06 dihydrolipoamide succinyltransferase (E2 subunit) 
PA1588 sucC  -2.67 succinyl-CoA synthetase beta chain 
PA1596 htpG  -4.25 heat shock protein HtpG 
PA1610 fabA 2.54  beta-hydroxydecanoyl-ACP dehydrase 
PA1617  -3.72  probable AMP-binding enzyme 
PA1626 
 
2.27 2.62 probable major facilitator superfamily (MFS) 
transporter 
PA1630  3.09 3.55 probable transcriptional regulator 
PA1632 kdpF 2.34  KdpF protein 
PA1641  -5.26  hypothetical protein 
PA1645  2.64 4.28 hypothetical protein 
PA1651  6.74 5.35 probable transporter 
PA1656   -15.39 hypothetical protein 
PA1657   -5.24 conserved hypothetical protein 
PA1658   -10.97 conserved hypothetical protein 
PA1659   -11.02 hypothetical protein 
PA1660   -11.14 hypothetical protein 
PA1661   -7.27 hypothetical protein 
PA1668   -3.49 hypothetical protein 
PA1669   -2.94 hypothetical protein 
PA1676   4.81 hypothetical protein 
PA1677  2.44 10.46 conserved hypothetical protein 
PA1701 pcr3   -4.44 conserved hypothetical protein in type III secretion 
PA1710 exsC -4.30  ExsC, exoenzyme S synthesis protein C precursor. 
PA1713 exsA  -8.18 transcriptional regulator ExsA 
PA1714 exsD  -3.22 ExsD 
PA1728   27.25 hypothetical protein 
PA1729   3.24 conserved hypothetical protein 
PA1730   2.83 conserved hypothetical protein 
PA1733   2.97 conserved hypothetical protein 
PA1741  2.27  hypothetical protein 
PA1742  2.45 2.60 probable amidotransferase 
PA1751   2.87 hypothetical protein 
PA1752   2.43 hypothetical protein 
PA1754 cysB -2.77  transcriptional regulator CysB 
PA1762  -2.61  hypothetical protein 
PA1767   -3.31 hypothetical protein 
PA1768   -3.48 hypothetical protein 
PA1775 cmpX 3.73 
 
conserved cytoplasmic membrane protein, CmpX 
protein 
PA1778 cobA 4.03 4.24 uroporphyrin-III C-methyltransferase 
PA1779 nasC 3.59 3.51 assimilatory nitrate reductase 
PA1780 nirD 7.32 5.99 assimilatory nitrite reductase small subunit 
PA1781 nirB 3.86 3.91 assimilatory nitrite reductase large subunit 
PA1782  3.05  probable serine/threonine-protein kinase 
PA1783 nasA 4.05 4.02 nitrate transporter 
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PA1784  -4.19  hypothetical protein 
PA1800 tig 2.33  trigger factor 
PA1804 hupB -2.89  DNA-binding protein HU 
PA1805 ppiD  -3.58 peptidyl-prolyl cis-trans isomerase D 
PA1812 mltD 
 
-7.41 membrane-bound lytic murein transglycosylase D 
precursor 
PA1814   2.32 hypothetical protein 
PA1817   3.25 hypothetical protein 
PA1819 yjdE  -2.93  probable amino acid permease 
PA1830   -4.87 hypothetical protein 
PA1833 yhfP   2.71 probable oxidoreductase 
PA1837  3.45 3.58 hypothetical protein 
PA1838 cysI 3.46 2.85 sulfite reductase 
PA1847 yhgI  3.95  conserved hypothetical protein 
PA1852  3.94  hypothetical protein 
PA1856  2.90 3.23 probable cytochrome oxidase subunit 
PA1872   3.50 hypothetical protein 
PA1874   3.18 hypothetical protein 
PA1875 opmL  -3.10 5.98 probable outer membrane protein precursor 
PA1876  -3.01  probable ATP-binding/permease fusion ABC transporter 
PA1887  -9.80  hypothetical protein 
PA1888  -5.64  hypothetical protein 
PA1901 phzC2 -2.21  phenazine biosynthesis protein PhzC 
PA1912  2.59 3.30 probable sigma-70 factor, ECF subfamily 
PA1914 hvn  -3.74  conserved hypothetical protein 
PA1927 metE 18.66 17.21 5-methyltetrahydropteroyltriglutamate-homocysteine 
S-methyltransferase 
PA1931  -2.69 2.67 probable ferredoxin 
PA1944  -3.00  hypothetical protein 
PA1946 rbsB 2.65 
 
binding protein component precursor of ABC ribose 
transporter 
PA1950 rbsK  4.03 ribokinase 
PA1963  4.28 6.69 hypothetical protein 
PA1970  4.44 4.35 hypothetical protein 
PA1984 exaC1  10.91 3.62 probable aldehyde dehydrogenase 
PA1985 pqqA  4.84 pyrroloquinoline quinone biosynthesis protein A 
PA1998  2.63 2.59 probable transcriptional regulator 
PA2006 
 
-2.97 
 
probable major facilitator superfamily (MFS) 
transporter 
PA2007 maiA -6.68 2.58 maleylacetoacetate isomerase 
PA2008 fahA -4.87  fumarylacetoacetase 
PA2009 hmgA -3.74  homogentisate 1,2-dioxygenase 
PA2016 liuR 3.33  regulator of liu genes 
PA2019 amrA 3.85  
Resistance-Nodulation-Cell Division (RND) multidrug 
efflux membrane fusion protein precursor 
PA2020 amrR  3.57 probable transcriptional regulator 
PA2024   12.06 probable ring-cleaving dioxygenase 
PA2025 gor  2.41 glutathione reductase 
PA2026 yfeH   2.44 conserved hypothetical protein 
PA2027  -39.54  hypothetical protein 
PA2030  8.66 38.76 hypothetical protein 
PA2031  30.40 82.64 hypothetical protein 
PA2034  -2.97  hypothetical protein 
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PA2045 yidD  3.35 2.66 conserved hypothetical protein 
PA2071 fusA2 -4.49  elongation factor G 
PA2092 
 
2.66 2.42 probable major facilitator superfamily (MFS) 
transporter 
PA2112   -2.30 conserved hypothetical protein 
PA2114 
  
-3.11 probable major facilitator superfamily (MFS) 
transporter 
PA2116   -3.02 conserved hypothetical protein 
PA2134   3.76 hypothetical protein 
PA2143   9.20 hypothetical protein 
PA2146 yciG   54.64 conserved hypothetical protein 
PA2149  -2.55  hypothetical protein 
PA2152   2.61 probable trehalose synthase 
PA2159  -3.30 2.51 conserved hypothetical protein 
PA2166  -2.40 8.88 hypothetical protein 
PA2169   5.46 hypothetical protein 
PA2170   9.66 hypothetical protein 
PA2172   2.88 hypothetical protein 
PA2173   2.64 hypothetical protein 
PA2174   4.48 hypothetical protein 
PA2190   7.17 conserved hypothetical protein 
PA2210 
 
2.20 
 
probable major facilitator superfamily (MFS) 
transporter 
PA2229 yiiM  2.98 3.17 conserved hypothetical protein 
PA2231 pslA  -3.38 PslA 
PA2233 pslC -4.21 -2.91 probable glycosyl transferase 
PA2234 pslD -3.24 -2.82 PslD 
PA2235 pslE -2.47  hypothetical protein 
PA2237 pslG -2.43  probable glycosyl hydrolase 
PA2240 pslJ  -2.44 hypothetical protein 
PA2247 bkdA1 -15.61 -2.50 2-oxoisovalerate dehydrogenase (alpha subunit) 
PA2248 bkdA2 -9.80  2-oxoisovalerate dehydrogenase (beta subunit) 
PA2249 bkdB -10.17 
 
branched-chain alpha-keto acid dehydrogenase 
(lipoamide component) 
PA2250 lpdV -12.16  lipoamide dehydrogenase-Val 
PA2259 ptxS 8.63 17.39 transcriptional regulator PtxS 
PA2260 kguE  17.27 16.81 hypothetical protein 
PA2261 kguK 3.38 3.46 probable 2-ketogluconate kinase 
PA2263 kguD 3.89 4.78 probable 2-hydroxyacid dehydrogenase 
PA2306  12.14 19.61 conserved hypothetical protein 
PA2321 gntV 2.46  gluconokinase 
PA2322 gntU 3.06 2.93 gluconate permease 
PA2364   3.35 hypothetical protein 
PA2372  -2.79 -3.06 hypothetical protein 
PA2375   9.18 hypothetical protein 
PA2380  10.80 7.86 hypothetical protein 
PA2381  -18.11 -5.12 hypothetical protein 
PA2383   2.53 probable transcriptional regulator 
PA2384   6.28 hypothetical protein 
PA2404   2.42 hypothetical protein 
PA2405  3.27 3.77 hypothetical protein 
PA2409  2.18  probable permease of ABC transporter 
PA2411  2.52 6.43 probable thioesterase 
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PA2412  4.32 9.87 conserved hypothetical protein 
PA2414  -4.26  L-sorbosone dehydrogenase 
PA2422  -3.46  hypothetical protein 
PA2426 pvdS 1.79 3.45 sigma factor PvdS 
PA2433  -6.31 2.79 hypothetical protein 
PA2434  -2.46  hypothetical protein 
PA2456   -4.10 hypothetical protein 
PA2457   -2.33 hypothetical protein 
PA2459   -4.64 hypothetical protein 
PA2467 foxR  3.84 Anti-sigma factor FoxR 
PA2468 foxI  2.39 ECF sigma factor FoxI 
PA2484   3.87 conserved hypothetical protein 
PA2491   5.89 probable oxidoreductase 
PA2501  -6.80  hypothetical protein 
PA2504  -4.41  hypothetical protein 
PA2511   2.88 probable transcriptional regulator 
PA2519 xylS 3.19 3.36 transcriptional regulator XylS 
PA2532 tpx  2.79 thiol peroxidase 
PA2560  2.63 4.57 hypothetical protein 
PA2562  -2.54 2.86 hypothetical protein 
PA2564 tam  -8.50  hypothetical protein 
PA2565  -8.28 2.95 hypothetical protein 
PA2566  -13.64  conserved hypothetical protein 
PA2568   2.30 hypothetical protein 
PA2570 lecA 3.18 5.66 LecA 
PA2571  -6.56  probable two-component sensor 
PA2572  -2.51  probable two-component response regulator 
PA2573   5.25 probable chemotaxis transducer 
PA2577  -2.78  probable transcriptional regulator 
PA2581  -2.60  hypothetical protein 
PA2582   2.39 hypothetical protein 
PA2584 pgsA 5.09 
 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase 
PA2587 pqsH -3.45  probable FAD-dependent monooxygenase 
PA2593   -6.05 hypothetical protein 
PA2605 yheN   2.82 conserved hypothetical protein 
PA2606 yheM   3.26 conserved hypothetical protein 
PA2607   2.67 conserved hypothetical protein 
PA2612 serS  -2.35 seryl-tRNA synthetase 
PA2615 ftsK  2.33 cell division protein FtsK 
PA2619 infA 3.28 -3.60 initiation factor 
PA2620 clpA  2.60 ATP-binding protease component ClpA 
PA2621   2.94 conserved hypothetical protein 
PA2622 cspD  2.72 cold-shock protein CspD 
PA2624 idh  -2.86 isocitrate dehydrogenase 
PA2629 purB 3.23  adenylosuccinate lyase 
PA2639 nuoD  -2.58 NADH dehydrogenase I chain C,D 
PA2640 nuoE -2.82 -2.89 NADH dehydrogenase I chain E 
PA2644 nuoI -3.02 -3.29 NADH Dehydrogenase I chain I 
PA2645 nuoJ -2.39 -2.57 NADH dehydrogenase I chain J 
PA2646 nuoK -2.83 -2.67 NADH dehydrogenase I chain K 
PA2647 nuoL -2.60 -2.51 NADH dehydrogenase I chain L 
PA2662  13.53 13.14 conserved hypothetical protein 
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PA2663  14.08 14.22 hypothetical protein 
PA2664 fhp 42.02 42.92 flavohemoprotein 
PA2666 ptpS  3.84  probable 6-pyruvoyl tetrahydrobiopterin synthase 
PA2667   -3.60 conserved hypothetical protein 
PA2705  -2.48  hypothetical protein 
PA2709 cysK  3.19 cysteine synthase A 
PA2710   2.98 hypothetical protein 
PA2718   2.44 probable transcriptional regulator 
PA2737  -3.64  conserved hypothetical protein 
PA2738 himA -2.68  integration host factor, alpha subunit 
PA2741 rplT 2.70  50S ribosomal protein L20 
PA2743 infC 4.16  translation initiation factor IF-3 
PA2746  6.73 101.01 hypothetical protein 
PA2747   3.48 hypothetical protein 
PA2754  -3.92  conserved hypothetical protein 
PA2756   4.07 hypothetical protein 
PA2759  5.63 8.97 hypothetical protein 
PA2762  -2.61  hypothetical protein 
PA2769   -4.48 hypothetical protein 
PA2771  -3.46  conserved hypothetical protein 
PA2779   2.94 hypothetical protein 
PA2786  4.70 4.89 hypothetical protein 
PA2799   5.13 hypothetical protein 
PA2827 yeaA   3.55 conserved hypothetical protein 
PA2840 deaD  4.09  probable ATP-dependent RNA helicase 
PA2841  -2.43  probable enoyl-CoA hydratase/isomerase 
PA2844   2.29 conserved hypothetical protein 
PA2847  312.50 312.50 conserved hypothetical protein 
PA2849  -6.22  probable transcriptional regulator 
PA2851 efp 2.65  translation elongation factor P 
PA2897   5.85 probable transcriptional regulator 
PA2899  -2.21  probable transcriptional regulator 
PA2906  2.76  probable oxidoreductase 
PA2918   2.92 probable short-chain dehydrogenase 
PA2937   8.26 hypothetical protein 
PA2939 pepB  -4.15  probable aminopeptidase 
PA2946  2.27 2.68 hypothetical protein 
PA2950  2.44  hypothetical protein 
PA2953 
  
-3.36 electron transfer flavoprotein-ubiquinone 
oxidoreductase 
PA2957  2.58  probable transcriptional regulator 
PA2960 pilZ  -2.85 type 4 fimbrial biogenesis protein PilZ 
PA2966 acpP 4.19  acyl carrier protein 
PA2970 rpmF 2.87  50S ribosomal protein L32 
PA2971 yceD  3.10  conserved hypothetical protein 
PA2985  5.00 3.22 hypothetical protein 
PA3006 psrA  -2.83 transcriptional regulator PsrA 
PA3009  9.73  hypothetical protein 
PA3011 topA -3.03 -2.70 DNA topoisomerase I 
PA3013 foaB  -5.59 fatty-acid oxidation complex beta-subunit 
PA3014 faoA  -2.55 fatty-acid oxidation complex alpha-subunit 
PA3017   10.72 conserved hypothetical protein 
PA3031   -2.56 hypothetical protein 
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PA3032 snr1 -3.18  cytochrome c Snr1 
PA3033  2.32  hypothetical protein 
PA3034  2.53 2.42 probable transcriptional regulator 
PA3040 yqjD  -2.65 2.73 conserved hypothetical protein 
PA3041 yqjE   2.33 hypothetical protein 
PA3042  -2.90  hypothetical protein 
PA3049 rmf  4.75 ribosome modulation factor 
PA3050 pyrD 2.72  dihydroorotate dehydrogenase 
PA3057   -3.79 hypothetical protein 
PA3068 gdhB -3.39  NAD-dependent glutamate dehydrogenase 
PA3096 xcpY  2.79 general secretion pathway protein L 
PA3109 cvpA  4.53  hypothetical protein 
PA3111 folC 2.53  folylpolyglutamate synthetase 
PA3123  -3.21  conserved hypothetical protein 
PA3126 ibpA  -2.64 heat-shock protein IbpA 
PA3161 himD  3.85 integration host factor beta subunit 
PA3162 rpsA 2.90  30S ribosomal protein S1 
PA3167 serC 2.62  3-phosphoserine aminotransferase 
PA3168 gyrA 6.17  DNA gyrase subunit A 
PA3171 ubiG  -2.87 3-demethylubiquinone-9 3-methyltransferase 
PA3173 yciK   -3.00 probable short-chain dehydrogenase 
PA3178   5.97 hypothetical protein 
PA3182 pgl 3.24 3.39 6-phosphogluconolactonase 
PA3183 zwf  2.68 glucose-6-phosphate 1-dehydrogenase 
PA3186 oprB -2.96 
 
Glucose/carbohydrate outer membrane porin OprB 
precursor 
PA3188 gltG  -2.69  probable permease of ABC sugar transporter 
PA3189 gltF  -2.99  probable permease of ABC sugar transporter 
PA3194 edd  3.18 phosphogluconate dehydratase 
PA3195 gapA  4.44 glyceraldehyde 3-phosphate dehydrogenase 
PA3202 yciI  4.59 3.56 conserved hypothetical protein 
PA3216  -3.04  hypothetical protein 
PA3217 cyaB  -2.55 CyaB 
PA3227 ppiA -3.99 -2.42 peptidyl-prolyl cis-trans isomerase A 
PA3229   3.08 hypothetical protein 
PA3231   8.27 hypothetical protein 
PA3232   2.62 probable nuclease 
PA3234 yjcG   4.43 probable sodium:solute symporter 
PA3235 yjcH   4.35 conserved hypothetical protein 
PA3245 minE  -3.50 cell division topological specificity factor MinE 
PA3259   2.42 hypothetical protein 
PA3266 capB 39.06  cold acclimation protein B 
PA3280 oprO 
 
-2.75 Pyrophosphate-specific outer membrane porin OprO 
precursor 
PA3285  3.22 2.82 probable sigma-70 factor, ECF subfamily 
PA3292   -13.59 hypothetical protein 
PA3299 fadD1  -2.76 long-chain-fatty-acid--CoA ligase 
PA3309 uspK  -2.57  conserved hypothetical protein 
PA3311  -2.47  conserved hypothetical protein 
PA3316   2.40 probable permease of ABC transporter 
PA3332   -4.34 conserved hypothetical protein 
PA3346  -3.99  probable two-component response regulator 
PA3347  -3.86  hypothetical protein 
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PA3349   2.29 probable chemotaxis protein 
PA3351 flgM  3.02 FlgM 
PA3352  4.08 10.58 hypothetical protein 
PA3354   5.62 hypothetical protein 
PA3361 lecB 6.20  fucose-binding lectin PA-IIL 
PA3371   3.07 hypothetical protein 
PA3383 phnD  
 
-2.70 binding protein component of ABC phosphonate 
transporter 
PA3397 fpr 3.88  ferredoxin--NADP+ reductase 
PA3415   3.57 probable dihydrolipoamide acetyltransferase 
PA3416  -3.62  
probable pyruvate dehydrogenase E1 component, beta 
chain 
PA3417 
  
7.94 probable pyruvate dehydrogenase E1 component, 
alpha subunit 
PA3418 ldh  11.44 leucine dehydrogenase 
PA3431 ywbG  5.63 4.36 conserved hypothetical protein 
PA3432  7.51 7.91 hypothetical protein 
PA3436  3.12  hypothetical protein 
PA3438 folE1 2.17  GTP cyclohydrolase I precursor 
PA3450 lsfA  5.81 7.06 probable antioxidant protein 
PA3451  2.64 9.46 hypothetical protein 
PA3458  -2.32  probable transcriptional regulator 
PA3459 asnB  -3.59  probable glutamine amidotransferase 
PA3461 yhfE  -2.46  conserved hypothetical protein 
PA3465 yfiS  -4.74  conserved hypothetical protein 
PA3472  2.28  hypothetical protein 
PA3473  2.53  hypothetical protein 
PA3479 rhlA 4.34  rhamnosyltransferase chain A 
PA3489 rnfA   -4.38 conserved hypothetical protein 
PA3496   -2.71 hypothetical protein 
PA3525 argG 3.15  argininosuccinate synthase 
PA3526 motY   3.28 probable outer membrane protein precursor 
PA3531 bfrB  -4.20 bacterioferritin 
PA3533 ydhD  4.60 3.45 conserved hypothetical protein 
PA3536   5.14 hypothetical protein 
PA3567  2.48 2.51 probable oxidoreductase 
PA3568 ymmS  -16.53  probable acetyl-coa synthetase 
PA3569 mmsB -15.16  3-hydroxyisobutyrate dehydrogenase 
PA3570 mmsA -6.75  methylmalonate-semialdehyde dehydrogenase 
PA3572   4.21 hypothetical protein 
PA3576   6.68 hypothetical protein 
PA3578  6.67 6.75 conserved hypothetical protein 
PA3580 ybaK   -3.36 conserved hypothetical protein 
PA3584 glpD 11.15  glycerol-3-phosphate dehydrogenase 
PA3601 ykgM  2.25  conserved hypothetical protein 
PA3611  2.44  hypothetical protein 
PA3618 ygaD   5.40 conserved hypothetical protein 
PA3621 fdxA 3.56  ferredoxin I 
PA3622 rpoS  5.13 sigma factor RpoS 
PA3636 kdsA  -2.67 2-dehydro-3-deoxyphosphooctonate aldolase 
PA3637 pyrG  -2.79 CTP synthase 
PA3642 rnhB  -2.53 ribonuclease HII 
PA3644 lpxA  -3.34 UDP-N-acetylglucosamine acyltransferase 
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PA3645 fabZ 
 
-2.91 (3R)-hydroxymyristoyl-[acyl carrier protein] 
dehydratase 
PA3646 lpxD 
 
-4.87 UDP-3-O-[3-hydroxylauroyl] glucosamine N-
acyltransferase 
PA3648   -4.07 probable outer membrane protein precursor 
PA3652 uppS  -2.68 undecaprenyl pyrophosphate synthetase 
PA3653 frr  -2.86 ribosome recycling factor 
PA3655 tsf 2.55  elongation factor Ts 
PA3662  -8.00  hypothetical protein 
PA3668   3.08 conserved hypothetical protein 
PA3674  -3.39  hypothetical protein 
PA3684   3.45 hypothetical protein 
PA3686 adk  -3.17 adenylate kinase 
PA3688   15.53 hypothetical protein 
PA3691  -2.50  hypothetical protein 
PA3692  -2.53  probable outer membrane protein precursor 
PA3698  -2.45  hypothetical protein 
PA3720  2.68  hypothetical protein 
PA3722   -5.04 hypothetical protein 
PA3723 yqjM  -3.37  probable FMN oxidoreductase 
PA3724 lasB -3.83  elastase LasB 
PA3737 dsbC 2.70  thiol:disulfide interchange protein DsbC 
PA3740   4.38 hypothetical protein 
PA3741   -3.70 hypothetical protein 
PA3742 rplS 2.18 -4.78 50S ribosomal protein L19 
PA3743 trmD 2.86  tRNA (guanine-N1)-methyltransferase 
PA3744 rimM 2.92  16S rRNA processing protein 
PA3745 rpsP 3.04  30S ribosomal protein S16 
PA3747  3.10  conserved hypothetical protein 
PA3754 yeaB  3.05 3.85 hypothetical protein 
PA3756 yafK  3.00  hypothetical protein 
PA3770 guaB  -2.56 inosine-5'-monophosphate dehydrogenase 
PA3784  -6.60  hypothetical protein 
PA3785  -7.56  conserved hypothetical protein 
PA3796   7.41 hypothetical protein 
PA3804   -3.57 hypothetical protein 
PA3806 yfgB   -3.21 conserved hypothetical protein 
PA3808 yfhJ  3.16 4.19 conserved hypothetical protein 
PA3811 hscB 2.97  heat shock protein HscB 
PA3812 iscA 2.85 2.49 probable iron-binding protein IscA 
PA3813 iscU 11.05 8.81 probable iron-binding protein IscU 
PA3814 iscS 5.62 2.78 L-cysteine desulfurase (pyridoxal phosphate-
dependent) 
PA3815  8.88  conserved hypothetical protein 
PA3817  2.37  probable methyltransferase 
PA3818 suhB  2.65  extragenic suppressor protein SuhB 
PA3819 ycfJ   3.90 conserved hypothetical protein 
PA3822 yajC   -2.61 conserved hypothetical protein 
PA3824 queA 
 
-3.60 S-adenosylmethionine:trna ribosyltransferase-
isomerase 
PA3833   4.23 hypothetical protein 
PA3841 exoS -3.03  exoenzyme S 
PA3844   2.34 hypothetical protein 
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PA3846   7.10 hypothetical protein 
PA3847  -3.07  conserved hypothetical protein 
PA3848  -2.88  hypothetical protein 
PA3851   3.47 hypothetical protein 
PA3858 aapJ  -8.70  probable amino acid-binding protein 
PA3899  2.08 3.69 probable sigma-70 factor, ECF subfamily 
PA3903 prfC  -2.89 peptide chain release factor 3 
PA3905   -4.23 hypothetical protein 
PA3906   -3.47 hypothetical protein 
PA3907   -2.85 hypothetical protein 
PA3908   -5.48 hypothetical protein 
PA3914 moeA1 2.71 2.68 molybdenum cofactor biosynthetic protein A1 
PA3915 moaB1 7.01 5.88 molybdopterin biosynthetic protein B1 
PA3916 moaE 2.70 3.73 molybdopterin converting factor, large subunit 
PA3918 moaC 4.39 4.47 molybdopterin biosynthetic protein C 
PA3922  -3.89  conserved hypothetical protein 
PA3940   -2.61 probable DNA binding protein 
PA3945  -2.98  conserved hypothetical protein 
PA3957   4.42 probable short-chain dehydrogenase 
PA3966  2.84 -2.67 hypothetical protein 
PA3967   -6.13 hypothetical protein 
PA3974 ladS  2.41  Lost Adherence Sensor, LadS 
PA3979  2.83  hypothetical protein 
PA3982  2.25  conserved hypothetical protein 
PA3986   59.52 hypothetical protein 
PA4002 rodA 2.23  rod shape-determining protein 
PA4007 proA 2.92  gamma-glutamyl phosphate reductase 
PA4012   3.96 hypothetical protein 
PA4021   3.20 probable transcriptional regulator 
PA4026   2.68 probable acetyltransferase 
PA4029 dedA  3.02 2.49 conserved hypothetical protein 
PA4031 ppa 4.27  inorganic pyrophosphatase 
PA4034 aqpZ 6.87 5.59 aquaporin Z 
PA4044 dxs 3.39  1-deoxyxylulose-5-phosphate synthase 
PA4045 btuF 2.22  conserved hypothetical protein 
PA4046  4.45  hypothetical protein 
PA4051 thiL 2.50  thiamine monophosphate kinase 
PA4067 oprG  -2.72 Outer membrane protein OprG precursor 
PA4069  2.45  hypothetical protein 
PA4079  -2.37  probable dehydrogenase 
PA4090  4.92 9.29 hypothetical protein 
PA4112  -2.44  probable sensor/response regulator hybrid 
PA4129  -2.90 -3.58 hypothetical protein 
PA4130   -3.05 probable sulfite or nitrite reductase 
PA4131   -5.74 probable iron-sulfur protein 
PA4132   -5.18 conserved hypothetical protein 
PA4133 ccoN -4.43 -10.55 cytochrome c oxidase subunit (cbb3-type) 
PA4134  -4.75 -18.67 hypothetical protein 
PA4135   -2.79 probable transcriptional regulator 
PA4139  -35.52 -284.87 hypothetical protein 
PA4140   -8.17 hypothetical protein 
PA4141   -5.68 hypothetical protein 
PA4142   -10.00 probable secretion protein 
Appendix 
 
192 
 
PA4147 acoR 7.01 10.16 transcriptional regulator AcoR 
PA4175 piv  2.76 protease IV 
PA4176 ppiC2 2.22 3.13 peptidyl-prolyl cis-trans isomerase C2 
PA4218  -3.28  probable transporter 
PA4219 yfpB  -6.77  hypothetical protein 
PA4220 fptB  -4.16 4.81 hypothetical protein 
PA4221 fptA -2.94  Fe(III)-pyochelin outer membrane receptor precursor 
PA4222 pchI  -3.89  probable ATP-binding component of ABC transporter 
PA4223 pchH  -6.02  probable ATP-binding component of ABC transporter 
PA4224 pchG -8.90  pyochelin biosynthetic protein PchG 
PA4225 pchF -4.53  pyochelin synthetase 
PA4226 pchE -5.13  dihydroaeruginoic acid synthetase 
PA4227 pchR -3.47  transcriptional regulator PchR 
PA4228 pchD -6.21  pyochelin biosynthesis protein PchD 
PA4229 pchC -8.75  pyochelin biosynthetic protein PchC 
PA4230 pchB -2.63  salicylate biosynthesis protein PchB 
PA4231 pchA -9.31  salicylate biosynthesis isochorismate synthase 
PA4237 rplQ  -3.91 50S ribosomal protein L17 
PA4239 rpsD  -2.53 30S ribosomal protein S4 
PA4240 rpsK 2.73 -2.45 30S ribosomal protein S11 
PA4241 rpsM 4.15  30S ribosomal protein S13 
PA4245 rpmD 2.45  50S ribosomal protein L30 
PA4247 rplR  -3.46 50S ribosomal protein L18 
PA4248 rplF 4.52  50S ribosomal protein L6 
PA4250 rpsN 2.70  30S ribosomal protein S14 
PA4252 rplX  -3.53 50S ribosomal protein L24 
PA4253 rplN  -3.05 50S ribosomal protein L14 
PA4254 rpsQ  -3.42 30S ribosomal protein S17 
PA4261 rplW  -2.75 50S ribosomal protein L23 
PA4262 rplD 3.21  50S ribosomal protein L4 
PA4263 rplC 3.02  50S ribosomal protein L3 
PA4264 rpsJ 5.85  30S ribosomal protein S10 
PA4265 tufA 2.54  elongation factor Tu 
PA4268 rpsL 2.45  30S ribosomal protein S12 
PA4270 rpoB 2.50  DNA-directed RNA polymerase beta chain 
PA4271 rplL  -2.95 50S ribosomal protein L7 / L12 
PA4272 rplJ 4.65  50S ribosomal protein L10 
PA4273 rplA 3.41  50S ribosomal protein L1 
PA4274 rplK 5.93  50S ribosomal protein L11 
PA4275 nusG 10.56  transcription antitermination protein NusG 
PA4276 secE 9.32  secretion protein SecE 
PA4290  -3.34  probable chemotaxis transducer 
PA4292  2.23  probable phosphate transporter 
PA4293 pprA  6.91 two-component sensor PprA 
PA4294   18.28 hypothetical protein 
PA4296 pprB  7.11 two-component response regulator, PprB 
PA4297 tadG -10.49  TadG 
PA4298  -10.92  hypothetical protein 
PA4299 tadD -5.04  TadD 
PA4300 tadC -5.81 2.29 TadC 
PA4301 tadB -4.48  TadB 
PA4302 tadA -17.19  TadA ATPase 
PA4303 tadZ -8.11  TadZ 
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PA4304 rcpA -19.23  RcpA 
PA4305 rcpC -4.80 6.54 RcpC 
PA4306 flp  33.22 Type IVb pilin, Flp 
PA4312  -3.61  conserved hypothetical protein 
PA4317   -3.49 hypothetical protein 
PA4318   -2.98 hypothetical protein 
PA4319   -2.66 conserved hypothetical protein 
PA4326  2.73 7.50 hypothetical protein 
PA4328  -2.55  hypothetical protein 
PA4348   -2.31 conserved hypothetical protein 
PA4352   4.30 conserved hypothetical protein 
PA4362  -2.79  hypothetical protein 
PA4377  -4.10  hypothetical protein 
PA4379   2.95 conserved hypothetical protein 
PA4385 groEL  -2.64 GroEL protein 
PA4386 groES -2.78 -2.89 GroES protein 
PA4405   -5.16 hypothetical protein 
PA4407 ftsZ -7.57 -2.81 cell division protein FtsZ 
PA4408 ftsA -4.12  cell division protein FtsA 
PA4409 ftsQ -3.13 -2.77 cell division protein FtsQ 
PA4410 ddlB -3.09  D-alanine--D-alanine ligase 
PA4411 murC -3.98  UDP-N-acetylmuramate--alanine ligase 
PA4412 murG 
-2.47  
UDP-N-acetylglucosamine--N-acetylmuramyl-
(pentapeptide) pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
PA4413 ftsW -2.66  cell division protein FtsW 
PA4414 murD -4.05  UDP-N-acetylmuramoylalanine--D-glutamate ligase 
PA4415 mraY -4.64 -4.62 phospho-N-acetylmuramoyl-pentapeptide-transferase 
PA4416 murF -2.57  UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-
diaminopimelate--D-alanyl-D-alanyl ligase 
PA4417 murE -3.16  UDP-N-acetylmuramoylalanyl-D-glutamate-2, 6-
diaminopimelate ligase 
PA4418 ftsI -2.80  penicillin-binding protein 3 
PA4419 ftsL -7.62 -2.73 cell division protein FtsL 
PA4420 ylxA -4.17  conserved hypothetical protein 
PA4421 yabB  -3.82  conserved hypothetical protein 
PA4426 yraP -2.71 -8.66 conserved hypothetical protein 
PA4427 sspB  -3.04 stringent starvation protein B 
PA4428 sspA  -5.23 stringent starvation protein A 
PA4429   -3.88 probable cytochrome c1 precursor 
PA4430   -8.23 probable cytochrome b 
PA4431   -4.98 probable iron-sulfur protein 
PA4432 rpsI 3.82 -3.15 30S ribosomal protein S9 
PA4433 rplM 2.99 -4.06 50S ribosomal protein L13 
PA4442 cysN 2.27 3.27 ATP sulfurylase GTP-binding subunit/APS kinase 
PA4443 cysD 3.94 3.64 ATP sulfurylase small subunit 
PA4451 yrbA  2.61  conserved hypothetical protein 
PA4452  -4.03  conserved hypothetical protein 
PA4458 yrbI   -3.27 conserved hypothetical protein 
PA4459 yrbK   -4.34 conserved hypothetical protein 
PA4460 yhbN   -2.54 conserved hypothetical protein 
PA4461 yhbG   -2.50 probable ATP-binding component of ABC transporter 
PA4463 yhbH   2.73 conserved hypothetical protein 
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PA4467   5.13 hypothetical protein 
PA4468 sodM -1.28 3.72 superoxide dismutase 
PA4469  -1.88 2.89 hypothetical protein 
PA4470 fumC1  5.58 fumarate hydratase 
PA4474 tldD  -2.61  conserved hypothetical protein 
PA4479 mreD 2.88 -2.46 rod shape-determining protein MreD 
PA4480 mreC  -3.22 rod shape-determining protein MreC 
PA4481 mreB  -3.33 rod shape-determining protein MreB 
PA4482 gatC 3.58  Glu-tRNA(Gln) amidotransferase subunit C 
PA4494   -5.12 probable two-component sensor 
PA4507  -5.10  hypothetical protein 
PA4523   5.68 hypothetical protein 
PA4528 pilD  -4.21 type 4 prepilin peptidase PilD 
PA4530   -2.81 conserved hypothetical protein 
PA4542 clpB -3.47 -3.76 ClpB protein 
PA4544 rluD 2.75  pseudouridine synthase 
PA4545 comL  -3.28 competence protein ComL 
PA4550 fimU 4.31  type 4 fimbrial biogenesis protein FimU 
PA4551 pilV 2.55  type 4 fimbrial biogenesis protein PilV 
PA4556 pilE 2.25  type 4 fimbrial biogenesis protein PilE 
PA4563 rpsT 16.23 -3.53 30S ribosomal protein S20 
PA4567 rpmA 7.25  50S ribosomal protein L27 
PA4568 rplU 5.20  50S ribosomal protein L21 
PA4569 ispB  -2.55 octaprenyl-diphosphate synthase 
PA4570   5.87 hypothetical protein 
PA4572 fklB -3.02 3.71 peptidyl-prolyl cis-trans isomerase FklB 
PA4573   11.24 hypothetical protein 
PA4575   6.22 hypothetical protein 
PA4578   -2.62 hypothetical protein 
PA4587 ccpR  -2.87 cytochrome c551 peroxidase precursor 
PA4590 pra -3.04  protein activator 
PA4602 glyA3 6.77  serine hydroxymethyltransferase 
PA4607  -6.13  hypothetical protein 
PA4608   11.53 hypothetical protein 
PA4611   3.74 hypothetical protein 
PA4614 mscL -2.90  conductance mechanosensitive channel 
PA4625   -7.49 hypothetical protein 
PA4630  2.95 3.42 hypothetical protein 
PA4633   2.62 probable chemotaxis transducer 
PA4637  11.93 9.48 hypothetical protein 
PA4638   -3.00 hypothetical protein 
PA4640 mqoB  -3.07 malate:quinone oxidoreductase 
PA4641  -3.69  still frameshift hypothetical protein 
PA4648  -25.98  hypothetical protein 
PA4651  -3.01  probable pili assembly chaperone 
PA4657   3.04 hypothetical protein 
PA4661 pagL -4.21  Lipid A 3-O-deacylase 
PA4666 hemA 2.48  glutamyl-tRNA reductase 
PA4667  2.75  hypothetical protein 
PA4670 prs 6.05 -3.68 ribose-phosphate pyrophosphokinase 
PA4671 rplY  4.41  probable ribosomal protein L25 
PA4672 pth  3.30 -3.74 peptidyl-tRNA hydrolase 
PA4673 ychF  3.27  conserved hypothetical protein 
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PA4678 rimI  -2.63 peptide n-acetyltransferase RimI 
PA4701   2.30 conserved hypothetical protein 
PA4702   5.88 hypothetical protein 
PA4703  -2.68  hypothetical protein 
PA4713   3.66 hypothetical protein 
PA4717   4.50 conserved hypothetical protein 
PA4726 cbrB 3.72 6.66 two-component response regulator CbrB 
PA4733 acsB -2.49  acetyl-coenzyme A synthetase 
PA4735  -2.74  hypothetical protein 
PA4736  -3.07  hypothetical protein 
PA4737  -2.90  hypothetical protein 
PA4740 pnp 2.36  polyribonucleotide nucleotidyltransferase 
PA4741 rpsO 2.73  30S ribosomal protein S15 
PA4742 truB 2.86  tRNA pseudouridine 55 synthase 
PA4743 rbfA  -5.30 ribosome-binding factor A 
PA4745 nusA 3.83  N utilization substance protein A 
PA4746 yhbC  7.78 -2.52 conserved hypothetical protein 
PA4747 secG 3.29  secretion protein SecG 
PA4748 tpiA 6.20  triosephosphate isomerase 
PA4750 folP 3.14  dihydropteroate synthase 
PA4751 ftsH  2.34 cell division protein FtsH 
PA4753 yhbY  4.59  conserved hypothetical protein 
PA4754  2.57  hypothetical protein 
PA4756 carB 2.50  carbamoylphosphate synthetase large subunit 
PA4757 yeaS  3.62  conserved hypothetical protein 
PA4758 carA 2.57  carbamoyl-phosphate synthase small chain 
PA4759 dapB  -3.95 dihydrodipicolinate reductase 
PA4765 omlA  -3.19 Outer membrane lipoprotein OmlA precursor 
PA4766 yfjF  -2.83  conserved hypothetical protein 
PA4767 yfjG  -2.86  conserved hypothetical protein 
PA4768 smpB  -2.65 SmpB protein 
PA4780   3.61 conserved hypothetical protein 
PA4781   5.91 probable two-component response regulator 
PA4782  -2.45  hypothetical protein 
PA4787  -3.20  probable transcriptional regulator 
PA4793   2.85 hypothetical protein 
PA4811 fdnH -4.02  nitrate-inducible formate dehydrogenase, beta subunit 
PA4833  -2.21 2.63 conserved hypothetical protein 
PA4841  -2.45  conserved hypothetical protein 
PA4842  -3.00  hypothetical protein 
PA4846 aroQ1 3.26  3-dehydroquinate dehydratase 
PA4852 yhdG  4.59  conserved hypothetical protein 
PA4853 fis  -2.87 DNA-binding protein Fis 
PA4859  2.32 2.43 probable permease of ABC transporter 
PA4870 ybiI  5.86 15.95 conserved hypothetical protein 
PA4874 psiF   2.53 conserved hypothetical protein 
PA4876 osmE  3.18 osmotically inducible lipoprotein OsmE 
PA4880  -5.13 -4.56 probable bacterioferritin 
PA4881  11.55 14.99 hypothetical protein 
PA4907 ydfG  3.27 2.63 probable short-chain dehydrogenase 
PA4913 
  
2.46 probable binding protein component of ABC 
transporter 
PA4915  -4.04  probable chemotaxis transducer 
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PA4922 azu  -2.70 azurin precursor 
PA4925  -3.26  conserved hypothetical protein 
PA4929  -10.24  hypothetical protein 
PA4932 rplI 5.38  50S ribosomal protein L9 
PA4933  4.85  hypothetical protein 
PA4934 rpsR 4.35  30S ribosomal protein S18 
PA4935 rpsF 2.61 -2.56 30S ribosomal protein S6 
PA4939 hisX  4.46  conserved hypothetical protein 
PA4940 yjeT  3.53  conserved hypothetical protein 
PA4947 amiB -2.83  N-acetylmuramoyl-L-alanine amidase 
PA4962 ybcI   -2.85 conserved hypothetical protein 
PA4965   -2.48 hypothetical protein 
PA4971 aspP  4.57 adenosine diphosphate sugar pyrophosphatase 
PA4997 msbA 2.51  transport protein MsbA 
PA5000  -2.47  probable glycosyl transferase 
PA5028  2.40 2.54 conserved hypothetical protein 
PA5033   -3.24 hypothetical protein 
PA5040 pilQ -2.54 -3.81 Type 4 fimbrial biogenesis outer membrane protein 
PilQ precursor 
PA5041 pilP -2.34 -4.56 type 4 fimbrial biogenesis protein PilP 
PA5042 pilO  -2.96 type 4 fimbrial biogenesis protein PilO 
PA5043 pilN  -2.63 type 4 fimbrial biogenesis protein PilN 
PA5044 pilM  -2.61 type 4 fimbrial biogenesis protein PilM 
PA5045 ponA  -2.71 penicillin-binding protein 1A 
PA5047   2.38 hypothetical protein 
PA5048  4.09 3.17 probable nuclease 
PA5049 rpmE 14.73  50S ribosomal protein L31 
PA5053 hslV  -2.40 heat shock protein HslV 
PA5054 hslU  -4.68 heat shock protein HslU 
PA5055   -3.12 hypothetical protein 
PA5058 phaC2 -2.86  poly(3-hydroxyalkanoic acid) synthase 2 
PA5062   3.15 conserved hypothetical protein 
PA5097 hutT  -2.61  probable amino acid permease 
PA5101  -3.22  hypothetical protein 
PA5108  -2.37  hypothetical protein 
PA5116   2.48 probable transcriptional regulator 
PA5117 typA 3.98  regulatory protein TypA 
PA5129 grx 2.40  glutaredoxin 
PA5130 yibN   -2.38 conserved hypothetical protein 
PA5139   -4.21 hypothetical protein 
PA5148 yggX  -2.77  conserved hypothetical protein 
PA5150   3.92 probable short-chain dehydrogenase 
PA5164 rmlC -2.67  dTDP-4-dehydrorhamnose 3,5-epimerase 
PA5170 arcD  3.53 arginine/ornithine antiporter 
PA5171 arcA -3.36  arginine deiminase 
PA5172 arcB -6.56  ornithine carbamoyltransferase, catabolic 
PA5173 arcC -4.88  carbamate kinase 
PA5176 yrfE  2.65 3.22 conserved hypothetical protein 
PA5182   2.48 hypothetical protein 
PA5200 ompR  2.43 two-component response regulator OmpR 
PA5208  -5.33  conserved hypothetical protein 
PA5212   3.29 hypothetical protein 
PA5213 gcvP1 -4.88  glycine cleavage system protein P1 
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PA5231 yhiH   -2.74 probable ATP-binding/permease fusion ABC transporter 
PA5232 yhiI  -2.68  conserved hypothetical protein 
PA5236 ubiB   3.03 probable aromatic hydrocarbon reductase 
PA5239 rho 5.83  transcription termination factor Rho 
PA5240 trxA 3.80  thioredoxin 
PA5242 ppk -2.44 -3.39 polyphosphate kinase 
PA5244 yohD  2.22  conserved hypothetical protein 
PA5245 yhbL  -5.42  conserved hypothetical protein 
PA5249  3.67 3.08 hypothetical protein 
PA5253 algP  4.42 alginate regulatory protein AlgP 
PA5255 algQ  6.01 Alginate regulatory protein AlgQ 
PA5258 hemX   2.33 hypothetical protein 
PA5259 hemD  2.57 uroporphyrinogen-III synthetase 
PA5261 algR  6.06 alginate biosynthesis regulatory protein AlgR 
PA5263 argH  -2.46 argininosuccinate lyase 
PA5271   2.53 hypothetical protein 
PA5274 rnk 2.99  nucleoside diphosphate kinase regulator 
PA5275 cyaY  2.78 9.15 conserved hypothetical protein 
PA5276 lppL 2.22  Lipopeptide LppL precursor 
PA5287 amtB 4.44 4.27 ammonium transporter AmtB 
PA5288 glnK  5.53 nitrogen regulatory protein P-II 2 
PA5295  2.51  hypothetical protein 
PA5298 xpt  6.75  xanthine phosphoribosyltransferase 
PA5302 dadX  -2.41 catabolic alanine racemase 
PA5303  -3.11 -4.65 conserved hypothetical protein 
PA5315 rpmG 10.78  50S ribosomal protein L33 
PA5316 rpmB 5.89  50S ribosomal protein L28 
PA5331 pyrE 4.12  orotate phosphoribosyltransferase 
PA5333   -2.48 conserved hypothetical protein 
PA5337 rpoZ 5.97 4.41 RNA polymerase omega subunit 
PA5338 spoT 2.94 
 
guanosine-3',5'-bis(diphosphate) 3'-
pyrophosphohydrolase 
PA5340  3.66  hypothetical protein 
PA5346 sadB  2.80 SadB 
PA5348  -3.29 2.67 probable DNA-binding protein 
PA5359  -2.59 2.56 hypothetical protein 
PA5366 pstB  -4.34 ATP-binding component of ABC phosphate transporter 
PA5367 pstA 
 
-2.99 membrane protein component of ABC phosphate 
transporter 
PA5373 betB 2.37  betaine aldehyde dehydrogenase 
PA5374 betI 13.48 3.45 transcriptional regulator BetI 
PA5380 gbdR  6.30 GbdR 
PA5383 yeiH  6.44 7.63 conserved hypothetical protein 
PA5408   3.57 hypothetical protein 
PA5409   3.68 hypothetical protein 
PA5424 yeaQ   2.49 conserved hypothetical protein 
PA5435 oadA   -3.78 probable transcarboxylase subunit 
PA5438   2.63 probable transcriptional regulator 
PA5446  4.25  hypothetical protein 
PA5460  10.48 24.15 hypothetical protein 
PA5468  3.62 3.84 probable citrate transporter 
PA5479 gltP  -5.25 proton-glutamate symporter 
PA5481   3.69 hypothetical protein 
Appendix 
 
198 
 
PA5482   5.68 hypothetical protein 
PA5490 cc4  -5.85 cytochrome c4 precursor 
PA5494   3.43 hypothetical protein 
PA5504  4.80  probable permease of ABC transporter 
PA5505   -3.63 probable TonB-dependent receptor 
PA5527   12.39 hypothetical protein 
PA5528   3.08 hypothetical protein 
PA5531 tonB  4.56 TonB protein 
PA5543  -3.14  hypothetical protein 
PA5546  -3.35  conserved hypothetical protein 
PA5553 atpC  -7.97 ATP synthase epsilon chain 
PA5554 atpD  -3.60 ATP synthase beta chain 
PA5555 atpG  -6.51 ATP synthase gamma chain 
PA5556 atpA  -3.86 ATP synthase alpha chain 
PA5557 atpH  -3.87 ATP synthase delta chain 
PA5558 atpF  -5.16 ATP synthase B chain 
PA5559 atpE -3.08 -5.31 atp synthase C chain 
PA5560 atpB  -7.12 ATP synthase A chain 
PA5568 yidC  2.58 -3.96 conserved hypothetical protein 
AF035937cds10 wbpT 
 
-3.27 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds11 wbpU 
 
-2.44 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds3 wzz 
 
-2.68 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds4 wbpO 
 
-4.26 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds7 wzx 
 
-2.62 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds8 wbpR 
 
-3.14 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF035937cds9 wbpS 
 
-3.12 P. aeruginosa IATS gene cluster for O-antigen 
biosynthesis 
AF043558cds   -1.54 P. aeruginosa beta-lactamase OXA-13-1  
L81176cds4 fliS  2.47 P. aeruginosa flagellin  
M21652cds  8.97 4.05 P. aeruginosa P1 type IV pilin precursor 
Pae_tRNA_Asn  1.82  tRNA_Asparagine 
Pae_tRNA_Gln  2.35  tRNA_Glutamine 
Pae_tRNA_Gly  2.83  tRNA_Glycine 
Pae_tRNA_His  2.83  tRNA_Histidine 
Pae_tRNA_Ile  3.26  tRNA_Isoleucine 
Pae_tRNA_Leu  4.17  tRNA_Leucine 
Pae_tRNA_Lys  4.94  tRNA_Lysine 
Pae_tRNA_Phe  5.25  tRNA_Phenylalanine 
Pae_tRNA_Pro  5.61  tRNA_Proline 
Pae_tRNA_Ser  8.24  tRNA_Serine 
Pae_tRNA_Trp  9.19  tRNA_Tryptophan 
Pae_tRNA_Tyr  9.96 2.57 tRNA_Tyrosine 
Pae_tRNA_Val   18.38 tRNA_Valine  
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Figure 8-1: OD, Relative Fluorescence Units (RFU) and RFU/OD. Monitor strain PAO1 harbouring the lasB-
gfp(ASV) fusion. Concentration of protoanemonin: ▲ 174 μM, × 86 μM, ▲ 43 μM, ● 22 µM, ▲11 μM, ♦ 5 
µM, ▲ Reference, no compound added. Experiment performed by Mette Elena Skindersoe at the DTU 
Biocetrum, Denmark. 
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Tobie. Poradziłem sobie z doktoratem, dzięki Tobie. Mógłbym tak wymieniać długo. 
Dziękuję Ci z całego serca za pomoc i cierpliwość niejednokrotnie wystawianą na ciężką 
próbę. Wszystko co robię ma sens tylko kiedy Ty jesteś obok. Kocham Cię. 
